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Preface
The main task of the Nordic Expert Group for Criteria Documentation of Health
Risks from Chemicals (NEG) is to produce criteria documents to be used by the
regulatory authorities as the scientific basis for setting occupational exposure
limits for chemical substances.
For each document NEG appoints one or several authors. Evaluation is made
of all relevant published, peer-reviewed original literature found. The document
aims at establishing dose-response/dose-effect relationships and defining a critical
effect. No numerical values for occupational exposure limits are proposed.
Whereas NEG adopts the document by consensus procedures, thereby granting
the quality and conclusions, the author is responsible for the factual content of the
document.
The evaluation of the literature and the drafting of this document on Fungal
spores were made by Dr Wijnand Eduard, National Institute of Occupational
Health, Norway. The draft document was discussed within the group and the final
version was accepted by NEG October 10, 2006. The following individuals
participated in the elaboration of the document:
Gunnar Johanson, Institute of Environmental Medicine, Karolinska Institutet and National
Institute for Working Life, Sweden (chairman)
Maria Albin, Department of Occupational and Environmental Medicine, University Hospital,
Lund, Sweden (NEG expert)
Karin Sørig Hougaard, National Institute of Occupational Health, Denmark (NEG expert)
Kristina Kjærheim, Cancer Registry, Norway (NEG expert)
Vidir Kristjansson, Administration of Occupational Safety and Health, Iceland (former NEG
expert)
Kai Savolainen, Finnish Institute of Occupational Health, Finland (former NEG expert)
Vidar Skaug, National Institute of Occupational Health, Norway (NEG expert)
Jill Järnberg and Anna-Karin Alexandrie, National Institute for Working Life, Sweden (NEG
secretariat)
We are grateful to Aino Nevalainen, National Public Health Institute, Finland,
for valuable comments on the draft document. Editorial work and technical
editing were performed by the NEG secretariat. This work was financially
supported by the Swedish National Institute for Working Life, the Norwegian
Ministry of Labour and Social Inclusion and the Nordic Council of Ministers.
All criteria document produced by the Nordic Expert Group may be down-
loaded from www.nordicexpertgroup.org.
Gunnar Johanson, Chairman of NEG
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11. Introduction
Fungi are heterophilic organisms, i.e. dependent on dead or living organisms for
their growth. They can quickly colonise all kinds of dead organic material and are
together with bacteria the most important organisms that recycle organic material.
Fungi are ubiquitous and have been estimated to comprise approximately 25% of
the global biomass (138, 224).
Fungi replicate by formation of sexual and asexual spores. Many species pro-
duce spores, which are easily dispersed into the air and can be transported over
long distances, even across the globe; for an overview see Shinn et al (222). We
therefore inhale substantial numbers of fungal spores from outdoor and indoor air.
Exposure levels are highly variable because fungi can rapidly multiply when
conditions for growth are favourable, and some species release their spores on
specific times of the day. Actinomycetes are a group of bacteria that resemble the
fungi in growth and replication, and may also be present in indoor and outdoor air.
Spores of fungi and actinomycetes have been recognised as occupational ha-
zards; reviews by Lacey and Crook, and Malmberg (116, 128). In 1950-1980
several species were identified as causes of hypersensitivity pneumonitis (also
called allergic alveolitis) in a number of occupations including farmers, malt
workers and wood workers. Exposure levels in these occupations regularly exceed
106 spores/m3 and can be as high as 1010 spores/m3. These levels are much higher
than levels usually found outdoors, which seldom exceed 104 spores/m3. Fungal
spore exposure has also been associated with indoor air problems, especially in
damp buildings. Airborne concentrations in such environments may be higher
than outdoors, but levels rarely exceed 104 colony forming units/m3 (cfu/m3),
which correspond to approximately 105 spores/m3; review by Levetin (122).
Fungal spores are complex agents that may contain multiple hazardous com-
ponents. Health hazards may differ across species because fungi may produce
different allergens and mycotoxins, and some species can infect humans.
1.1 Delimitations
Delimitations of this document are needed due to the complexity of the subject.
Infectious diseases will not be addressed. Also genetically altered fungi are
omitted since limited information is available on occupational health risks.
β(1→3)-Glucans, which have been studied as fungal agents (review by Douwes
(42)), are also excluded because they are not specific to fungi but can also be
found in plants and bacteria. Mycotoxins have been subject for review elsewhere
(27, 96) since they are of great concern in the public health sector from the per-
spective of oral intake of contaminated food. However, mycotoxins present in
spores will be considered as their presence increases the toxicity of the spores.
The actinomycetes are included because they have similar effects on health as
fungal spores and may represent important health risks to working populations.
Terms as used in this document are presented in Appendix 1.
22. Species characterisation
The fungi comprise a large group of organisms including mushrooms, moulds,
and yeasts. The fungi are placed in the kingdom Mycota, and most fungi relevant
to human health belong to the division Amastigomycota. Fungi are traditionally
identified by morphological characteristics of colonies and reproductive structures
including spores, and conditions for growth in culture. These characteristics are
compared to the characteristics of type species described in the literature and
stored in type collections. The use of molecular biological methods is rapidly
increasing, however. Important genera in occupational environments are shown
in Table 3.
Many species have been described in the literature under different names, and
have later been recognised as the same species. Appendix 2 aims at identifying
species described in older publications cited in this review. The most recent names
have been used in this document.
3. Biological and physical properties
General references to this topic are Gregory (70), Al-Doory and Domson (5),
Burge (22) and Green (64).
3.1 Fungi
Fungi are eukaryotic organisms that lack chlorophyll and depend on other or-
ganisms for their supply of nutrients. Most fungi are saprophytic, i.e. live on dead
organic material. Fungi play an important role in the ecosystem in the recycling
of nutrients. However, as fungi can exploit all organic materials, they may also
damage food, wood and textiles as well as building materials in buildings with
humidity problems. Fungi may even invade living organisms and infect plants,
animals, and humans. Plant pathogenic fungi are of major concern for farmers as
they cause significant damage to crops.
Filamentous fungi (moulds and mushrooms) grow as branched multicellular
filamentous structures (hyphae) that collectively form the mycelium. Fungi need
organic material, oxygen, and water for growth. As oxygen and organic material
are readily available in most environments, access to water is usually the limiting
factor. A water content above 12-15% in materials such as grain and wood is
usually sufficient to sustain fungal growth, but some fungi can even grow in
materials with lower water content if the humidity of the air is high, e.g. above
85% relative humidity.
Temperature has a major influence on the growth of microorganisms. Most
fungal and actinomycete species are mesophilic and show optimal growth at
15-30 °C. Psychrophilic and psychrotolerant species grow at lower temperatures,
e. g. Cladosporium herbarum can grow at temperatures down to -5 °C. Thermo-
philic species have growth optima above 30 °C. Fungi may also grow outside the
3optimal temperature range. However, higher temperatures may kill organisms
while lower temperatures are less lethal. Aspergillus fumigatus is the most
important opportunistic infectious agent with a growth optimum close to the
human body temperature. pH conditions for growth are often broad with optima
around pH 6, but few fungi grow below pH 3 or above pH 9.
3.2 The compost reaction
When organic material with sufficient water content is stored for a long time,
psychrophilic or mesophilic organisms may start to grow. The metabolic activity
produces heat, which may raise the temperature in the stored material and mo-
dulate fungal growth depending on the growth optima of the microorganisms
present. Proliferation of thermophilic species may raise the temperature even
further. The maximum temperature that stored material may reach mainly de-
pends on the original water content (116). The material may eventually catch fire
due to ignition of volatile organic compounds produced by the microorganisms
(MVOCs). When nutrients are depleted, microbial growth slows down and
temperature declines again. Water content, storage temperature and storage time
are therefore important determinants of the level and the complexity of the
microbial contamination in organic materials.
3.3 Spores
Fungi that are adapted to aerial dispersion replicate by non-motile sexual and
asexual spores. Fruiting bodies may grow from the mycelium of a single organism
and produce asexual spores (Figure 1). Sexual reproduction involves fusion of the
mycelia of two different mating strains and subsequent development of sexual
spores. Yeasts grow as single cells and replicate by budding under wet conditions
and do not become easily airborne. However, some yeast species have both
cellular and mycelial growth and may produce airborne spores dependent on
environmental conditions.
Figure 1. Fungal colonisation of grass seeds. The micrographs show mycelium, spores,
and fruiting bodies from an Aspergillus (a) and a Penicillium species (b). Micrographs by
Lene Madsø.
4Both sexual and asexual spores are resting, metabolically inactive units
surrounded by a thick wall that protects the organism from the environment.
Spores can tolerate extreme physical conditions and may survive until conditions
become favourable for growth. Many species liberate their spores into the air.
As spores often have a small size they can stay airborne for long periods and be
transported over large distances. Thus, spore formation is important for survival,
and replication, as well as dispersion of the fungus.
Spore sizes range typically from 2 to 10 µm between species and vary even
between spores from the same species. The physical diameter of spherical and
smooth spores is probably similar to their aerodynamic diameter (AED), but
spores with elongated shape and/or surface ornamentation have smaller AEDs
than the diameter of a sphere with the same volume as the spore because of larger
drag forces in air. It should be noted that airborne spores may have a smaller size
than quoted in manuals since the size of hydrated spores observed with the light
microscope is usually reported, whereas spores rapidly desiccate when dispersed
in air. The specific gravity may have some influence on the AED as well since the
density of spores varies from 0.4 to 1.5 g/cm3. The AED of airborne spores is also
dependent on humidity.  The size of spores from five species did not change at a
relative humidity ranging from 30% to 90%, but the AED increased by 11 to 27%
at 100% relative humidity (194).  This may have some effect on the deposition of
inhaled spores in the airways (Chapter 7.1), but it is not known how rapid fungal
spores absorb water vapour as many spore types are hydrophobic.
Spores may be released aggregated as chains or clumps that are expected to
have larger AEDs than single spores. Figure 2 shows some examples of spores
and aggregates. The increase of the AED with aggregate size was relatively small,
however (191). AEDs of fungal spores measured in the laboratory are shown in
Table 1.
Figure 2. Fungal spores and aggregates with different morphology collected from
sawmill, farm, and common indoor environments. Single spores (a, b and c), small
aggregates (e and f) and large aggregates (d and g) are shown. Micrographs by
Wijnand Eduard.
5Table 1. Aerodynamic diameter (AED) of single and aggregated spores from fungi and
actinomycetes released from culture plates.
Species AEDa (µm) Reference
Fungi
Aspergillus fumigatus 2.0-2.7
1.9-2.2
2.1-2.2
(172)
(126)
(194)
Cladosporium cladosporoides 2.3-2.5
1.7-1.9
(126)
(194)
Penicillium brevicompactum 2.0-2.2
2.1-2.4
(194)
(193)
Penicillium chrysogenum 2.6-3.0 (126)
Penicillium melinii 2.7-2.8 (194)
Stachybotrys chartarum 4.5 (225)
Actinomycetes
Micromonospora halophytica 1.3 (195)
Streptomyces albus 0.9-1.9
0.85
(193)
(195)
Thermoactinomyces vulgaris 0.57 (195)
a Geometric mean.
Spores from some genera such as Fusarium and Stachybotrys are produced in
slimy aggregates, which are dispersed outdoors by raindrops (splash dispersal).
The sticky spores may adhere and infect nearby plants or fall to the ground.
Spores from these species can also be found airborne, however. The release of
spores from the plant material probably occurs by mechanical friction during
harvest and further handling of grain.
Most airborne fungal particles are single or aggregated spores whereas hyphal
fragments have only occasionally been reported. However, recent experimental
studies have demonstrated that spores as well as fungal fragments smaller than
spores can be released from fungal cultures by an air stream. This has been shown
for several species, e.g. Aspergillus versicolor, Cladosporium cladosporoides,
Penicillium melinii, Streptomyces albus, Trichoderma harzianum and Ulocladium
sp., but not Penicillium chrysogenum (61, 62, 107, 108, 127). Previously Sorenson
et al reported the liberation of hyphal fragments from cultures of Stachybotrys
chartarum (225). The fungal origin is supported by the presence of antigens in the
particle size fraction that only contained fragments (62), and by the staining of
fragments with a DNA/RNA fluorochrome (127). Recent environmental and
occupational studies indicate that the presence of hyphae may have been over-
looked (66, 72).
63.4 Composition of the fungal cell wall
Mycelial fungal and yeast cell walls are relatively thin, typically 0.2 µm
(Figure 3). The main constituents vary in composition between fungi of different
taxa. The cell wall is made up of a matrix containing β(1→3)-, α(1→3)- and
β(1→6)-glucans, glycoproteins and lipids reinforced by chitin (polyacetyl glucose-
amine) or cellulose fibres. Pigments like melanin may also be present. The lipid
constituent ergosterol is commonly present and is used as a chemical marker for
fungal mass (Chapter 5.1.4). The fungal cell wall has an outer layer mainly con-
sisting of glycoproteins that determine the antigenic properties of the cell. The
cell wall has also been shown to contain high levels of fungal allergens (18). The
secretion of hydrophobins (small, hydrophobic proteins) from growing hyphae
has recently been described. The hydrophobins coats the outer surface of aerial
hyphae and spores. The hydrophobin coating allows hyphae to attach to hydro-
phobic surfaces and hosts, and play an important role in fungal infections; review
by Wessels (244). The hydrophobins have also been shown to be allergenic (242).
Pathogenic species may have an extracellular mucous layer on the cell surface that
contains adhesins, molecules that allows the fungus to adhere to the host/substrate,
and enzymes that may help to invade the host or liberate nutrients. Spores have
much thicker cell walls than mycelia (Figure 3). The outer layer is hydrophobic
and contains lipids and proteins. The inner cell wall is similar to the mycelial wall
and consists of a β(1→3)-glucan matrix reinforced with chitin fibrils. The spore
wall may liberate antigens that may induce allergic responses after deposition in
the respiratory system (32, 143, 161). All these components are primary metabo-
lites as they are essential for the survival of the microorganisms.
Figure 3. Structure of the mycelial cell and spore walls of the button mushroom Agaricus
brunnescens (137, 188).
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73.5 Actinomycetes
The actinomycetes are Gram-positive bacteria that mimic the fungi as they
grow as branched cell chains and reproduce by production of asexual spores.
Spores from actinomycetes are smaller than fungal spores, typically 0.5-1.5 µm,
but otherwise have similar shape and surface characteristics. Most species are
mesophilic and are abundant in soil. They usually require higher water content for
growth than fungi. Thermophilic species such as Thermoactinomyces sp. and
Saccharopolyspora rectivirgula grow at higher temperatures than the fungi, up
to 60-65 °C, and may dominate the microbial biota in composting material at
temperatures exceeding approximately 50 °C.
3.6 Metabolites
Primary metabolites are constituents of microorganisms that are essential for
survival of the organism, such as the cell wall components (described in Chapter
3.4). Microorganisms may also produce secondary metabolites, which are com-
pounds that are not vital but may be beneficial to the organism, e.g. mycotoxins,
which are used in the competition with other organisms and, enzymes. MVOCs
are formed during both the primary and the secondary metabolism. The different
metabolites are briefly described below.
Mycotoxins are potent toxins that a number of fungi can produce and excrete
in the substrates they colonise. These toxins may also be present in spores from
toxigenic species (225). Mycotoxins have mainly been studied as contaminants
of food and feed; review by CAST (27). Especially aflatoxins produced by Asper-
gillus flavus and Aspergillus parasiticus have obtained much attention because
of their carcinogenic and toxic properties. Other important mycotoxins are the
trichothecenes produced by Fusarium and Stachybotrys species, fumonisins
and zearalenone produced by Fusarium species, and ochratoxin A produced
by Aspergillus ochraceus and Penicillium verrucosum. Many mycotoxins are
immunotoxic. However, the trichothecene mycotoxins are immunostimulating
at lower doses; review by Bondy and Pestka (15).
The production of mycotoxins strongly depends on growth conditions. A toxic
strain of Stachybotrys chartarum e.g. did not produce satratoxins when grown
on pine or on other materials at a relative humidity below 84% (158).
Some mycotoxins are antibiotics, i.e. they are highly toxic to bacteria, but
have low toxicity in humans. These antibiotics include penicillins produced by
Penicillium chrysogenum and cephalosporins produced by Cephalosporium
species. A review of penicillins was recently published by the Nordic Expert
Group for Criteria Documentation of Health Risks from Chemicals (NEG) (142).
Many fungal enzymes are glycopeptides with allergenic properties and fungi
may therefore represent a risk of allergic disease (113). Enzymes are present in
spores, and are released in greater amounts during germination of spores (65, 140)
and mycelial growth (94). Purified fungal enzymes such as α-amylase from
Aspergillus oryzae (90), cellulase, xylanase, phytase and α-amylase from
8Trichoderma reesei (239), and phytase from Aspergillus niger (41), have been
shown to be potent occupational allergens in the food industry.
Fungi may produce a variety of allergens. For example, an international
allergen nomenclatural committee has approved 17 different allergens from
Aspergillus fumigatus, 6 allergens from Alternaria alternata, and 10 allergens
from Cladosporium herbarum. A smaller number of allergens (1 to 3) have been
recognised in three Aspergillus and four Penicillium species (113).
A few fungal species are commonly recognised as aeroallergens. Species from
the genera Cladosporium, Alternaria, and Aspergillus are most often involved in
fungal allergy and have been studied in detail; reviews by Hoffman, and Kurup et
al (86, 113). These species are also most prevalent in outdoor air (115). Several
other species and genera have been related to asthma in asthmatic patients (113)
and in working populations, (review by Lacey and Crook (116)), but they are not
commonly included in allergy tests, probably because their occurrence in outdoor
air is low (115). It is therefore possible that other species than Cladosporium,
Alternaria, and Aspergillus spp. have been underestimated as causal agents of
fungal allergy.
Spores have mainly been studied as respiratory allergens as they have been
regarded as the most prevalent airborne fungal particles. This may be a simpli-
fication, as hyphae (Chapter 3.1) may not have been recognised. Furthermore,
fungi may excrete allergens that may be present in other particles as well (190).
The increased production of allergens in the germination phase suggests that
viable spores may be more allergenic than dead spores if germination occurs in
the respiratory tract (65, 140) and Sercombe et al recently demonstrated that
germinating spores in the nasal cavity of healthy subjects were common (216).
Górny et al showed in an experimental study that fungal fragments smaller than
spores were liberated from sporulating cultures, and that these fragments had high
antigenic activity (62).
Microorganisms produce a large number of MVOCs. These compounds include
alcohols, aldehydes, ketones, esters, terpenes, and sulphur and nitrogen compounds.
MVOCs are mainly regarded to be side-products of the primary metabolism during
synthesis of DNA and amino and fatty acids. However, the division between pri-
mary and secondary metabolism is not absolute and it is likely that MVOCs are
formed during both (111). The production of MVOCs strongly depends on the
substrate and environmental conditions and many compounds denoted MVOCs
may also originate from non-microbial sources. A separate criteria document on
MVOCs has been produced by NEG (111).
3.7 Summary
Fungal spores are very different from chemical agents as spores may contain
multiple components such as allergens, antigens, polysaccharides like the
β(1→3)-glucans, and mycotoxins. Many species produce spores that differ not
only with respect to composition but also morphology (size, shape and aggre-
gation), which may influence the deposition in the respiratory system. Fungi are
9living organisms that multiply rapidly under favourable conditions and may
colonise organic material when water is available in sufficient quantity. Many
fungi produce large numbers of spores that are adapted to aerial dispersion. High
exposure situations are therefore often related to handling of mouldy material.
Actinomycetes are Gram-positive bacteria for which the growth and sporulation
resemble that of filamentous fungi, but they have smaller spores. Recently de-
scribed phenomena are the liberation of small fragments from fungal colonies
and the presence of airborne hyphal fragments.
4. Occurrence, production and use
Fungi are found in practically all habitats. Fungi liberate spores into the air, and
spores can be transported over long distances by air currents because of their
small size. Fungal spores are therefore ubiquitous in outdoor air. Spores are also
present in indoor air as they enter the indoor environment with outdoor air. Indoor
fungal levels may increase further by culture of the organisms, by unintended
proliferation or by handling of mouldy materials.
Outdoor levels vary between regions and seasons over a range of < 20 to >105
cfu/m3; review by Gots et al (63). Outdoor levels are highest in warm regions and
in the summer and autumn in temperate regions, and lowest in the winter in sub-
arctic regions, e.g. <102 cfu/m3 or <103 spores/m3 in Finland; review by Pasanen
(171).
Fungal spores in outdoor air enter the indoor environment by natural and
mechanical ventilation but spore levels in common indoor environments are
usually lower since spores are removed by filtration and/or they settle due to
lower air velocities indoors. In spite of this, fungi in office buildings and houses
have frequently been studied as a health risk. Fungi may grow on many types of
building materials if the humidity of the air and/or in the materials is sufficient.
A typical cause of fungal growth is unattended water leakage. After the energy
crisis of the 1970s, buildings in temperate regions were built more tightly and
with higher thermal isolation to reduce energy costs. Lower air exchange rates and
inadequate construction methods repeatedly resulted in condensation of water and
microbial growth in the walls, floors, and roofs. Although the presence of fungi
can often be demonstrated in damp buildings, the levels of airborne fungi indoors
are mostly similar or only moderately elevated compared to outdoor levels, and
rarely exceed 104 cfu/m3. Measurements of airborne fungi may therefore fail to
detect indoor fungal growth. Specific quantitation of Penicillium, Aspergillus,
Stachybotrys chartarum and yeasts may improve such assessments as these fungi
are indicative of humidity problems while outdoor levels are often low; review by
Levetin (122). In subarctic climates, assessments of fungal growth in buildings are
preferably performed in the winter due to low outdoor levels (Chapter 5.3).
Although the assessment of mould problems by measurements of airborne fungi
is problematic, it is interesting that remediation of humidity problems in buildings
seems to reduce building-related health problems.
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Table 2. Working populations potentially exposed to fungal and actinomycete spores
(228-232).
Occupation Working population in thousands
Denmark
2005
Norway
2005
Sweden
2004
Finland
2005
Iceland
2005
Agriculture and forestry
Agriculture
Forestry
65
61
4
59
55
4
36
23
13
116 7
Food industry 72 44 63 nf nf
Wood industry 14 9 36 nf nf
Wood processing 7 4 40 nf nf
Furniture 19 nf 44 nf nf
Total working population 2 400 2 800 4 200 2 500 160
nf: not found.
Fungal spore levels can be much higher at workplaces where the presence of
fungi is related to production and the contribution from natural outdoor levels is
usually negligible. Fungi are used in the food industry, e.g. for production of dairy
products, alcoholic beverages, bread, and soy sauce, in the biotechnological in-
dustry for production of citric acid, antibiotics, and enzymes, and for composting
of plant debris and the organic fraction of domestic waste. Fungi can also be
produced as an end-product, e.g. baker’s yeast and mushrooms. Exposure levels
often exceed 106 spores/m3 and can be as high as 1010 spores/m3; reviews by Lacey
and Crook, and Malmberg (116, 128). The highest levels occur when fungi colo-
nise organic materials unintentionally. These conditions are usually avoided
because fungal contamination may lead to economical losses. Exposure levels
in general are therefore much lower. Consequently, exposure levels may show
high variability in industries such as agriculture and sawmills (Table 5-6).
The numbers of people employed in work environments with potential fungal
exposure in the Nordic countries are listed in Table 2. Important fungal and
actinomycete genera in these work environments are shown in Table 3.
5. Measurement methods and strategies for assessment of
workplace exposure
For reviews of bioaerosol measurement methods, see Eduard and Heederik (51)
and Douwes et al (44).
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Table 3. Fungal and actinomycete genera frequently found in work environments (116).
Genus Environments
Fungi
Alternaria Outdoors, fruit stores
Aspergillus Malt workers, tobacco workers, agriculture, mushroom growers,
citric acid production, organic waste, compost, common indoor air
Cladosporium Agriculture, outdoors
Penicillium Cheese workers, malt workers, cork workers, fruit stores, penicillin
production, sawmill workers, common indoor air
Rhizopus Sawmill workers, malt workers
Stachybotrys Common indoor air, damp buildings
Actinomycetes
Saccharopolyspora Agriculture, composting and compost handling
Thermoactinomyces Agriculture, bagasse workers, composting and compost handling
5.1 Measurement methods for airborne fungal and actinomycete spores
Spores can be collected by impaction on semi-solid nutrient plates or glass slides,
by impaction in liquid (impingers) or on filters. Most sampling instruments are
stationary except filters, which are well adapted for personal sampling. Samples
may be quantified by culture-based or non-culture methods.
5.1.1 Culture-based methods
Culture-based methods rely on growth of collected organisms into recognisable
colonies on semi-solid nutrient plates under standardised conditions. The results
are expressed as cfu. Different media and conditions for cultivation such as
temperature, time, and use of growth inhibitors are applied to culture different
groups of organisms. Culture methods have several important weaknesses. A
major limitation is that dead fungi and those that cannot grow under the conditions
chosen for culture remain undetected. Moreover, a colony may originate from a
single spore as well as a large aggregate. When spores are dispersed in a liquid,
e.g. impinger sampling and filter samples that are resuspended before analysis,
substantially higher numbers of cfu are detected than when spores are collected
and cultured directly on nutrient plates because aggregates break up when sus-
pended in a liquid. Sampling time is limited to 30 minutes for impactors and most
impingers. Impactors and filters expose microorganisms to sampling strain, which
may affect the viability of the collected organisms. This problem is probably less
pronounced for fungal spores than vegetative cells because in general spores
tolerate environmental stress better. To prevent overloading, the sampling time in
highly contaminated environments must be very short when impactors that collect
spores directly on nutrient plates are used. Finally, not only spores but also hyphal
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fragments may grow into colonies. Recent studies indicate that such fragments
may represent a significant proportion of airborne fungal particles (66, 72).
The lower detection limit of a count is four colonies1. The detection limit of
a concentration is obtained by division with the sampled volume of air. As an
example, the lower detection limits range from 4 to 150 cfu/m3 for a 400-hole
single stage impactor sampling at 28 l/min for 1 to 30 minutes. Impactors also
have an upper detection limit when colonies are detected beneath all holes. This
limit is approximately 4⋅104 cfu/m3 for 1 minute sampling with a 400-hole single
stage impactor at 28 l/min. Impactor and filter samples can be cultivated by
dilution plating, which increases both the lower and the upper detection limits
because only a fraction of the collected fungi are cultured.
5.1.2 Microscopic counting
Microscopic counting is the traditional non-culture method for quantification
of fungal spores. Most fungal spores have distinct morphology and are easily
recognised with light, fluorescence, and scanning electron microscopy (SEM)
(Figure 2). The SEM shows surface structure with most detail as this microscope
has the highest resolution. However, the light microscope may provide other
information as internal structure and colour can be observed. Least morphological
detail is obtained with the fluorescence microscope, but stained microorganisms
are more easily observed among other particles, and fungi may be stained specifi-
cally with antibody-fluorochrome conjugates. The latter technique is seldom
applied, however. Some classification is possible when spores are counted with
a microscope, but seldom at the species level.
The fluorescence microscope underestimated the number of spores by approxi-
mately 75% compared to the light and SEM in a Scandinavian interlaboratory
study (52).
The detection limit of microscopic counts is 4 counted spores1, and is further
dependent on the magnification, the size of the view field, number of counted
fields and the sampled volume of air. A typical detection limit is 2⋅104 spores/m3
when counting 50 fields at 2 000x with a SEM and a sampling time of 8 hours
at 2 l/min. Light and fluorescence microscope counts are usually performed at
lower magnification (approximately 1 000x) and view fields are typically larger,
which decreases the detection limit. Samples for counting by the fluorescence
microscope are usually resuspended and only a subsample is counted, which
increases the detection limit again.
5.1.3 The CAMNEA method
Combined analysis by microscopy and culture is possible with the so-called
CAMNEA method (collection of airborne microorganisms on nucleopore filters,
                                    
1 The smallest concentration or amount of a component of interest that can be detected by a single
measurement with a stated level of confidence. Results based on counting, such as colony
and microscopic counts, are approximately Poisson distributed. The Poisson distribution with
a mean of 4 contains values >0 in approximately 98% of the distribution. A value of 4 is
therefore commonly used as the detection limit.
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estimation and analysis). Bioaerosol samples are collected on smooth polycar-
bonate filters, resuspended in a liquid and subsamples of the suspension can be
analysed by different methods such as culture and fluorescence microscopy (168).
The detection limits are higher since the suspension is divided between the two
methods (Chapters 5.1.1 and 5.1.2).
5.1.4 Other non-culture methods
Other non-culture methods quantify fungal metabolites by chemical, biochemical,
immunochemical, and molecular biological methods. These metabolites can either
be non-toxic or active agents such as allergens and glucans.
The former category includes ergosterol, a lipid component that is commonly
found in fungi and algae but not in terrestrial plants (156). The ergosterol content
of spores and mycelium differs across species with a factor of 3-6 (10, 139),
however, making quantitative analysis difficult.
Similarly, β(1→3)-glucans have been measured as markers of fungi, using
biochemical and immunochemical methods. Although such glucans are found
in fungal mycelium and spores, some bacteria, algae and terrestrial plants may
contain glucans as well. The specificity of β(1→3)-glucans as markers of fungal
exposure thus depends on the presence of other glucan sources. However, glucans
from different sources have been shown to have inflammatory effects in animal
studies and should therefore be studied as specific agents in bioaerosols independ-
ent of their role as marker of fungal exposure (42).
Antigens can be used as more specific markers of fungi (3) although cross-
reactivity of antibodies with other species than the one used for antibody pro-
duction is a problem. For example, monoclonal antibodies against Penicillium
brevicompactum showed substantial cross-reactivity with other Penicillium as
well as Aspergillus species and even with species from other genera. In addition,
sample collection and preparation methods had a major influence on the results
(213). Similar results were reported for Aspergillus versicolor (214).
Molecular biological methods probably have the greatest potential for quanti-
fication of microbial exposure. However, these methods are at present most
developed for qualitative assessment of fungi (247, 249, 257). Quantitative
methods based on real-time polymerase chain reaction have recently been de-
scribed (8, 258). The specificity of these methods may complicate the assessment
of a diverse fungal biota, as many assays with different primers have to be applied.
Alternatively, less specific primers may allow the detection of broader groups of
organisms e.g. the genus Cladosporium (259). The unit of quantification is differ-
ent from microscopy and culture as the number of fungal genomes is quantified,
which includes DNA from spores and hyphae.
Fungal fragments with smaller particle size than spores have recently been
detected in laboratory studies using particle counters and SEM (62, 107). The
occurrence of such fragments in the environment has not been described,
however. Larger hyphal fragments can be detected by immunomicroscopy (66)
and have been detected in a residential environment (67).
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5.1.5 Discussion
Most measurement methods for microorganisms estimate different entities.
At present there is no general agreement on how fungal spore exposure should
be assessed. The demonstration of fungal particles other than spores further
complicates the assessment of fungal exposure, and their importance is not yet
clear.
Filter sampling is generally preferred since personal sampling is straightforward
and can be carried out according to criteria for health related size fractions (28).
Filter samples can be analysed by a variety of non-culture methods. In epidemio-
logical studies mainly culture-based and microscopic methods have been used and
both methods have shown exposure-response relationships in the majority of the
studies (review by Eduard (47)) with no clear difference between methods used
for quantification of fungal exposure.
However, culture-based methods suffer from several well-documented errors.
The cfu is at best a semi-quantitative measure. The main advantages of culture-
based methods are that microorganisms can be identified and that the detection
limit is lower than with microscopic methods, which is particularly important
in environments with common indoor exposure levels. The best measurement
strategy at present seems to be the combined use of culture-based methods
for identification of species and non-culture methods for quantification of the
exposure. By further development of quantitative molecular biological methods
more specific measurements of fungal spores with low detection limits may be
possible.
5.2 Specific IgG antibodies
Specific serum immunoglobulin (Ig)G antibodies to fungi may develop in humans
and animals after continued exposure to airborne fungal spores. These antibodies
have been studied as a marker of hypersensitivity pneumonitis but their presence
is primarily related to repeated exposures. Specific serum IgG is most useful as an
indicator of fungal exposure in the diagnosis of hypersensitivity pneumonitis
where documentation of exposure is required (174, 197, 205) (Chapter 9.1).
Although development of serum IgG is a biological response (Chapter 9) IgG
levels have been shown to be associated with exposure levels during the preceding
months. IgG in serum can be used as a marker of exposure in populations working
in highly contaminated environments. However, many species cross-react,
individual differences in the antibody response are large and the precision of
individual serum IgG antibody levels as an exposure estimate is relatively poor.
The precision can be improved if evaluations can be based on group mean levels
of similarly exposed individuals. Changes in exposure level can also be detected
with better precision from intra-individual IgG changes; review by Eduard (45). In
building-related illness, where exposure levels are usually low, the value of IgG is
very limited; review by Trout et al (237).
To sum up, serum IgG antibody levels may only provide semi-quantitative
information on fungal exposure and are difficult to interpret as exposure levels.
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However, IgG antibodies are fairly specific and serum levels reflect exposure
during the preceding months (45). IgG antibodies therefore indicate previous
exposure to fungi, which can be valuable in case studies where measurement data
are rarely available. IgG antibodies have been used in epidemiological studies in
the past but are now mainly used to document exposure in the diagnosis of
hypersensitivity pneumonitis.
5.3 Measurement strategies
Exposure assessment of fungal spores in highly contaminated work environments
is similar to that of chemical agents. Personal sampling is preferred. This is
straightforward for non-viable methods and even possible for some culture-based
methods. There is no general understanding of the relevant sampling time, how-
ever. In environments where the exposure arises from contamination of handled
materials, exposure levels may show high variability even within days (123).
Collection of samples over extended periods will reduce this variability and
reduce the number of samples that have to be analysed. At present the commonly
used 8-hour sampling time seems appropriate in the absence of better information
on relevant sampling time.
Exposure levels in common indoor environments without apparent sources
of fungal exposure, e.g. in offices, are much lower than in environments where
mouldy material is handled. Fungal spore levels in common indoor air are indeed
expected to be similar or lower than outdoors because fresh air is often filtered
before entering the ventilation system. Even in damp buildings spore levels are
often lower than outdoors. Nevertheless, indoor air problems seem to be related
to moisture-damage and fungal growth in buildings (16) and recognition of such
damage is important for remediation of the problem. Inspections of buildings for
fungal contamination and/or humidity problems by competent investigators and
analysis of settled dust, floor dust and building material samples for the presence
of fungi have therefore been recommended (1, 4, 75, 95). If such inspections are
negative, airborne fungi can be measured to detect fungal growth in the building
that is hidden from observation, e.g. within walls or ventilation systems. Indoor
levels must be compared to outdoor levels to evaluate if concentrations of fungal
species that may proliferate indoors are elevated. As fungal levels in outdoor air
can be substantial, especially in the summer and autumn, comparisons are based
on species that are rare in outdoor air. It is important that outdoor fungal levels are
measured several times a day because of their high within-day variability (226). It
is an advantage in subarctic regions to evaluate fungi in common indoor air in the
winter when outdoor fungal levels are low. This strategy is adopted in Finland
(192).
5.4 Conclusions
At present fungal spores can only be reliably quantified by microscopic counting.
Viable as well as non-viable spores are counted but cannot be discriminated.
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Culturable fungi can be quantified by culture-based methods but only semi-
quantitatively as spore aggregates are counted as single colonies and also
mycelium can be detected. However, many factors influence the results, and
results obtained by different methods or even by the same method in different
environments are difficult to compare. The main advantages of culture-based
methods are the possibility to identify fungal species, and the higher sensitivity
compared to microscopic counting.
Other methods may also be used to detect fungal agents including ergosterol,
glucans, antigens, and allergens, which may indicate the presence of fungal
particles. None of these methods discriminate between spores and mycelium.
Results can therefore not be interpreted directly as spore levels. The detection
of IgG antibodies can be useful in case studies of hypersensitivity pneumonitis
where exposure data are not available.
The assessment of fungi in common indoor environments has a different focus
than in highly contaminated work environments where fungi represent a risk for
respiratory disease. The detection of water-damage and fungal growth is the main
goal of investigations in buildings and measurement of airborne fungi is only one
of several methods that can be applied for this purpose. Culture-based methods are
currently preferred for detection of airborne fungi in common indoor environments.
6. Occupational exposure data
6.1 Highly contaminated environments
Occupational environments with high levels of exposure to fungi are found in
agriculture, wood and food industry, and waste handling. Bioaerosol exposure at
such workplaces is usually complex and fungi and actinomycetes comprise only
some of the agents present. However, in some environments fungal spores are the
main component of the bioaerosol and the exposure can even be limited to one or
a few species. In such environments, specific organisms have been associated with
hypersensitivity pneumonitis and asthma (Table 4).
When fungal colonisation occurs unintentionally, high spore concentrations
may be generated when mouldy materials are handled. Work processes, preven-
tive measures, and task performance further influence exposure levels. Exposure
levels may therefore show large variability. This is clearly seen in farm work,
where exposures during some tasks may differ by more than 4 orders of magni-
tude (Table 5).
Many exposure studies of non-agricultural occupations have been carried out.
The number of epidemiological studies including quantitative exposure assess-
ments is much smaller, however. The exposure data from these epidemiological
studies are summarised in Table 6 as they are of greater importance for the present
review. Exposure levels often exceed 104 cfu/m3 or 105 spores/m3.
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Table 4. Workplaces in which fungi and actinomycetes have been associated with
hypersensitivity pneumonitis and asthma; summarised from Lacey and Crook (116).
Workplace Source Species
Agriculture Mouldy hay Saccharomonospora viridis
Saccharopolyspora rectivirgula
Thermoactinomyces vulgaris
Aspergillus umbrosus
Grain Aspergillus fumigatus
Grain (maize) Aspergillus flavus
Straw Aspergillus versicolor
Mushroom compost Saccharomonospora viridis
Saccharopolyspora rectivirgula
Thermoactinomyces vulgaris
Aspergillus fumigatus
Mushrooms Lentinus edodus
Pleurotus ostreatus
Dairy Cheese Penicillium camembertii
Penicillium rockeforti
Penicillium casei
Brewery Malted barley Aspergillus fumigatus
Aspergillus clavatus
Citric acid fermentation Culture fluid Aspergillus niger
Compost Compost Aspergillus fumigatus
Cork industry Cork Penicillium glabrum
Sugar mill Bagasse Thermoactinomyces vulgaris
Thermoactinomyces sacchari
Tobacco factory Tobacco Aspergillus fumigatus
Wood industry Maple bark Cryptostroma corticale
Coniferous wood Rhizopus microsporus
Penicillium spp.
6.2 Common indoor environments
Exposure levels in common indoor environments without fungal problems are
much lower than in the highly contaminated environments described above. A
review of 10 studies including non-complaint commercial buildings showed
average levels of 17-1 200 cfu/m3 and 610-1 000 spores/m3, which amounted
to 6-120% of outdoor levels (63). Additional studies of office buildings typically
show fungal levels below 103 cfu/m3, rarely exceeding 104 cfu/m3 (Table 7). The
main source of fungi in office environments is outdoor air. As outdoor air is often
filtered before it enters the ventilation system and/or fungi settle due to lower air
velocities in the buildings, common indoor fungal levels are expected to be lower
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Table 5. Exposure levels of culturable and countable fungi and actinomycetes during
farm work (46).
Task Agent Exposure range a, b
102 103 104 105 106 107 108 109
Handling of
grain Fungi                         <–––––––––––––––––––––––––––>
hay Fungi                                <–––––––––––––––––>
Fungi                                                                  <...>
Actinomycetes                                                                                     <...>
straw Fungi                                <–––––––––––––––––––––>
compost Actinomycetes                                                                      <............>
Animal tending
dairy/cattle Fungi                  <–––––––––––––––––––––––––––>
Fungi                                                             <......>
Actinomycetes                                                             <......>
swine Fungi       <––––––––––––––>
poultry Fungi            <–––>
a Whole lines show colony forming units/m3 (cfu/m3) and dotted lines spores/m3.
b One cfu/m3 corresponds approximately to 10 spores/m3.
than levels in outdoor air. This is also observed in the studies summarised in Table
7. In buildings with fungal growth levels indoors may be somewhat higher than
outdoors but differences are usually small. Spores are easily dispersed by heating,
ventilation and air-conditioning systems, and contamination of such systems is an
important cause of increased indoor fungal levels (145).
An important activity that may contaminate indoor environments is the reme-
diation of mouldy building materials. Fungal levels may then exceed 105 cfu/m3
(189).
In non-problem indoor environments outdoor fungi dominate with Cladospo-
rium and to some extent Alternaria and Penicillium as the dominating species.
In buildings with fungal problems levels of Penicillium and to some extent
Aspergillus and yeasts are more often elevated compared to outdoor air. Very
humid conditions favour growth of Stachybotrys chartarum.
Levels of culturable fungi are much lower than fungi counted by microscopical
techniques. Russell et al found that culturable fungi amounted to 9% of counted
spores in dwellings (208). This is also found in comparative studies in highly
contaminated environments; review by Eduard and Heederik (51).
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6.3 Conclusions
Exposure levels in highly contaminated environments often exceed 104 cfu/m3
and 106 spores/m3 and may even exceed 108 spores/m3. In indoor environments
without fungal contamination, levels are generally below 103 cfu/m3 and lower
than in outdoor air. Fungal levels in buildings with fungal growth may be some-
what higher than in buildings without such contamination. Exposure levels in
highly contaminated environments are thus several orders of magnitude higher
than in common indoor environments without fungal contamination.
7. Uptake, distribution and elimination
7.1 Uptake
The major exposure route of fungal spores is inhalation.
The size, shape and surface structure of the individual spores as well as ag-
gregates are of major importance for their aerodynamic behaviour and thus the
region where inhaled spores deposit in the airways. Individual spores of fungi are
typically 2-10 µm in size. Spores of actinomycetes are smaller, typically 0.5-1.5
µm. Due to the variable spore size of single spores, the presence of aggregates,
differences in density, and absorption of water vapour by inhaled spores, fungal
spores may be expected to deposit in the whole respiratory system. A substantial
fraction of the smaller spore types may reach the alveoli, while the larger spore
types (>7-10 µm) do not. Aggregates, which are larger may deposit to a greater
extent in the lower and upper airways rather than in the alveoli. Spores of the
outdoor fungus Alternaria alternata are so large that they are not expected to
reach the alveoli.
Gastro-intestinal exposure may occur via mucociliary clearance of spores that
have deposited in the airways (and are swallowed when mucous reaches the
throat).
Some pathogenic fungi may infect the skin, but such organisms are beyond the
scope of this review.
7.2 Distribution
A limited number of in vivo studies have addressed dissemination of spores from
the airways to other organs. All studies used Aspergillus fumigatus or Aspergillus
terreus. In addition, a Penicillium species and Rhizopus oryzae were included in
two of the studies, respectively. The studies are summarised below and described
in more detail in Appendix 3.
Two studies showed that spores of A. fumigatus disseminated to the spleen,
liver, and kidneys in rabbits (112) and mice (241). The latter study also showed
that viable counts had cleared from these organs after 10 days. However, in a
study by Schaffner et al, mice exposed to A. fumigatus spores showed no dis-
semination to other organs (210). The latter study used more realistic conditions
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as airborne spores were inhaled and the dose may have been lower (4⋅103 spores/g
bw) than in the study by Waldorf et al (241) who exposed mice intranasally to a
20 times higher dose. However, Schaffner et al (210) estimated the dose after 2
hours by culture of lung tissue and probably underestimated the applied dose.
A study of spores of R. oryzae intranasally instilled in mice showed that spores
migrated to the liver, spleen, and kidneys and were still present in the liver and
spleen 10 days after exposure (241). Two studies of A. terreus spores adminis-
tered intratracheally to rats and rabbits showed only minor migration of spores
to the tracheobronchial lymph nodes (68, 165).
In a rabbit study, Thurston et al found a small fraction of spores in the digestive
system 6 hours after aerosol exposure to A. fumigatus and a Penicillium sp. (235).
No fungi could be cultured a week after exposure. No other organs than the lung
and the digestive system were studied.
In summary, these studies show different results even for the same species
A. fumigatus. Dissemination to other organs than the lung and the digestive sys-
tem was observed only for the facultative pathogenic organisms A. fumigatus
and R. oryzae. However, only one non-pathogenic fungus, a Penicillium species,
has been studied, and all studies showing dissemination to other organs applied
intratracheal or intranasal instillation, which may have caused local overload of
macrophages (Chapters 10.1 and 12.1). One study found that inhaled spores of
A. fumigatus and a Penicillium sp. reached the digestive system suggestive of
mucociliary clearance. However, the proportion of the inhaled dose was small and
the fungi were cleared within a week, indicating that effects on the digestive
system are minor.
7.3 Elimination
7.3.1 In vivo studies
Elimination of spores from lung tissue and phagocytosis and destruction of spores
by pulmonary alveolar macrophages have been studied for several species of fungi
and laboratory animals. The studies are summarised here (Table 8) and more
details are given in Appendix 4.
In three of the studies animals were exposed to aerosols of Aspergillus fumi-
gatus spores and the deposited dose was estimated by culture of lung tissue.
Colony counts declined in Guinea pigs, rabbits and immunised mice, although
small numbers were detectable after ≥ 6 days (210, 235, 240). Counts of Penicil-
lium sp. declined more slowly in rabbits inhaling spore aerosols, and colonies
were still observed after 3 weeks (235). Saccharopolyspora rectivirgula counts
declined much slower in aerosol exposed Guinea pigs (240). In a second study
on S. rectivirgula in Guinea pigs, 102-103 times higher doses were applied by
intratracheal instillation and a rapid decline in colony counts was found (256),
similar to the results obtained for A. fumigatus. Elimination was delayed when
exposure to S. rectivirgula spores was combined with hay dust, compared with
what was observed after exposure to spores alone (256). In two other studies using
intratracheal instillation of Candida albicans cells in Guinea pigs, and Aspergillus
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terreus spores in rats and rabbits most microorganisms had been cleared after one
day (165, 240). A study of mice intranasally exposed to Rhizopus oryzae showed
culturable fungi in the lungs 10 days after exposure, although no quantitative data
were presented (241).
To sum up, although several studies found that the major part of culturable
fungi was eliminated from the lung after a few days, elimination was not complete
after a week and could last considerable longer for R. oryzae and S. rectivirgula.
The applied doses in the latter studies did not exceed the overload limit of 60
µm3/macrophage suggested by Morrow (147) (Chapter 8.1).
Spores of A. fumigatus, A. terreus, and Penicillium chrysogenum were rapidly
phagocytised by alveolar macrophages in mice, rats, and rabbits (33, 68, 112,
241). Phagocytised spores of A. fumigatus, and P. chrysogenum were killed by
mouse alveolar macrophages (33, 241). However, spores of A. fumigatus seemed
to resist rabbit alveolar macrophages in one study (112). Mouse alveolar macro-
phages prevented germination of spores of Rhizopus oryzae but did not kill the
spores (241). The role of alveolar macrophages in prevention of spore germination
was demonstrated by mycelial growth of S. rectivirgula in the lungs of Guinea
pigs that had been depleted of alveolar macrophages by treatment with anti-
alveolar macrophage serum (240). It was also observed that alveolar macrophages
migrated from peripheral alveoli to alveoli adjacent to the respiratory bronchioles
(68).
In conclusion, the alveolar macrophages are the primary line of defence against
fungal spores. Alveolar macrophages killed spores from most tested species, and
if spores withstood macrophage attack, germination was prevented.
7.3.2 In vitro studies
In vitro studies have been carried out with viable and killed spores of various
microbial species using different cell types, and a variety of responses were
studied. The studies are described in more detail in Appendix 5.
Spores from Aspergillus fumigatus, Aspergillus candidus and Penicillium
ochrochloron attached readily to different phagocytic cells. P. ochrochloron
spores were more easily phagocytised than A. fumigatus spores, and heat-killed
A. fumigatus spores were phagocytised more rapidly than inert particles (152,
153, 199). Ingested spores of Aspergillus flavus and Aspergillus niger, but not
A. fumigatus, were killed by rabbit alveolar macrophages and the latter even
germinated after 4 hours (112).
Killing of microorganisms by phagocytes involves reactive oxygen species
(ROS) such as superoxide anion (O2-), hydrogen peroxide (H2O2), and nitric oxide
(NO). ROS production by different types of phagocytic cells differed between
species of fungi and actinomycetes (84, 207, 218, 220). Differences were also
observed between isolates of the same species and even the same strain grown
on different substrates using a mouse macrophage cell line (85, 206). Similar
differences were also observed for NO and inducible NO synthase production
(81, 82, 84, 91, 92, 105, 150, 151, 176, 206).
26
The production of cytokines as interleukin (IL)-6, IL-1, IL-1β, and tumour
necrosis factor alpha (TNFα) by phagocytic cells, and cytotoxicity in a mouse
macrophage cell line varied between species, cell types and the medium used for
culture of the microorganisms including building materials (91, 153, 182, 206,
219). Different results were even reported for similar tests carried out by the
same laboratory (81, 82, 85, 91, 92, 148-151, 176, 204). Cytotoxic strains of
Stachybotrys produced satratoxin but did not induce IL-6 and TNFα in a mouse
macrophage cell line while non-toxic strains induced these inflammatory media-
tors (157), indicating that mycotoxins impair the cytokine response.
Positive interactions were found between Stachybotrys chartarum with the
actinomycete Streptomyces californicus on IL-6 production, apoptosis, cell-cycle
arrest, and caspase-3 enzyme activity in a mouse macrophage cell line, while no
or weaker responses were found for NO and TNFα production (92, 176). Two
other fungi did not show such interactions with this actinomycete.
Spore viability has shown different effects on the elicited inflammatory res-
ponses of macrophages to spores. The response to viable and dead spores was
similar regarding superoxide anion induction, NO production, and phagocytosis.
However, killed spores induced less ROS than viable spores while both higher and
lower cytotoxicity was observed in a mouse macrophage cell line. These studies
included many fungal and actinomycetes species (84, 218). Viable A. fumigatus
induced production of a variety of cytokines whereas killed spores did not (182).
However, Shahan et al found no difference in macrophage superoxide production
between viable and killed spores in a similar study of this fungus (218). A recent
study by Hohl et al showed a large increase in TNFα and macrophage inflam-
matory protein (MIP)-2 in murine alveolar macrophages after exposure to live
A. fumigatus spores, while no response was observed after exposure to heat-killed
spores (88). However, when spores were incubated, the inflammatory response of
heat-killed spores increased with incubation time indicating that germination of
spores alters their inflammatory potential.
7.3.3 Discussion
The in vivo studies demonstrated that most fungal spores were eliminated from
the lung within a few days, although elimination was not complete and could
last considerably longer for Rhizopus oryzae and Saccharopolyspora rectivirgula.
It was also observed that alveolar macrophages phagocytised the spores, and
although some spores maintained viability, they did not germinate. One study
demonstrated that the alveolar macrophages were crucial in germination
prevention.
The exposure levels used in in vivo studies were rather high. The lowest dose
was 2⋅103 spores/g bw, which corresponds to a human dose of >108 spores. Such
doses can be inhaled during an 8-hour workday at exposure levels >107 spores/m3,
i.e. at the higher end of occupational exposures and many orders of magnitude
higher than in environments with common indoor exposure to fungal spores
(Tables 5-7). However, the dose was estimated by culture of lung tissue 2 hours
after aerosol exposure and the actual dose may have been substantially higher
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(Chapter 10.1). Thus, the delayed elimination of spores of some species may not
be relevant for populations working in highly contaminated environments except
in extreme exposure situations.
In vitro studies further documented that alveolar macrophages bind spores
rapidly to their cell walls. The alveolar macrophages phagocytise attached spores,
kill ingested spores by NO and ROS and may produce cytokines. Differences in
induced macrophage NO and ROS production were observed between fungal
species, isolates of the same species and even isolates grown on different
substrates, but results were not consistent across studies. Similarly, results on
production of cytokines such as TNFα and IL-6 were not consistent although
these and other cytokines were demonstrated in response to spores from many
species. The use of different cell types in in vitro tests may account for some of
the differences together with the presence of secondary metabolites in the spore
preparations.
Some in vitro studies showed that spores of fungi and actinomycetes were able
to resist and even kill alveolar macrophages although results were not consistent.
The decline of culturable microorganisms in lung tissue may also be due to mig-
ration of spores to other organs. This was shown for the opportunistic pathogens
A. fumigatus and R. oryzae that seem able to resist pulmonary defence mechanisms.
Some results are indicative of mucociliary clearance of spores in the respiratory
tract. Alveolar macrophages with phagocytised spores migrated from the periphe-
ral alveoli to those closest to the terminal bronchioles. The detection of microor-
ganisms in the digestive system indicates that they probably had been swallowed.
The effect of viability was explored in in vitro studies and one in vivo study.
Although results were variable, there are indications that the elicited response
from viable spores can be stronger than that from dead spores when they are able
to germinate.
8. Mechanism of toxicity
Viable microorganisms such as spores of fungi and actinomycetes are different
from chemical agents, as they may be able to germinate and proliferate in the
host. When the host’s defence systems fail, toxicity may arise, leading to various
clinical outcomes such as organic dust toxic syndrome (ODTS), mucosal mem-
brane irritation, and chronic restrictive and obstructive lung diseases such as
hypersensitivity pneumonitis and asthma.
8.1 The innate and adaptive response to fungi
The alveolar macrophages are the first line of defence against microorganisms at
the alveolar level. Their role in elimination of fungal spores has been described in
Chapter 7.3. Alveolar macrophages phagocytise spores and migrate to the airways
where they are removed by mucociliary clearance. Morrow reviewed studies on
migration of rat alveolar macrophages from the alveoli into the airways (147). The
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migration was impaired when the total volume of phagocytised non-soluble
particles exceeded approximately 60 µm3 per alveolar macrophage. If this
clearance limit also applies to fungal spores, it corresponds to human alveolar
doses of 6⋅109 to 9⋅1010 of spores with sizes 5 and 2 µm, respectively, as the
human lung contains approximately 6⋅109 alveolar macrophages (233). This
relates to exposure levels of 109-2⋅1010 spores/m3 during a work shift assuming
an alveolar ventilation of 10 l/min for 8 hours. Such levels are rare in the work
environment (Chapter 6.1) but have been reported in relation to fever attacks
typical of ODTS (Chapters 8.3 and 11.4.2). It is therefore possible that clearance
overload leading to prolonged presence of fungal spores at the alveolar level is a
contributing factor to ODTS.
The defence of human and murine macrophages against hyphae is not effective,
which has been shown for the pathogenic species Aspergillus fumigatus and
Histoplasma capsulatum (109, 210). However, human neutrophils destroyed the
mycelial form of Aspergillus fumigatus and Rhizopus oryzae by attaching to the
hyphae and by extra-cellular production of ROS (40, 210).
Several receptors have been found on human and murine phagocytic cells, i.e.
the alveolar macrophages, neutrophils and dendritic cells, by which these cells
attach to inhaled microorganisms. The Toll-like receptors (TLR) are probably the
most important receptors for microbial recognition. It has been shown that TLR2,
TLR4, TLR6, and TLR9 on mouse and human phagocytes bind to the pathogenic
fungi Aspergillus fumigatus, Cryptococcus neoformans, and Candida albicans
(12); review by Netea et al (155). The binding of A. fumigatus to TLR2 and TLR4
promoted fungicidal activity in neutrophils through different oxidative pathways,
while TLR3, TLR5, TLR6, TLR7, TLR8 and TLR9 further modulated the
response (13). Other innate receptors involved in fungal recognition are the IL-1
receptor that is structurally related to the TLRs, the mannose receptor and the
Dectin-1 receptor that binds to β-glucans (12, 19, 154). These receptors seem to
act in combination in the recognition of pathogenic microorganisms. For example,
TLR2, TLR4, the Dectin-1 receptor and the mannose receptor have been shown to
bind to different molecules on the cell wall of Candida albicans yeast cells (154).
Fungal spores and hyphae bind differently to the innate pattern recognition
receptors. Conidia of Aspergillus fumigatus were recognised by TLR2, TLR4 and
TLR9 on human and murine neutrophils while hyphae were only recognised by
TLR4 (13). Gantner et al found that yeast cells of Candida albicans bound to
the Dectin-1 receptor on murine macrophages (59), which the authors ascribed to
β-glucan being exposed on the outer cell wall at the scars formed by the budding
yeast cells. Hyphae were not recognised probably because the β-glucan in the
hyphal cell wall was covered by other compounds. The Dectin-1 receptors on
murine and human macrophages were also found to bind preferentially to germi-
nating spores of A. fumigatus compared to resting spores. This was similarly
explained by disruption of the layer that covers the β-glucan on the spore wall
during spore germination (60, 88). Thus, the composition of the cell wall surface
has a major effect on the binding to phagocytic cells.
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Other pattern recognition receptors are present on surfactant proteins A and D
that are produced by epithelial cells in the alveoli and bronchi. These proteins play
an important role in the lung by reducing the surface tension on the alveoli, but
they also contain a mannose receptor that binds to a range of sugars that can be
present on invading microorganisms including fungi; review by Turner (238).
After binding, the surfactant proteins can activate complement directly, or they
can stimulate phagocytosis by binding to collectin receptors on phagocytic cells;
review by Crouch (37).
Recent publications have addressed the role that antigen presenting pulmonary
dendritic cells play in the immune responses to fungi. Dendritic cells phagocytise
pathogens and present their antigens to precursor T-helper (Th) cells, which may
mature into Th1 and Th2 cells. The Th1 cells mediate a cellular response by
stimulating macrophages to phagocytise the pathogen and T-cells to develop into
cytotoxic T-cells that phagocytise and kill specific organisms. The Th2 cells
stimulate B-cells to proliferate into specific antibody producing plasma cells. The
Th1 and Th2 cells further modulate the type of antibodies that are produced by
secretion of different cytokines. Th1 cells promote the development of IgG
antibodies that bind specifically to antigens and facilitate their uptake by phago-
cytic cells. Th2 cells may stimulate B-cells to produce IgE antibodies and can also
induce proliferation of mast cells and eosinophilic leukocytes, which are important
characteristics of the allergic response. The balance between Th1 and Th2 cells is
thus important for the type of immune response that is mounted against invading
organisms. Recently, T regulatory cells involved in suppression of the Th2 re-
sponse and thought to prevent sensitisation and allergic disease were described;
review by Robinson et al (200). However, their role in fungal allergy is not clear.
Mouse dendritic cells have been shown to respond differently to spores and
hyphae (19). Resting spores of Aspergillus fumigatus were more efficiently
phagocytised than swollen conidia and hyphae in vitro. In vivo mouse alveolar
dendritic cells with phagocytised spores translocated through the alveolar
epithelial barrier migrated to the thoracic lymph nodes and the spleen and
underwent functional maturation. Dendritic cells produced IL-12p70 and TNFα
after ingestion of spores, which primed the maturation of precursor Th cells to
interferon gamma (IFNγ) producing Th1 cells, while ingestion of hyphae induced
IL-4, IL-10 and TNFα production and priming of IL-4 producing Th2 cells
(Figure 4).
Similar findings were reported in an in vitro study of Candida albicans. Dend-
ritic cells that had ingested hyphae primed Th2 cells in mice, while dendritic cells
primed Th1 cells after ingestion of yeast cells (167). A difference from Aspergillus
fumigatus was, however, that hyphae of Candida albicans escaped from the
phagosomes, while yeast cells were destroyed. The response of dendritic cells to
fungi therefore seems to depend both on the species and on the cellular form of
the organism. The production of fungal allergens during germination and mycelial
growth is likely to play a role (Chapter 3.6). It seems therefore possible that viable
spores may induce an allergic response if they germinate in the airways.
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Figure 4. Differential maturation of precursor T helper cells (pTh) by dendritic cells
(DCs). A non-allergic response was observed after DCs ingested Aspergillus fumigatus
spores, while ingestion of hyphae induced an allergic response. Elaborated from Bozza et
al (19).
Some support for this hypothesis is found in in vivo studies of viable and/or
germinating spores (Chapters 10.3, 10.4.2 and 10.5).
Also epithelial cells seem to be involved in interactions with fungi. It has been
proposed that proteases present in fungi and other allergens may facilitate passage
of allergens through the epithelial barrier; review by Kauffman and van der Heide
(106).
Mycotoxins may further modulate the immune response, as many mycotoxins
are cytotoxic to immune cells. The mycotoxins citrinin, gliotoxin and patulin
induced a stronger suppression of human Th1 cells than Th2 cells in vitro, which
favours an allergic response to the toxin producing fungi (245). Mycotoxins can
also have other health effects (Chapter 3.6).
8.2 Allergic responses
Allergy has been defined in different ways. In this document the definitions of
allergy and hypersensitivity pneumonitis given by the European Academy of
Allergology and Clinical Immunology are used (99) (Appendix 1).
IgE-mediated allergy is probably the most important allergic mechanism in the
general population. Exposure of sensitised individuals (i.e. with elevated IgE
antibodies) to the corresponding allergen causes mast cells to release histamine
and other inflammatory mediators. In asthmatic patients histamine release causes
constriction of the bronchi by smooth muscle contraction, and cytokines attract
eosinophils. The subsequent eosinophilic inflammation further constricts the
airways by swelling of the mucosa resulting in airway obstruction that can be life
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threatening. In patients with allergic rhinoconjunctivitis the mast cells produce
the same inflammatory agents resulting in sneezing, running or blocked nose, and
eye irritation. Although not all individuals with detectable IgE are symptomatic,
the presence of specific IgE antibodies is a predictor of future allergic disease if
exposure to the allergen continues; review by Platts-Mills (179).
Few occupational studies of IgE-sensitisation to fungi have been published.
These studies provide conflicting information on the occurrence of sensitisation
and IgE-mediated diseases in working populations exposed to fungi. This may
be due to the limited number of available assays for detection of IgE to fungal
allergens in serum and the low sensitivity of these assays (Chapter 11.2.2).
Individuals with IgE against commonly occurring allergens also have greater
risk to develop IgE against occupational allergens such as fungal amylase in
bakers (89) and rodent allergens in laboratory animal workers (77). Such
individuals are called atopic and their identification is important as they may
represent a sensitive group. Although fungal allergy is quite common in atopic
individuals of the general population, the role of atopy for fungal allergy in
occupational populations is unclear.
Another type of allergic disease that seems to be more important in populations
occupationally exposed to fungi is hypersensitivity pneumonitis, which is also
called allergic alveolitis. This disease is characterised by alveolar and bronchiolar
inflammation, and is caused by inhalation of spores from fungi and actinomycetes,
and also by other allergens. Typical symptoms and clinical findings are attacks
with fever, chills, dry cough, dyspnoea, basal crepitations, nodular bilateral X-ray
changes, malaise and headache, and declines in forced vital capacity (FVC) and
gas diffusion capacity. IgG but not IgE can usually be detected. The attacks are
similar to those of ODTS (Chapter 8.3) but patients with ODTS recover within
a few days without persisting symptoms or clinical findings. Acute attacks of
hypersensitivity pneumonitis occur a few hours after episodes with massive
exposure to spores of fungi and/or actinomycetes. Recurrent attacks may even-
tually progress into pulmonary fibrosis if exposure continues, and may even be
fatal (174, 205). Patients typically work in environments where high exposures
occur repeatedly.
Hypersensitivity pneumonitis is thought to be an allergic disease, although the
mechanisms are not entirely clear. The disease is not IgE-mediated, as IgE
antibodies are not generally found in patients with hypersensitivity pneumonitis.
Specific IgG antibodies to fungi can often be demonstrated in serum of these
patients indicating a type III allergic reaction. However, the role of IgG antibodies
in the disease is unclear as these antibodies are common in healthy exposed
individuals. The presence of serum IgG antibodies is therefore regarded as a
marker of exposure and not of disease (24) (Chapter 9.1). Additionally, type IV
hypersensitivity is suggested by the presence of granuloma in the lungs of the
patients (Chapter 11.5.1.), and by granuloma formation in animal studies
(Chapters 10.4 and 10.5) indicating the involvement of cytotoxic T-cells. Host
factors may play a role as well because only a small proportion of the exposed
individuals develop the disease (17) (Chapter 11). Neutrophilic inflammation is
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generally observed in this disease and production of the pyrogenic cytokines
TNFα and IL-6 by neutrophils probably explain the fever attacks that are typical
for hypersensitivity pneumonitis.
Although the mechanisms of hypersensitivity pneumonitis are not entirely clear,
the allergic nature of the disease is clearly demonstrated by bronchial challenge to
fungal extracts and even spores in numerous case studies and a few epidemio-
logical studies (Chapters 11.2.1 and 11.5.1.).
8.3 Non-allergic responses
Chronic bronchitis and ODTS are generally regarded as non-allergic diseases (56,
170). ODTS is also described as toxic alveolitis or inhalation fever (56, 187).
ODTS patients develop febrile attacks with chills, headache, malaise, cough and
dyspnoea 4-8 hours after massive exposure to some substances, e.g. metal fumes,
organic particles and spores from fungi and actinomycetes. IgG antibodies
against fungi are often not detectable. Patients recover within a few days without
functional and X-ray changes or persisting symptoms, which distinguishes this
condition from hypersensitivity pneumonitis.
Mucous membrane irritation may be due to allergic rhinoconjunctivitis, but is
prevalent also in individuals without atopy. A substantial proportion of the
patients with diagnosed asthma and rhinoconjunctivitis do not have atopy or
eosinophilic inflammation but probably neutrophilic inflammation (43, 175, 254).
Non-allergic diseases are therefore important outcomes in populations exposed to
fungi.
Most experimental and animal studies report non-allergic inflammation after
challenge to fungal spores. The following mechanisms are supported by these
studies (reviewed in Chapter 7). Alveolar macrophages phagocytise spores
and destroy spores in phagolysosomes by ROS and by non-oxygen dependent
mechanisms involving lysosomal enzymes. Spores from some species, and hyphae
in general, are resistant to destruction by alveolar macrophages. The alveolar
macrophages can produce a variety of cytokines, among which IL-8 is most
important to attract neutrophils. The neutrophils can phagocytise and destroy
hyphae and swollen spores by oxidative and non-oxidative mechanisms. The
fungicidal agents are present in granules within the neutrophils and are released
inside the cells, but they can also be excreted and cause tissue damage. Both
activated alveolar macrophages and neutrophils can produce the pyrogenic
cytokines TNFα and IL-6, which provides a likely explanation for febrile
symptoms during attacks of ODTS.
8.4 Summary
The inflammatory response to spores is mainly non-allergic in occupational
populations although allergic diseases such as allergic asthma, allergic rhino-
conjunctivitis, and hypersensitivity pneumonitis can be induced by exposure to
fungi. The allergic and non-allergic responses indicate that different inflammatory
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mechanisms are involved, many of which are not fully elucidated. Fungi are
recognised by phagocytic cells with innate receptors. They become phagocytised
and induce both innate and adaptive immune responses. Hyphae and germinating
spores are able to induce allergic responses, which may be due to allergen pro-
duction during germination and growth.
Allergic asthma and rhinoconjunctivitis are IgE-mediated while hypersensitivity
pneumonitis is most likely due to cellular hypersensitivity (type IV allergy) and/or
IgG-mediated type III allergy.
Non-allergic asthma and rhinoconjunctivitis are at least as prevalent as the
allergic forms of the diseases, and are probably mediated by neutrophilic inflam-
mation. ODTS is characterised by similar acute symptoms as hypersensitivity
pneumonitis, but the chronic effects seem to be absent. The fever attacks in both
outcomes are probably caused by macrophage and neutrophilic inflammation.
Macrophage overload may play a role in ODTS.
9. Biological monitoring
9.1 Markers of exposure
Specific IgG antibodies to Saccharopolyspora rectivirgula, Aspergillus, Penicil-
lium, and Rhizopus species in serum have been used as markers of exposure in
studies of farmers and sawmill, cork, tobacco, and malt workers.
The importance of specific IgG antibodies as marker of airborne exposure
depends on the absence of other exposure routes as the development of these
antibodies is a general response to antigen exposure. In earlier studies, IgG anti-
bodies have been detected by precipitation of the antibody-antigen complex in a
diffusion gel, and are called precipitins. This method is semi-quantitative but is
easy to perform with several antigens simultaneously. Enzyme-linked immuno-
sorbent assays have been developed for quantitative measurements.
IgG antibodies may appear after repeated exposure to airborne fungal spores.
This has been shown in several animal studies. An interesting study is the one
by Thurston et al who exposed rabbits once a day for 1-10 days to aerosols of
Aspergillus fumigatus spores with doses ranging from 4⋅105 to 2⋅106 cfu/g lung
tissue (236). They found that precipitating antibodies only developed after expo-
sure to the highest dose (2⋅104 spores/g bw corresponding to a human dose of
more than 109 spores) and that exposure had to be repeated at least once. This
is in agreement with the mechanism for immunisation through development of
IgG antibodies (201). After a single exposure few or no animals developed IgG
antibodies (114, 160, 164, 165, 235, 236) except in one study where rabbits were
exposed to a very high dose of A. fumigatus (approximately 2⋅106-5⋅106 spores/g
bw) (146). Cooley et al exposed mice intranasally to doses of 1⋅104 spores of
Penicillium chrysogenum once a week for 6 weeks. Both killed and viable spores
caused decreased specific IgG2a levels, although total IgG2a levels increased after
exposure to killed spores (33). The presence of specific IgG2a antibodies before
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exposure indicates that the animals had been exposed to P. chrysogenum or other
fungi cross-reacting with this species before the challenges, however. Thurston et
al found a relatively high threshold for precipitin formation against A. fumigatus
in rabbits (236), which may explain why an increase in specific IgG2a levels was
not found in the study by Cooley et al (33).
Only two epidemiological studies were found that examined the relationship
between serum IgG levels and fungal exposure levels. In wood trimmers, levels
of serum IgG against Rhizopus microsporus and Paecilomyces variotii were
associated with exposure levels of spores from these fungi in the preceding
months (53). In school children, however, levels of serum IgG against fungi from
water-damaged schools were poorly correlated with airborne levels (93). This may
be due to the relatively low exposure level in this environment, and to exposure to
similar or even higher levels in their homes or outdoors. The authors therefore did
not recommend serum IgG levels as markers of exposure in schools.
Inter-individual differences in the serum antibody response are large and absence
of IgG antibodies does not prove that a worker has not been exposed. Group mean
IgG levels of similarly exposed individuals indicate exposure with better precision
and have been used successfully as markers of exposure in epidemiological
studies of populations working in highly contaminated environments, e.g. farmers
and sawmill workers. Changes in the intra-individual IgG levels indicate relative
changes in exposure with better precision than a single individual measurement
because the inter-individual variability is eliminated; review by Eduard (45).
To sum up, individual IgG antibody levels are difficult to interpret as exposure
levels, and their use as markers of exposure has not been validated. However,
the presence of IgG antibodies may indicate exposure to relatively high levels of
specific fungi, which is valuable in the diagnosis of hypersensitivity pneumonitis.
It should be noted that the detection of IgG antibodies is not a diagnostic tool of
the disease, as healthy individuals can have high IgG antibody levels (Chapter
8.2).
9.2 Markers of effect
The demonstration of specific IgE antibodies to allergens is an important tool in
the etiologic diagnosis of atopic disease. Allergens from Cladosporium herbarum,
Alternaria alternata, and Aspergillus fumigatus have been best characterised and
are used in commercial IgE tests (113). The skin prick test and the radioallergo-
sorbent test (RAST) in serum have been used predominantly but these methods
are mainly semi-quantitative. The allergenic composition of spores, mycelia, and
culture fluid is different and fungal extracts also vary between strains. There is
therefore a need for standardisation of fungal allergens (25, 209). Most allergen
extracts have been prepared from culture fluid or mycelia. Positive tests thus
indicate an allergic response to the fungus, but not necessarily to its spores since
the allergen composition of the extract may deviate from that of spores. Another
problem, which complicates the diagnosis of fungal allergy, is that allergic
individuals can be sensitised to some but not all allergens from the same species
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and no allergen is common to all allergic individuals (113). Major allergens
have been recognised, however. For example, 85% of the patients allergic to
A. fumigatus were positive when tested with the allergen Asp f 1 and 80% of the
patients allergic to Alternaria alternata were positive to Alt a 1. However, only
50% of patients allergic to C. herbarum were positive to Cla h 1. Antigen extracts
of this fungus used in diagnostic tests should therefore contain a combination of
Cladosporium allergens. On the other hand, closely related (e.g. Alternaria,
Stemphylium and Curvularia species) and more distantly related fungi (e.g.
C. herbarum and A. alternata) may contain or produce similar allergens. Allergic
individuals may therefore cross-react to fungi they have not been exposed to (86,
121). RAST analyses can be carried out by the Pharmacia CAP system, which is
an automated system that has been calibrated against the World Health Organiza-
tion (WHO) IgE standard and allows quantitation of total and allergen-specific
IgE. Recently an automated enzyme-linked immunosorbent assay system has been
developed, which may replace RAST for the detection of IgE in serum.
The RAST and the skin prick test may underestimate serum IgE against fungi.
Griese et al found a better sensitivity (90%) and specificity (86%) for a histamine-
release test with fungal extracts compared with skin prick tests and RASTs in
asthmatic children using bronchial provocation as the standard (71). Similar
results have been reported by Nolte et al but the sensitivity (67%) and specificity
(80%) were lower (162). In one study the presence of IgE antibodies against
Penicillium chrysogenum was demonstrated by a histamine-release test in
individuals who did not respond in skin prick tests and a fluorometric enzyme
immunoassay (Magic Lite test) (120). The histamine-release tests were performed
by exposure of circulatory basophils passively immunised with serum from the
subjects to spores from fungi that had been isolated from the environment. The
role of IgE in these tests was validated by testing sera from unexposed individuals
and sera from subjects where IgE had been removed as negative controls. The
authors claim that whole spores that can be used in histamine-release tests provide
a better allergen source than allergens extracted from culture fluid, mycelium, or
spores. This assumption is reasonable since allergen extracts contain only soluble
allergens and proteolytic enzymes may have degraded allergens during purifica-
tion. Furthermore, spores from fungi that are isolated from the environment can
be used. However, the concentration of spores needed to induce histamine release
seems very high although the number of basophils was not given, 0.06-0.5 mg
spores/ml, which is approximately equal to 1⋅107-5⋅107 spores/ml.
Nasal lavage and sputum induction by inhalation of a hypertonic saline aerosol
have been used to study inflammatory markers and mediators in small-scale
epidemiological studies of populations occupationally exposed to fungi (Chapter
11). Their usefulness as markers of fungal diseases is unclear at present.
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10. Effects in animals
10.1 Dose considerations
Only animal studies in which the respiratory system was exposed to whole spores
have been included. Exposure is either by aerosol inhalation, intratracheal, or
intranasal instillation.
All dose estimates were recalculated to estimate the number of spores/g bw as a
common unit since doses had been expressed in different ways. Viable counts of
spore suspensions were assumed to be half of the total number of spores unless
viability had been assessed. In case of aggregation this is an underestimation.
However, spore suspensions used for intratracheal or intranasal instillation were
often homogenised, filtered, and inspected before use. Spore weights were
computed from the mean of size ranges obtained from other references, as this
information was seldom supplied in the studies. In addition, a globular shape and
a specific gravity of 1 g/cm3 were assumed. In aerosol inhalation studies, either
airborne concentrations and exposure durations were given or viable counts in
lung tissue obtained quickly (up to 4 hours) after the challenge. The latter method
is sometimes used in instillation studies as well. Culture of lung tissue is likely to
underestimate the applied dose substantially as only 0.3% of an intratracheally
instilled dose could be cultured from lung tissue 4 hours after instillation (114).
Inhaled doses in animal studies were computed by multiplication of the airborne
concentrations with the respiration rate of the animal (26). Finally, the applied
doses were normalised by the number of spores/g bw using tables of body and
lung weight (133).
Intratracheal and intranasal instillation circumvent the normal deposition
processes in the airways, and distribute spores deeper into the lung. In rats, four
times more cerium oxide with a mass median AED of 2.2 µm reached the lung
after intratracheal instillation compared to inhalation (180). Further, intratra-
cheally instilled dust was less homogeneously distributed in the lung compared
with inhaled aerosols, with little dust reaching the periphery. This may lead to
local overload conditions even if the average dose does not exceed the overload
limit suggested by Morrow (147) (Chapter 8.1). Pritchard et al recommended
not to extrapolate dose-response relationships from animal studies that applied
intratracheal instillation to the human condition (180).
The tracheobronchial structure and dimensions of the human lung differ from
the lungs of laboratory animals, especially small rodents. Based on different
deposition models in the airways and dose metrics Jarabek et al estimated that the
exposure level applied in an animal experiment has to be multiplied by a factor
of 0.03-0.2 for particle number per alveolus, and by 1-7 for particle mass per unit
area for particle sizes ranging from 0.3 µm to 6 µm (98). Finally, the degree of
aggregation of fungal spores is often unknown, a problem that applies to human
as well as animal studies.
Macrophage overload may occur when the alveolar dose of spores 2 and 5 µm
in size exceeds approximately 106 and 105 spores/g bw in humans, respectively.
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These limits are similar in rats that have approximately 2.8⋅107 alveolar mac-
rophages, or 9⋅104 per g bw assuming a body weight of 300 g, while humans
have approximately 6⋅109 alveolar macrophages, or 1⋅105 per g bw assuming
a body weight of 60 kg (147, 233) (Chapter 8.1). Overload may even occur at
lower levels after intratracheal instillation due to uneven distribution in the lung.
Comparisons between studies can be difficult because of methodological
differences. Comparisons within studies are therefore more reliable and are given
most weight.
A neglected issue in studies using instillation of spore suspensions is that spores
may be metabolically activated. Green et al showed that germinating spores had
higher allergen content than resting spores (65). It is therefore possible that the
responses in studies using intranasal or intratracheal instillation of spore suspen-
sions differ from results from aerosol exposure to dry spores.
10.2 Irritation
No studies of irritation have been found.
10.3 Sensitisation
Only two experimental studies of sensitisation with whole spores were found.
Hogaboam et al exposed non-sensitised mice, and mice sensitised by injections
with Aspergillus fumigatus antigen intratracheally to a single dose of 5⋅106 spores
(2⋅105 spores/g bw) of A. fumigatus (87). Both groups developed specific serum
IgE antibodies after 3 days that lasted at least to the end of the observation
period of 30 days. The IgE level in the sensitised group was 5 times higher.
Cooley et al exposed mice intranasally to 1⋅104 spores (7⋅102 spores/g bw) of
Penicillium chrysogenum once a week for 6 weeks (33). After exposure to killed
spores specific serum IgE levels decreased while specific serum IgE and IgG1
levels increased after exposure to a spore preparation containing 25% viable
spores.
The two studies indicate that viable spores can induce serum IgE. It should be
noted, however, that both studies applied spore suspensions, which may have
activated the spores and induced allergen production. Exposure to non-viable
spores did not induce IgE antibodies, and IgE levels even decreased indicating
that the animals had developed some degree of sensitisation before the experi-
ment. This was not mentioned in the paper. Sensitisation might have occurred
from ambient exposure, as P. chrysogenum is prevalent in common indoor air
although the animals were kept in a high efficiency particulate air (HEPA)
filtered room. The induction of IgG1 antibodies in mice after exposure to viable
spores in the latter study also indicates the involvement of Th2 cells and an
allergic response.
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10.4 Effects of single exposure
Effects of single exposures other than irritation and sensitisation have been
studied in eleven species of fungi and three species of actinomycetes in rabbits,
rats, mice and Guinea pigs. The studies are summarised in Table 9.
10.4.1 Mortality
Mortality was observed after a single exposure to toxic and non-toxic Stachy-
botrys chartarum in rat pups, with lethal doses for 50% (LD50) and 18% (LD18)
of the animals of 3⋅105 spores/g bw and 8⋅105 spores/g bw, respectively (250). For
Aspergillus fumigatus an LD11 of 6⋅105 spores/g bw was found in adult mice (210),
and mortality in rats varied from 0/3 to 3/3 after exposure to 6⋅106 spores/g bw of
five different strains (117). The A. fumigatus strains from the latter study were
studied for production of the mycotoxins gliotoxin but none produced the toxin.
Although the presence of mycotoxins in the spores is likely to be an important
factor for mortality, the toxicity of these fungi was not solely dependent on
mycotoxins. In one study of A. fumigatus the dose was quantified by culture of
lung tissue and substantially underestimated (210). At the applied doses overload
of alveolar macrophages is very likely, which may contribute to toxicity.
10.4.2 Inflammatory markers
Bronchoalveolar lavage
Neutrophils and/or alveolar macrophages increased in rats, mice and Guinea pigs
after exposure to Aspergillus fumigatus, Aspergillus versicolor, Penicillium
spinulosum, toxic Stachybotrys chartarum, Saccharopolyspora rectivirgula and
Streptomyces californicus (58, 87, 101-103, 185, 250) and in sensitised mice also
after exposure to Cladosporium herbarum (74). Lymphocyte counts were in-
creased after exposure to toxic S. chartarum and exposure of sensitised animals
to A. fumigatus (87, 185, 250). Alveolar macrophage counts decreased after
exposure of mice to the highest dose of P. spinulosum (102). Eosinophil counts
were increased after exposure of mice to Alternaria alternata (74), Guinea pigs
to S. rectivirgula (58) and rats to toxic S. chartarum (185). In sensitised mice,
eosinophil responses were observed to A. fumigatus (87), A. alternata and
C. herbarum and in non-sensitised mice also to A. alternata (74).
Many studies showed transient increases in lung cell counts after exposure to
relatively high doses of 2⋅105 spores/g bw or more. However, one study showed
that alveolar macrophage counts decreased after exposure to a very high dose of
4⋅106 P. spinulosum spores/g bw (102). Comparisons within studies showed a
stronger response to toxic S. chartarum compared to a non-toxic strain of the
fungus (184, 250), and to A. alternata compared to C. herbarum (74). Dose-
related responses were observed for A. versicolor (103) and toxic S. chartarum
spores (184). The responses in alveolar macrophage, neutrophil, eosinophil, and
lymphocyte counts were stronger in sensitised animals than in non-sensitised
animals (74, 87). Eosinophil counts were induced by A. alternata, C. herbarum
(in sensitised animals), toxic S. chartarum and S. rectivirgula (58, 74, 87). In one
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of the studies, four fungal species including A. fumigatus did not induce
eosinophils or any other cells by doses up to 2⋅105 spores/g bw. Spores were
applied by inhalation, which reduces the dose that reach the alveolar region
compared to intratracheal or intranasal instillation applied in the other studies
(58).
Increases in the number of inflammatory cells were parallelled by increases in
the cytokines TNFα, IL-1β, and IL-6 and markers of tissue damage, i.e. lactate
dehydrogenase, albumin and haemoglobin in rats (184, 185, 250), in mice (101,
103) and in specific pathogen free mice (57, 102, 103). Myeloperoxidase in-
creased after exposure to toxic and non-toxic S. chartarum (184). The responses
to A. versicolor, Cladosporium cladosporoides, non-toxic and toxic S. chartarum
were dose-related (57, 103, 184). In studies of A. alternata and C. herbarum
increases in IL-4, IL-5 and IL-13 in sensitised mice were also reported, indicative
of an allergic response (74). The increased levels generally returned to normal
within 3-28 days (57, 101, 103, 185, 250).
One study of specific pathogen free mice that were intratracheally exposed to
A. fumigatus indicated that viable spores induced a large increase of neutrophils in
bronchoalveolar lavage fluid, which was not observed when heat-killed spores
were applied. However, when spores were incubated until swollen before heat-
killing, a similar inflammatory response was seen as induced by viable spores
(88). The applied dose (1⋅107 spores/animal, approximately 4⋅105 spores/g bw)
was high compared to the doses used in the other studies. The study indicates that
agents produced during germination can be responsible for the inflammatory
response.
Increased surfactant production was observed after exposure of specific patho-
gen free mice to toxic S. chartarum but only minor changes after exposure to
C. cladosporoides (131). These results indicate that alveolar type II cells are
involved, but it is not clear how these changes contribute to the inflammatory
process.
Lung tissue
In many studies, increases in inflammatory cells in lung tissue, mainly alveolar
macrophages, lymphocytes, and polymorphonuclear leukocytes (PMN) were
observed. These studies included Aspergillus fumigatus, Aspergillus versicolor,
Penicillium spinulosum, Saccharopolyspora rectivirgula, Streptomyces californi-
cus, Streptomyces thermohygroscopicus and toxic and non-toxic Stachybotrys
chartarum, and exposed Guinea pigs (255, 256), rabbits (30), rats (30, 87, 117,
250) and mice (101-103, 159), of which two studies used specific pathogen free
animals (102, 103). The increase in inflammatory cells was observed after ≥3 days
and was temporary in most studies within the observation times of 1-26 weeks.
Exposure levels were often high, 105-4⋅107 spores/g bw, and overload of the
alveolar macrophages is likely. One study of A. fumigatus and two studies of toxic
and non-toxic S. chartarum showed inflammation that did not return to normal.
However, the applied doses were so high that mortality was observed in two of the
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studies (117, 159, 250). In three studies, histopathological changes in lung tissue
were dose-related (101, 102, 250).
No inflammation of lung tissue by formation of granuloma and fibrosis was
observed within 4 hours after exposure to A. fumigatus, Aspergillus terreus,
Penicillium aurantiogriseum, Phanerochaete chrysosporium, Rhizopus stolonifera
and S. rectivirgula in pathogen free rabbits (165) and Guinea pigs (58). The doses
were 102 to 2⋅105 spores/g bw and were applied by inhalation except for A. terreus
that was instilled intratracheally. However, granuloma formation was observed
after intratracheal instillation of A. terreus, A. fumigatus, A. versicolor, Clado-
sporium cladosporoides, and toxic and non-toxic S. chartarum spores in rabbits,
rats, mice and specific pathogen free mice (68, 103, 114, 117, 159, 165, 183), and
aerosol exposure of rabbits to A. fumigatus (235). Most granulomas contained
spores, alveolar macrophages and PMN, but also granulomas with eosinophilic
and basophilic granulocytes, germinating spores and hyphae were observed in two
studies of A. fumigatus (117, 235). Granuloma formation was temporary in three
studies (103, 114, 235) with observation times of 3-4 weeks, while the other
studies were shorter (1 week or less) except one high-level exposure study in
which mortality was observed (117). It seems therefore possible that granuloma
formation may regress within a few weeks unless exposure is extremely high.
The inhaled dose of A. fumigatus in the study by Thurston et al, 2⋅104 spores/g bw,
was estimated by culture (235) and may have been more similar to the intratra-
cheal dose applied by Land et al (6⋅106 spores/g bw) (117). In all studies except
the study by Green et al (68) doses of ≥1⋅105 spores/g bw were applied. Macro-
phage overload can therefore not be ruled out at least locally due to intratracheal
instillation.
In sensitised mice, eosinophil counts in lung tissue increased transiently after
intratracheal exposure to 2⋅105 A. fumigatus spores/g bw and fibrosis developed.
The eosinophilic inflammation in lung tissue was much weaker and no fibrosis
was observed in non-sensitised mice (87). However, Thurston et al observed
eosinophils in non-sensitised rabbits after exposure to A. fumigatus by inhalation
(235). The applied dose was probably much higher (see previous paragraph).
A special finding in studies of non-toxic and toxic S. chartarum is the presence
of erythrocytes and haemorrhage in the lung as well as increased haemoglobin
levels (159, 183-185, 250).
Two studies of specific pathogen free mice exposed to A. fumigatus showed
increased levels of the inflammatory markers IL-3, IL-4, IL-18, IFNγ, trans-
forming growth factor beta (TGFβ) and monocyte chemoattractant protein
(MCP)-1/CCL2 in lung tissue and a decreased level of IL-10 (14, 87). Most
changes returned to baseline levels within an observation time of 4 weeks.
Zaidi et al exposed Guinea pigs to Saccharopolyspora rectivirgula spores
(3⋅106-4⋅106 spores/g bw) and 75 mg hay dust or bagasse (255, 256). More intense
cellular inflammation was observed in lung tissue after exposure to hay dust
combined with S. rectivirgula than after exposure to the agents alone. The
inflammation had cleared after 30 days. Fibrosis developed after exposure to
hay dust with and without S. rectivirgula with no differences between the two
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exposure regimes, but no fibrosis occurred after exposure to S. rectivirgula alone
(256). Bagasse dust alone induced small granulomas, S. rectivirgula alone induced
pneumonitis, and interstitial fibrosis developed after combined exposure to these
agents (255).
These results suggest that development of inflammation in lung tissue takes
more than 4 hours. However, the studies with short observation time applied
lower doses than those of longer duration. Intratracheal instillation was mainly
applied, and overload may have contributed to the inflammatory effects. Most
changes returned to normal within a few weeks except after very high doses.
Three species of actinomycetes and eight fungal species showed inflammatory
responses including A. fumigatus, and toxic and non-toxic S. chartarum. Signs
of eosinophilic inflammation were observed after exposure to A. fumigatus in
three studies.
Bagasse dust but not hay dust seems to interact with S. rectivirgula. The
applied doses of hay and bagasse dust correspond to approximately 300 µm3/
alveolar macrophage assuming that Guinea pigs have the same number of alveolar
macrophages as rats (2.5⋅108). This dose exceeds by far the overload limit of 60
µm3/alveolar macrophage suggested by Morrow (147) (Chapters 8.1 and 10.1).
Overload conditions are therefore very likely in these studies and such exposure
levels seem unlikely in the work environment. The observed interaction effects
may thus be irrelevant.
10.4.3 Blood gas parameters
Arterial oxygen pressure and other blood parameters were measured in four
studies using rabbits exposed to airborne Aspergillus terreus spores at levels
from 4⋅102 to 2⋅105/g bw. Levels were measured in lung tissue except the highest
level that was estimated from the applied aerosol (166). In the other studies
exposure levels were underestimated because lung tissue was cultured after
aerosol exposure (11, 23, 164). Decreased arterial oxygen pressure as well
as reductions in platelet counts, haptoglobin and complement were observed,
although platelet counts in one study were unchanged (11, 23, 164, 166). A dose-
response association for arterial oxygen pressure was found in one study. The
latter study also included Aspergillus fumigatus, which reduced arterial oxygen
pressure after exposure to a ten-fold lower dose than A. terreus (164). The dose
estimated from the applied aerosol was probably below the level where macro-
phage overload would occur (approximately 106 spores/g bw for the 2-2.5 µm
spores of A. terreus).
10.4.4 Lung function
Only two studies included lung function parameters. Bronchial hyperreactivity
developed in mice sensitised to Aspergillus fumigatus and in non-sensitised
animals after intratracheal exposure to A. fumigatus spores (87). Airway resistance
increased in rat pups intratracheally exposed to spores of toxic Stachybotrys
chartarum but not after exposure to non-toxic spores (250). These changes
42
returned to normal within 2-4 weeks except in sensitised mice exposed to
A. fumigatus.
In one study, respiratory symptoms were reported. Land et al exposed rats
intratracheally to a single dose of A. fumigatus of five different strains (117). The
animals developed dyspnoea and tachypnea after exposure to four of the strains
and there were clear differences between the fungal strains. No gliotoxin was
detected in the spores of these strains.
In all studies, intratracheally administered spores from pathogenic species were
used and relatively high doses applied, 1⋅105 to 6⋅106 spores/g bw.
10.4.5 Discussion
Inflammatory changes in bronchoalveolar lavage and lung tissue, lung function
changes, and mortality were observed after exposure to diverse fungal and
actinomycete species in different types of laboratory animals. In several studies
overload of the alveolar macrophages is a problem, which may have aggravated
the response. However, such high exposure levels have been measured in relation
to attacks of ODTS (Chapters 8.1 and 11.4.2).
In general, most effects were temporary and returned to baseline levels within
weeks in spite of possible overload. A. fumigatus and toxic S. chartarum generally
elicited stronger responses than other species or non-toxic S. chartarum spores in
comparative studies. Dose-effect relationships were demonstrated in many studies
for various species, mainly for changes in inflammatory cells and markers in
bronchoalveolar lavage and inflammatory changes in lung tissue. The dose-effect
relationships in some of the studies may have been generated artificially due to
local aggregation of spores after intratracheal instillation (Chapter 10.1).
Granulomas in lung tissue contained spores, alveolar macrophages, neutrophils
and lymphocytes. However, after exposure to A. fumigatus also signs of allergic
inflammation were observed as indicated by granulomas with eosinophils,
increases in eosinophils and IL-4 in lung tissue, and increases in serum IgE.
Increases in eosinophils were also found in bronchoalveolar lavage after exposure
to toxic S. chartarum spores, and to A. alternata and C. cladosporoides in
sensitised animals.
One study addressed effects on lung surfactant in bronchoalveolar lavage. Toxic
S. chartarum induced stronger increases than C. cladosporoides. These results
indicate that alveolar type II cells are involved in the inflammatory process but it
is not clear how.
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10.5 Effects of short-term exposures (up to 90 days)
Seven short-term exposure studies have been found that are summarised in Table
10. The one study that applied aerosol exposure is also described in the text.
Fogelmark et al exposed Guinea pigs (n=not given) for 4 hours per day, 5 days
per week for 3 and 5 weeks to dry aerosols of Aspergillus fumigatus (7⋅105 and
3⋅107 spores/m3), Rhizopus stolonifera (2⋅107 spores/m3), Phanerochaete chryso-
sporium (2⋅109 spores/m3), Penicillium aurantiogriseum (1⋅109 spores/m3), and
Saccharopolyspora rectivirgula (3⋅108 spores/m3). The animals were sacrificed 24
hours after the last exposure. Spore concentrations were quantified by microscopic
counting of filter samples. Alveolar macrophage, neutrophil, eosinophil and
lymphocyte counts increased in bronchoalveolar lavage fluid for all examined
species, except alveolar macrophage and neutrophil counts after exposure to
the lowest dose of A. fumigatus. The strongest responses were observed for
P. aurantiogriseum followed by S. rectivirgula. Lung histology revealed changes
ranging from slight cell infiltration of the alveoli after exposure to the lowest dose
of A. fumigatus to severe cell infiltration in alveoli and interstitial tissue, alveolar
wall thickening and granuloma formation after exposure to P. aurantiogriseum
and the highest dose of A. fumigatus (58).
The Fogelmark et al (58) study is the most important study, as it is the only
study in which animals were exposed to spore aerosols. The exposure pattern was
not very different from workplace exposure, and five species were included of
which A. fumigatus at two levels. Exposure levels may have been underestimated
because spores were washed off cellulose ester filters before microscopic count-
ing, and such filters are not suitable for resuspension of collected particles. The
weakest responses were observed after exposure to 7⋅105 spores/m3 of A. fumigatus
with slight signs of lung inflammation. Responses to other species were stronger,
but exposure levels were higher and varied between species. However, some
generalisations can be made; 1) spores from all species induced increased counts
of alveolar macrophages, lymphocytes, neutrophils and eosinophils in broncho-
alveolar lavage fluid; 2) all spore types induced histopathological changes; 3) the
responses did not decline within the observation period; 4) higher exposure levels
of A. fumigatus induced stronger responses than lower levels; and 5) differences
between species were observed: A. fumigatus was more toxic than Rhizopus
stolonifera and Phanerochaete chrysosporium, and Penicillium aurantiogriseum
was more toxic than P. chrysosporium. The lowest observed effect level (LOEL)
was 7⋅105 A. fumigatus spores/m3, which corresponds to 4⋅105 spores/m3 for an
8-hour time weighted average exposure level.
Dose-related lung inflammation was observed in mice exposed intranasally
to spores of Stachybotrys chartarum (50 and 5⋅103 spores/g bw applied twice
weekly for 3 weeks). Spores with high levels of mycotoxins induced stronger
inflammation than spores with low levels (160). No histopathological changes
were observed in the thymus, spleen, or intestines, which are the target organs
for trichothecene mycotoxins.
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In mice intratracheally exposed to spores of the actinomycete Streptomyces
californicus (1⋅102-1⋅106 spores/g bw applied weekly for 6 weeks), dose-related
responses were found in bronchoalveolar lavage fluid for alveolar macrophages,
neutrophils, albumin and haemoglobin, and in lung tissue for activated T-cells and
non-T-lymphocytes (104).
Che et al studied the effect of exposure duration in rabbits and rats that were
intratracheally exposed to Streptomyces thermohygroscopicus (approximately
4⋅107 spores/g bw weekly during 7-10 weeks. Lung histology of both species
showed increased numbers of inflammatory cells as well as granulomas after 2-3
weeks. The granulomas had regressed after 7-10 weeks but were followed by
fibrosis (30). The exposure level in this study was higher than in any other study
in Table 10 (based on spore numbers), but the observation time was also longer.
The applied dose amounts to a volumetric dose of approximately 16 µm3/alveolar
macrophage in rats. This is below the overload limit of 60 µm3/alveolar macro-
phage suggested by Morrow (147) (Chapter 8.1) but intratracheal administration
may still have created overload conditions locally in the lung (Chapters 10.1 and
12.1).
Cooley et al studied the role of spore viability in mice intranasally exposed to
Penicillium chrysogenum (7⋅102 spores/g bw weekly for 6 weeks) (33). Spores
that had been killed by methanol treatment induced non-allergic responses in
blood with increased neutrophil counts and total IgG2a, although specific IgG2a
and specific IgE decreased. In bronchoalveolar lavage fluid IFNγ increased.
Viable spores (25% viability) induced allergic responses in blood with increased
total IgE, specific IgE, specific IgG1 and eosinophils, and decreased specific IgG2a.
In bronchoalveolar lavage fluid, eosinophils, IL-4 and IL-5 increased, and also
lung histology showed some eosinophils.
Schwab et al (215) extended the study by Cooley et al (33) to a 100 times
lower dose (7 spores/g bw weekly for 11 weeks) and used non-sensitised mice
and animals sensitised to P. chrysogenum. Inflammatory responses were only
observed in sensitised mice exposed to viable spores in serum (increased IgE and
IgG1), bronchoalveolar lavage (increased eosinophils) and lung tissue (eosino-
philic and neutrophilic inflammation).
Havaux et al tested sensitised and non-sensitised mice with spores of Alternaria
alternata and Cladosporium cladosporoides. In non-sensitised animals both
allergic (eosinophils in bronchoalveolar lavage (only A. alternata) and upregu-
lated eotaxinreceptors in lung tissue) and non-allergic responses (neutrophilic
inflammation and upregulated receptors for MIP-1α, MIP-2 and MCP-1 in lung
tissue) were found. In sensitised animals, more and stronger responses were
observed as well as airway hyperreactivity. The responses to A. alternata spores
were stronger than to C. cladosporoides but qualitatively similar (74).
Thus, non-allergic and allergic responses to fungal spores of eight species were
observed after repeated exposures in seven studies (30, 33, 58, 74, 104, 160, 215).
In one of those, the applied dose was 10 - >1 000 times lower than in the other
studies, and inflammatory responses, including allergic responses in broncho-
alveolar lavage, lung tissue and blood were observed in sensitised animals that
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had been exposed to viable spores (215). As expected, prior sensitisation in-
creased the intensity of allergic inflammation, but also non-allergic inflammation
was increased. Dose-related responses were observed in all three studies that
applied more than one dose level (58, 104, 160). The importance of viability of
the spores was demonstrated in two of the studies (33, 215) and it seems likely
that at least a fraction of the spores were viable in the other studies although
this was not mentioned. Two studies of two Streptomyces species showed only
non-allergic inflammation (30, 104), but these results cannot be generalised to
actinomycetes because Saccharopolyspora faeni induced eosinophils in broncho-
alveolar lavage fluid (58).
In summary, repeated exposure studies demonstrated long-lasting inflammatory
changes in bronchoalveolar lavage fluid, lung tissue and blood. Differences
between species that partly depended on the presence of mycotoxins, and dose-
related responses were generally observed.
Allergic responses to spores of various fungal species were observed in all
studies. Viable spores induced allergic responses in contrast to non-viable spores.
In one study with very low exposure allergic and non-allergic inflammation was
only observed in sensitised mice exposed to viable spores.
A single study showed that trichothecene mycotoxins in S. chartarum spores
did not affect the target organs for these toxins after oral exposure.
A LOEL of 7⋅105 A. fumigatus spores/m3 was observed in Guinea pigs in the
only study applying aerosol exposure (4 hours) (58).
10.6 Mutagenicity and genotoxicity
No studies have been found.
10.7 Effects of long-term exposure and carcinogenicity
Several mycotoxins are recognised carcinogens, e.g. the aflatoxins and ochra-
toxin A. Inhalation of spores containing the toxin as well as particles originating
from the substrates with fungal growth represent potential sources of exposure to
working populations (27). Experimental studies of the carcinogenicity of the pure
substances have been carried out but no studies of spores from fungi applied via
the respiratory route have been found.
10.8 Reproductive and developmental studies
No studies have been found.
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10.9 Discussion
Single and repeated exposure studies showed proinflammatory and inflammatory
responses in the lung. In bronchoalveolar lavage fluid, increases in alveolar
macrophages, PMN as neutrophils and eosinophils, pro-inflammatory cytokines
such as TNFα and IL-6, and markers of tissue damage as lactate dehydrogenase,
albumin and haemoglobin were observed. In lung tissue, alveolar macrophages,
PMN, lymphocytes, pro-inflammatory cytokines such as IL-3, IL-4, IL-18, TNFα,
TGFβ and MCP-1/CCL2 increased, IL-10 decreased and granulomas were
formed. Only one study observed fibrosis (90 days after repeated exposures to
high doses of an actinomycete). A major difference between single and repeated
exposure studies is that most changes were temporary after exposure to a single
dose, whereas repeated exposures generally induced responses that persisted
throughout the observation period.
Several single and three repeated exposure studies demonstrated dose-effect
associations. However, in most studies the maximum applied doses were so high
that overload seems likely. Only in the studies by Olenchock et al, Fogelmark et
al and Nikulin et al were dose levels below 104 spores/g bw applied (58, 160,
164). These studies showed dose-effect associations between arterial oxygen
tension and a single exposure to Aspergillus terreus, between inflammatory cells
in bronchoalveolar lavage and inflammatory changes in lung tissue and prolonged
exposure to aerosols of A. fumigatus spores, and between severity of lung inflam-
mation and repeated intranasal exposures to toxic and non-toxic Stachybotrys
chartarum, respectively. All tested species induced inflammatory effects but
differences between species were observed in several studies. Species differences
partly depended on mycotoxin production by the microorganism, as has been
shown in several studies of S. chartarum. However, species not known as toxin
producers, e.g. a strain of A. fumigatus not producing gliotoxin, S. rectivirgula,
and Penicillium aurantiogriseum, also elicited strong responses. It cannot be ruled
out, however, that microorganisms may produce toxins that have not yet been
identified.
Many studies reported non-allergic inflammatory responses involving TNFα,
IL-6, alveolar macrophages and neutrophils. However, as the majority of the
studies applied single exposures, development of an adaptive immune response
was prevented. Interestingly, in all repeated exposure studies including various
fungi allergic inflammation were observed together with non-allergic inflam-
mation. Viable spores and prior sensitisation were important determinants of the
allergic response (33).
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11. Observations in man
Studies with quantitative information on spore exposure, mainly obtained by
culture-based methods and microscopic methods, are reviewed. Spore levels
measured by culture methods were multiplied by a factor of 10 to estimate
airborne spore levels, although the ratio spore/cfu varied from 1.5 to 100 in
comparative studies; for a review see Eduard and Heederik (51). Studies using
specific serum IgG antibodies as measure of exposure are excluded, as immuno-
globulin levels are difficult to extrapolate to airborne spore levels. Human
challenge studies using fungal extracts are included as these studies provide
information on the specificity of the response.
Case reports (human challenge studies) are summarised in Tables 11-12 and
Appendix 8, epidemiological studies of highly exposed populations in Table 13
(symptoms), Table 14 (objective outcomes), and Appendix 6, and epidemiological
studies of populations with common indoor exposure in Table 15 and Appendix 7.
Tables 13-15 include only studies where associations were adjusted for confoun-
ders. If no specific levels were reported for an increased response, the median of
the reported exposure levels was used to indicate the exposure level where the
outcome was increased.
Diseases are described shortly in Appendix 1 and in more detail in Chapter 8.
11.1 Irritation
This chapter includes eye, nose, and throat irritation (Tables 13, 15). Symptoms
and effects of the lower airways are reviewed in Chapters 11.4 and 11.5.
11.1.1 Highly exposed populations
Irritation symptoms in the eyes and nose were recorded by a questionnaire simul-
taneously with exposure measurements in a study of 89 Norwegian farmers (49).
Exposure to many agents was measured including fungal and actinomycete
spores, bacteria, endotoxins, glucans, Aspergillus/Penicillium antigens and silica.
The prevalence of eye irritation was significantly elevated after exposure to 2⋅104-
5⋅105 fungal spores/m3 (odds ratio (OR) 8.3, 95% confidence interval (CI) 1.0-70
compared to exposure below 2⋅104 fungal spores/m3) and was not associated with
any of the other agents. The prevalence of nasal symptoms was elevated after
exposure to 2⋅104-5⋅105 fungal spores/m3 (OR 4.1, 95% CI 0.88-19) and signifi-
cantly after exposure to 5⋅105-2⋅107 fungal spores/m3 (OR 6.0, 95% CI 1.3-28).
Nasal symptoms were also associated with silica exposure and both agents seemed
to induce these symptoms, as the correlation between the two exposures was not
very strong.
Work-related cough, nasal irritation and sore throat have been studied by ques-
tionnaires in cross-sectional studies of wood workers in Norway and Australia,
and were associated with fungal exposure (6, 54). In wood trimmers, exposure
to 2⋅106 spores/m3 was associated with a 50% relative increase in self-reported
cough, nasal irritation and sore throat (54). However, this study may suffer
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from reporting bias as work-related symptoms had been recorded conditional
on handling of mouldy timber. In joinery, sawmill and chip mill workers an
increased prevalence of throat irritation was observed at an exposure level of 3⋅104
cfu/m3 or 3⋅105 spores/m3 (6). The dominant fungi in these studies were Rhizopus
microsporus (42%), and Penicillium/Aspergillus species (71%), respectively.
In both studies of wood workers associations were adjusted for age, smoking
and gender but not for atopy. Other relevant exposures such as wood dust (6, 54)
and endotoxins, glucans and Gram-negative bacteria (6) were either adjusted for
(54) or studied in separate models (6). In the latter study, endotoxins were also
associated with sore throat, but more weakly than fungal spores. Confounding of
the association with fungal exposure is not likely because endotoxin exposure was
only moderately correlated with fungal exposure. The farmer study (49) is the
most reliable as all relevant short-term exposure was measured. This study indi-
cates LOELs for nose irritation of approximately 3⋅106 spores/m3 (geometric mean
of the range 5⋅105 to 2⋅107 spores/m3) and for eye irritation of approximately 1⋅105
spores/m3 (geometric mean of the range 2⋅104 to 5⋅105 spores/m3) calculated to
equal 8-hour exposures. The Australian sawmill study (6) indicates a LOEL for
sore throat of 3⋅105 spores/m3 based on average exposure levels. No single species
was more potent in the data analysis.
11.1.2 Populations exposed to common indoor air
Li et al studied 264 day-care workers from 28 randomly selected day-care centres
in Taiwan. Nasal congestion and discharge were associated with total fungal
levels, and nasal congestion also with Aspergillus levels (geometric means 1 200
cfu/m3 and 32 cfu/m3, respectively, n not given). Cladosporium and Penicillium
were the dominating species. Associations were adjusted for age, gender, and
education, but not for smoking. House dust mite allergens were measured in
settled dust but were not associated with any outcome. The study suggests that
Aspergillus may be more irritating than other species as Aspergillus comprised
only a small fraction of all culturable fungi (124). Alternatively, this association
might be due to a correlation with the total fungal count, as such correlations were
not assessed.
Purokivi et al compared eye symptoms in 37 employees from a school building
with moisture problems and fungal growth with 23 employees from a school
without such problems in Finland at the end of spring term (181). Symptom
prevalences were not significantly different. Fungal levels in the problem and
non-problem buildings in the winter were 29 and 6 cfu/m3 (geometric mean),
respectively. No confounder adjustments were carried out, however.
Roponen et al studied nasal, laryngeal, and eye symptoms in 41 randomly
selected Finnish teachers (203). Exposure to fungi was measured by personal
sampling during 24 hours at home and 8 hours at work and the teachers were
dichotomised into groups with low and high exposure. Exposure levels in these
groups were 12 cfu/m3 (median, range 0-31 cfu/m3) and 67 cfu/m3 (median, range
31-270 cfu/m3), respectively. The prevalences of all symptoms were similar in the
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two groups. Exposure to bacteria was also measured. The influence of smoking
and asthma status was evaluated by stratified analysis.
Thus, only the study by Li et al found associations between nasal irritation
and fungi (124). This may be due to much higher exposure levels in this study
compared to the other studies. Li et al used random selection and controlled
for confounders, which strengthen the reliability of their results, although the
exposure assessment is poorly described. The geometric mean provides a LOEL
estimate of approximately 1⋅104 spores/m3. The study by Roponen et al (203) has
a strong design as both home and work exposure were assessed. The exposure
level of the highest exposed group in this study, median 67 cfu/m3 or approximately
700 spores/m3, thus represent a no observed effect level (NOEL) for irritation.
11.2 Sensitisation
Sensitisation is often understood as the presence of serum IgE antibodies to a
specific allergen. However, also hypersensitivity pneumonitis patients are more
sensitive to exposure to allergens, which indicates that the sensitisation is not
mediated by IgE. It is more likely that cytotoxic T-cells are involved (99, 174,
205) (Chapter 8.2). The hypersensitivity can be shown by bronchial challenge
and such studies are therefore also included here.
11.2.1 Human challenge studies
Fungi and actinomycetes have been identified as causes of hypersensitivity
pneumonitis and asthma by bronchial challenge of patients with the suspected
antigens. Provocations have mainly been carried out with extracts of the orga-
nisms to avoid late responses that may be provoked by spores. Positive tests are
strong evidence of sensitisation when performed with specific microorganisms
from the work environment. Challenge studies therefore provide important
information about the aetiology of diseases associated with fungi.
Provocation tests were carried out with close surveillance of patients (177), but
are no longer recommended because of the risk of severe late reactions and lack
of standardised antigens (197, 205). Exposure challenge to the workplace atmos-
phere is regarded sufficient to demonstrate an association with the disease, but
identification of the causal agent(s) is difficult when the patient is exposed to
many different agents.
The focus of this chapter is on species that may cause sensitisation, while the
applied doses are discussed in Chapter 11.4.1.
Table 11 summarises studies on hypersensitivity pneumonitis including more
than a single case. The provocations were carried out with spores or extracts of the
implicated organism, or by exposure to work environments with one dominating
species. A relevant non-occupational study (7) is also included in the table.
Studies reporting a single case identified Aspergillus clavatus, Aspergillus
glaucus, Lentinus edodes, Aspergillus fumigatus, Saccharomonospora viridis,
Scopulariopsis brevicaulis and Ustilago esculenta as cause of hypersensitivity
pneumonitis in a malt worker (198), two mushroom workers (132, 251), a green-
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house worker (253), a logging worker who also raised pigs (69), a tobacco worker
(118) and a traditional handicraft worker (252), respectively.
The case studies show that hypersensitivity pneumonitis can be induced by
several species of Aspergillus and Penicillium as well as mushrooms, smuts, wood-
rot fungi, and actinomycetes. Most patients tested positive for a single species.
Ando et al (7) even showed that the response was specific to a serotype. Thus, the
sensitisation seems to be specific although widely different species are involved.
Challenge studies of asthmatic cases are summarised in Table 12. Reports
describing a single case identified Neurospora sp. and Serpula lacrymans as
causal agents of asthma in a plywood factory worker (34) and in a patient from
a home with extensive dry rot (163), respectively. The latter patient was also
diagnosed with hypersensitivity pneumonitis.
Only four occupational studies of asthmatic patients have been found. In two of
these studies specific IgE or skin prick tests were negative (39, 217) indicating
that the asthma was non-allergic. In three studies of hypersensitivity pneumonitis
patients, obstructive responses were also observed (55, 69, 178) and one patient in
the study by Edwards et al developed an immediate asthmatic response (55). These
studies indicate that fungi and actinomycetes may also induce asthma attacks.
Two studies of nasal hypersensitivity were found. Thirteen furniture workers
with positive skin prick tests to fungi and three with elevated total IgE from a
population of 268 workers from five factories were challenged by nasal provo-
cation with fungal extracts. Five workers had positive tests but fungal species
were not reported (246). Seuri et al tested all 14 employees from a small hospital
with repeated water damage (217). Total fungal levels exceeded 500 cfu/m3 at
several locations, and approximately half of the counts were of Sporobolomyces
salmonicolor. Nasal provocations with S. salmonicolor extract were positive in
11 workers, but skin prick tests with S. salmonicolor were negative in all 12
employees tested. Three of the employees were atopic as evaluated by skin prick
tests.
No studies of ODTS patients challenged by bronchial provocation tests have
been found, probably because of the benign course of the disease (Chapter 8.3).
The asthma and nasal hypersensitivity studies show that the sensitisation to
fungi was IgE-mediated only in a fraction of the cases and in hypersensitivity
pneumonitis patients IgE is usually absent. It seems therefore likely that other
mechanisms are involved. The specificity of the response is most clearly demon-
strated in hypersensitivity pneumonitis studies, where extracts of several species
were often applied.
Most challenge studies used extracts. Aerosols of extracts differ from aerosols
of spores by metabolite composition, particle size, and solubility. In spite of this,
typical attacks of hypersensitivity pneumonitis and asthma were observed after
provocation with extracts.
11.2.2 Epidemiological studies
Few studies have been found on IgE-mediated sensitisation to fungi.
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Thomas et al found no elevation of IgE against fungi in 19 workers with work-
related symptoms (cough, wheeze or dyspnoea) from a population of 197 coffee
workers exposed to 3⋅103-2⋅104 fungal cfu/m3 using species isolated from the
work environment (234). IgE levels to green coffee beans and castor beans were
elevated, 14% and 15%, respectively.
However, Zhang et al reported high prevalences of IgE and positive skin prick
tests to Aspergillus fumigatus, 27% and 19%, respectively, and to Rhizopus
nigricans, 52% and 24%, respectively, in 130 Chinese tobacco workers (260).
Fungi were measured by sedimentation on culture plates showing that these fungi
were also abundant in the air.
Studies by Larsen et al (120) and Meyer et al (136) on staff members from a
school contaminated by fungi failed to demonstrate IgE against species found on
building construction materials by skin prick tests or Magic Lite tests in staff
members. However, serum IgE against fungi isolated from the school building
was demonstrated by histamine-release tests using blood basophils isolated from
the participants (120) or by passive immunisation with the participants serum
(119, 136). No fungal levels were reported.
In 39 greenhouse workers, a high rate of sensitisation to fungi (18%) and
flowers (21%) by skin prick testing was found (141). The workers were exposed
to 5⋅103 fungal cfu/m3.
As no studies have been published with information on exposure levels of the
specific organisms, unpublished results of a Norwegian population of wood
trimmers are interesting. Results communicated by B Rydjord (National Institute
of Public Health, Oslo, submitted for publication) show that levels of IgE against
Rhizopus microsporus were elevated in 1 of 343 sawmill workers. The most
intensively exposed workers in this population were wood trimmers exposed to a
median level of 3⋅106 spores/m3, about half of which were from R. microsporus
(54). Levels of IgE against R. microsporus in healthy blood donor controls were
elevated in 2 of 100.
The information on sensitisation to fungal spores in working populations
with relatively high exposure levels is contradictory. It is surprising that sensiti-
sation was practically absent among sawmill workers who were exposed to high
levels of Rhizopus microsporus spores. The reason for this is not understood
as tobacco workers showed a high prevalence of sensitisation to the related fungus
Rhizopus nigricans.
The higher prevalence of sensitisation found by the histamine-release test in
the indoor air studies (120, 136) may be due to the use of whole spores of fungi
isolated from the workplace, which seems more relevant than the use of fungal
extracts in RASTs and skin prick tests. It is also possible that the histamine-
release test is more sensitive than skin prick tests and RASTs, although good
agreement has been reported for fungal allergens in children (71, 162). Both
indoor air studies were performed by the same research group, and confirmation
of their findings in other indoor air studies and in highly exposed populations is
needed (see also Chapter 9.2).
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11.3 Effects of single exposure
Inhalation tests of naive subjects have not been performed because of concerns
of inducing irreversible sensitisation and allergy.
Brinton et al described an incident among novice college students (20). The
students participated in a “hay party” in a poorly ventilated room where the floor
had been covered with straw that emitted dense clouds of dust that did not settle
rapidly. Fifty-five of 67 students developed typical ODTS symptoms with cough,
muscle aches, and fever. Although no microbiological investigations were per-
formed it seems likely that the straw emitted large numbers of spores from fungi
and/or actinomycetes. As the incident occurred in students, previous exposure to
such levels is unlikely except for those raised on a farm. These findings indicate
that prior sensitisation is not needed for development of attacks of ODTS.
11.4 Effects of short-term exposure
This chapter includes provocation tests of patients with respiratory disease
inhaling spores of organisms suspected of causing the disease, and epidemi-
ological studies of acute responses recorded concurrent with exposure
measurements. Both study designs may demonstrate effects of short-term
exposure in repeatedly exposed individuals, and reflect exacerbations of
pre-existing health effects.
11.4.1 Provocation tests
Bronchial and nasal provocation tests have been carried out to study the role of
fungi and actinomycetes in hypersensitivity pneumonitis, allergic asthma, and
allergic rhinitis (Chapter 11.2.1). In these tests, subjects are exposed to either a
single dose or increasing doses of an agent until a reaction of sufficient intensity
occurs or the maximum predefined dose has been reached.
Studies that have applied challenge with spores are summarised in Tables 11-
12, and are described in more detail in Appendix 8. Bronchial provocations with
Aspergillus clavatus, Lentinus edodes, and Pleurotus ostreatus were positive in
malt - and mushroom workers with hypersensitivity pneumonitis after inhaled
doses of 109, 3⋅107 and 107 spores, respectively. The dose of Aspergillus clavatus
was specified as 20 mg of dry spores without further details, while the latter
two doses were based on occupational exposure levels causing attacks of hyper-
sensitivity pneumonitis (35, 36, 198). Only a single dose was applied in these
studies.
One study was performed in patients with mild non-occupational asthma using
increasing doses of spores of Alternaria alternata and a Penicillium sp. Seven
patients with strongly positive skin prick tests to these fungi were challenged with
graded doses (10-fold increments) of the organism they were allergic to. The
spores were mixed with lactose and inhaled with Spinhalers, probably during one
or a few inhalations (number not specified). The minimum doses for a positive
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bronchial provocation test were 9⋅104 A. alternata spores and 6⋅104 Penicillium
sp. spores (125).
Eight employees from moisture-damaged schools with building-related
symptoms but without asthma were challenged with aerosols of Penicillium
chrysogenum and Trichoderma harzianum at single concentrations during 6
minutes of 6⋅105 and 3.5⋅105 spores/m3, respectively. No changes in mucosal or
systemic symptoms, lung function or leukocytes in blood were observed com-
pared to placebo exposure. Participants had positive P. chrysogenum histamine-
release tests for detection of specific serum IgE but T. harzianum tests were
negative. Skin prick tests to these fungi were also negative (135).
These findings suggest that asthma attacks may be induced at lower dose
levels than hypersensitivity pneumonitis in IgE-sensitised individuals. However,
the number of studies is small, the species vary and it is not known if lower doses
could have induced a positive response in the hypersensitivity pneumonitis
studies as single dose levels were applied. The study on asthma patients (125)
indicates LOELs in a sensitive group of 2⋅104 A. alternata spores/m3 and 1⋅104
Penicillium sp. spores/m3 calculated to equal 8-hour exposures by dividing the
applied doses with 5 m3 assuming a minute ventilation of 10 l/min during 8 hours.
The findings in the employees from moisture-damaged schools with building-
related symptoms indicate NOELs of 8⋅103 P. chrysogenum spores/m3 and 4⋅103
T. harzianum spores/m3 calculated to equal 8-hour exposures in individuals with
IgE to P. chrysogenum but not to T. harzianum. However, the significance of the
detection of IgE by the histamine-release test used in the latter study (135) is
uncertain (Chapter 9.2).
In one study, symptom-free garbage recycling workers and retired garbage
workers with occupational asthma were tested by nasal provocation with a
suspension of A. fumigatus spores containing approximately 6⋅107 spores/ml. No
differences in inflammatory markers or nasal volume were observed between
the two groups or when compared to sham challenge (223).
11.4.2 Epidemiological studies
Further information on short-term exposure was obtained from epidemiological
studies of work-related symptoms and short-term functional changes, e.g. cross-
shift change in lung function. Work-related irritation symptoms are reviewed in
Chapter 11.1. Other outcomes are summarised in Appendix 6-7 and studies with
confounder adjustment have been summarised in Tables 13-15.
Highly exposed populations: Fever attacks of ODTS and hypersensitivity
pneumonitis
Patients who develop febrile attacks often recover within a few days without
functional and X-ray changes or persisting symptoms. This condition is different
from hypersensitivity pneumonitis (Chapter 11.5.1) and is called organic dust
toxic syndrome (ODTS), toxic alveolitis or inhalation fever (56, 187) (Chapter
8.3). The yearly incidence has been estimated to 10-190 per 10 000 farmers (56).
Febrile attacks may also occur in farmers with hypersensitivity pneumonitis. The
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role of fungal spores in ODTS is often clear as attacks rapidly develop after the
farmer handled mouldy materials emitting large numbers of spores.
Malmberg et al found that 6 farmers with diagnosed ODTS experienced fever
attacks after exposure to 14⋅109 spores/m3, and 4 farmers with hypersensitivity
pneumonitis reported fever attacks after exposure to 3⋅109 spores/m3 (arithmetic
means) (130). Another difference was that farmers with ODTS had carried out
extraordinary tasks such as removal of spontaneously heated grain that lasted
typically 1 hour, while farmers with hypersensitivity pneumonitis carried out
work that they did once or twice daily with a duration of 15-30 minutes. Maxi-
mum exposure levels in 17 farmers without febrile symptoms were much lower,
1⋅108 spores/m3 (arithmetic mean). Exposure had been measured when the work
causing a fever attack was repeated. The exposure level calculated to equal an
8-hour exposure was 2⋅109 spores/m3 in farmers with ODTS, 1⋅108-4⋅108 spores/m3
in farmers with hypersensitivity pneumonitis, and 3⋅106-1⋅107 spores/m3 in non-
symptomatic farmers. No species dominated and the proportion of actinomycetes
ranged from <1 to 96%.
Malmberg et al reported in another paper that the fever reactions were not
attributable to endotoxins (129), as exposure levels were similar in farmers
experiencing fever attacks and non-symptomatics although levels were high,
300 000 EU2/m3.
These results indicate a LOEL for fever attacks of 2⋅109 spores/m3 in farmers
with ODTS and a LOEL for individuals with hypersensitivity pneumonitis of
1⋅108-4⋅108 spores/m3.
Highly exposed populations: Work-related cough
Work-related cough was significantly elevated (OR 3.9, 95% CI 1.0-15) in 89
farmers after exposure to 5⋅105-2⋅107 fungal spores/m3 calculated to equal an
8-hour exposure and adjusted for confounders except atopy. Exposure to many
other agents was measured but none were associated with cough (49).
In 22 municipal waste handlers, cough was associated with exposure to fungal
spores but not with endotoxins and bacteria. The median exposure level of the
symptomatic workers was 3⋅105 spores/m3. Confounding by smoking and age was
evaluated qualitatively (78).
In both studies, cough was associated with short-term exposure to fungal
spores. Exposure was measured on the same day as symptoms were recorded, a
design eliminating the between day variability provided that the symptoms are
a response to short-term exposure. In the farmer study by Eduard et al (49) a
higher exposure level was associated with an increased prevalence of cough,
approximately 3⋅106 spores/m3 (geometric mean of the range 5⋅105-2⋅107 spores/m3,
calculated to equal an 8-hour exposure) than in the waste handler study (78). This
may either be a real difference, which reveals differences in the fungal flora in the
                                    
2 EU = endotoxin units, relative measure obtained by comparison to a standard endotoxin
prepared from E. coli. A Dutch occupational exposure limit of 200 EU/m3 has been
adopted.
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two environments, or be due to a shorter exposure time in the farmer study.
However, the small sizes of the populations and the lack of exposure data at the
species level prevent exploration of such hypotheses. Other bioaerosol agents
such as bacteria, endotoxins, and glucans were not associated with cough. Thus,
LOELs of 3⋅105 spores/m3 are indicated in waste handlers and 3⋅106 spores /m3 in
farmers.
Highly exposed populations: Lower airway inflammation
Heldal et al studied 25 organic waste collectors and measured inflammatory
cells and markers in induced sputum on Monday morning and Thursday morning
before work (80). Inflammatory changes were observed during this period but no
correlations were found with fungal spore exposure (median 2⋅105 spores/m3). The
IL-8 increase was correlated with exposure to glucans, but glucan exposure was
only weakly associated with fungal spores. This association is therefore more
likely due to glucans from non-fungal origin.
Highly exposed populations: Lung function
Lung function and fungal exposure was studied during four workdays in 29
wood trimmers from two sawmills with median exposures of 1⋅104 cfu/m3 and
3⋅105 cfu/m3, respectively. The FVC decline was significant in the sawmill with
highest exposure. FVC decline as well as forced expiratory volume in one second
(FEV1) and FVC as % of predicted at the end of the 4-day period were correlated
with exposure to fungi. Lung function had also been measured three months
earlier but no exposure measurements were performed at that time. Declines in
FVC and FEV1 were observed after 3 months in workers from the sawmill with
the highest exposure, while the lung function in workers from the other sawmill
did not change (76). No information on production changes was provided. It
seems likely, however, that the exposure levels were similar during the follow-up
as it takes time to implement preventive measures and to sort all unsorted dry
timber in stock.
FEV1 and maximum expiratory flow at 25% of FVC (MEF25) declined during
the workweek in 28 wood trimmers and correlated with exposure to fungi (median
1⋅105 spores/m3 dominated by Rhizopus and Paecilomyces) (38). Exposure to dust,
terpenes, bacteria, and endotoxins were also measured and were low, except to
bacteria (medians 0.3 mg/m3, 10 ppm, 1⋅105 cells/m3 and 20 EU/m3, respectively).
No adjustments were made for confounders in neither study, but studying intra-
individual changes in lung function reduces confounding by gender and age since
subjects are compared with themselves. The effect of smoking was evaluated
by separate analysis of smokers and non-smokers, but had no major influence
on the associations. In the study by Dahlquist et al (38), exposure to total dust,
endotoxins and terpenes was low and not likely to cause lung function changes.
Microscopical counts of bacteria were similar to fungal counts but were not
evaluated.
Both studies showed associations between lung function changes and exposure
to fungi, which was most consistent for FEV1. The study by Dahlquist et al (38)
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indicates that associations with lung function are observable at median exposure
levels of 1⋅105 spores/m3. A more than 10 times higher level is indicated by the
study by Hedenstierna et al, however (76).
Highly exposed populations: Upper airway inflammation
Nasal lavage fluid was analysed for inflammatory markers in two studies.
Roponen et al studied 11 sawmill workers and found no differences between
NO, TNFα, IL-4, IL-5 and IL-6 levels in nasal lavage after work compared to
samples collected during vacation. The exposure level of fungal spores was 6⋅105
spores/m3 (median, mainly Rhizopus and Penicillium) and exposure to endotoxins
and terpenes was also measured (202).
Heldal et al performed nasal lavage in 31 municipal waste handlers on Monday
morning and Thursday morning. Exposure to fungal spores (median 2⋅105 spores/
m3), bacteria, actinomycetes spores, endotoxins, and glucans was measured
between the lavages. The increase in proportion of neutrophils from Monday to
Thursday and the level on Thursday was associated with exposure to fungal
spores, whereas other inflammatory cells, myeloperoxidase, IL-8 and eosinophilic
cationic protein (ECP) were not. Possible confounding by smoking and age was
evaluated qualitatively (79).
Both studies agree in not finding associations between fungal spore exposure
and inflammatory cytokines. Heldal et al (79) found associations with neutrophilic
lymphocytes, which indicate an inflammatory response. Roponen et al (202) did
not study inflammatory cells. Thus, there is some evidence for a cellular response
to fungal spores at a level of 2⋅105 spores/m3. No changes in the level of inflam-
matory mediators were found, however. Associations with IL-8 were expected
because neutrophils are attracted by IL-8. Possible explanations are high intra-
and interindividual variability and different temporal developments of the IL-8
and neutrophil responses. A LOEL of 2⋅105 spores/m3 for neutrophilic infiltration
is thus indicated.
Highly exposed populations: Nasal congestion
Heldal et al studied nasal congestion in 31 municipal waste handlers by acoustic
rhinometry (79). A correlation was found between change in nasal congestion and
fungal spore exposure (median 2⋅105 spores/m3). The association was not due to
confounding or exposure to other agents (bacteria, actinomycetes spores, endo-
toxins and glucans). A LOEL of 2⋅105 spores/m3 is thus indicated by this study.
Populations exposed to common indoor air
Roponen et al studied 41 randomly selected teachers (203). Exposure to fungi
and bacteria were measured at work and at home. Irritation, non-specific symp-
toms and the levels of NO, IL-4, IL-6 and TNFα in nasal lavage were similar in
groups with high and low exposure to fungi (medians 12 cfu/m3 and 67 cfu/m3).
IL-1β was elevated in the high exposure group but not significantly. Particles
were resuspended from the filters and tested for cytokine production with a mouse
RAW264.7 macrophage cell line. In this assay samples of the high exposure
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group showed stronger IL-1β and IL-6 responses than samples of the low exposed
group, while no differences in TNFα and cell viability were observed.
These results are not likely to be due to random variation because the intra-
individual variability of the cytokines in the nasal lavages and the mouse macro-
phage tests was relatively low, subjects were randomly selected, and exposure at
home was included in the exposure assessment. Separate analyses in smoking and
asthma status subgroups showed that the findings were not due to confounding.
This study thus indicates that the two groups were exposed to particles with
different inflammatory potential, but that this did not result in observable changes
in nasal lavage. This may be due to differences between the individual responses
as the correlation between IL-1β, IL-6 and TNFα levels in the nasal lavages and
the macrophage assays were low. However, inflammatory reactions of cells in the
human nose may be different from isolated cells of a mouse macrophage cell line.
Furthermore, the exposure levels may have been too low. The median exposure of
the highest exposed group, 67 cfu/m3, is regarded as a NOEL for irritation and
non-specific symptoms, and inflammatory markers in the upper airways. This
estimate represents a 24-hour time weighted average.
11.4.3 Discussion of effects of short-term exposure
Inhaled doses inducing a 35% increase in airway conductance in asthmatic
patients after bronchial challenge were 6⋅104 Penicillium sp. spores and 9⋅104
Alternaria alternata spores (125). The patients were sensitised to the fungus used
in the challenge and thus represent a susceptible group. The dose was inhaled over
a short time period, but when the minimum dose for a positive challenge response
was calculated to equal an 8-hour exposure by dividing the applied dose with 5 m3
assuming a minute ventilation of 10 l/min during 8 hours, concentrations of 1⋅104
and 2⋅104 spores/m3 were found for the two fungal species, respectively.
In employees from moisture-damaged schools with building-related symptoms
and sensitised to P. chrysogenum but without asthma, NOELs of 6⋅105 P. chryso-
genum spores/m3 and 3.5⋅105 T. harzianum spores/m3 were found by bronchial
challenge to a single concentration for 6 minutes (135). Also this group may be
susceptible although less than the former. The applied doses are equal to 4⋅103-
8⋅103 spores/m3 for 8 hours.
In highly exposed working populations (farmers, sawmill workers and waste
handlers), LOELs of 1⋅105-2⋅105 spores/m3 were found for nasal congestion, eye
irritation, sore throat, and lung function changes (6, 38, 49, 76, 79). A higher
LOEL of 3⋅106 spores/m3 was found for nose irritation in farmers, but the preva-
lence was already increased (OR 4.1, 95% CI 0.88-19) at an exposure level of
1⋅105 spores/m3, although not significantly (49). No changes in inflammatory
markers were found in the upper or lower airways in four studies of sawmill
workers, waste handlers and teachers (79, 80, 202, 203). However, in waste
handlers neutrophils in nasal lavage but not in induced sputum were associated
with fungal spore exposure at a median level of 2⋅105 spores/m3 (79).
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Cough seems to be related to higher exposure levels with LOELs of 3⋅105
spores/m3 in a waste handler study (78) and 3⋅106 spores/m3 in a study of farmers
(49).
Even higher levels induced fever. Bronchial challenge of patients with
hypersensitivity pneumonitis using the main species found in the environment
(Aspergillus clavatus, Pleurotus ostreatus and Lentinus edodes) induced typical
attacks including fever in mushroom workers (35, 36) and a malt worker (198).
The applied doses are equal to 2⋅106-2⋅107 spores/m3 (calculated to equal an 8-hour
exposure). An epidemiological study in farmers (130) indicated even higher
exposure levels, 1⋅108-4⋅108 spores/m3 in hypersensitivity pneumonitis patients,
2⋅109 spores/m3 in ODTS patients, and 3⋅106-1⋅107 spores/m3 in non-symptomatic
farmers (equal to an 8-hour exposure). The farmers were exposed to spores from
various fungal and actinomycete species.
The response in bronchial challenge studies of patients with hypersensitivity
pneumonitis or asthma shows species specificity (Chapter 11.2.1), whereas
attacks of ODTS seem not to require previous sensitisation (Chapter 8.3). The
other studies provided little information on the importance of specific fungi.
11.5 Effects of long-term exposure
11.5.1 Epidemiological studies
Epidemiological studies of hypersensitivity pneumonitis, asthma, chronic
bronchitis, and systemic symptoms are reviewed as well as studies of chronic
lung function loss and X-ray changes.
Highly exposed populations: Hypersensitivity pneumonitis
The role of fungal spores in occupational respiratory disease was probably first
recognised in hypersensitivity pneumonitis. The disease is characterised by
alveolar and bronchiolar inflammation, and is caused by inhalation of spores
from fungi and actinomycetes, and also by other allergens. Acute attacks are
similar to ODTS. Recurrent attacks may eventually progress into pulmonary
fibrosis. IgG but not IgE can usually be detected (Chapter 8.2). The incidence
of hypersensitivity pneumonitis is lower than that of ODTS, 2-30 and 10-190
per 10 000 farmers/year, respectively (56).
Ávila and Lacey diagnosed 26 patients with hypersensitivity pneumonitis
among 648 cork workers in a cross-sectional study (prevalence 4%) (9). Penicil-
lium glabrum (previous name frequentans) was the dominating fungus with
exposure levels ranging from 1⋅106 to 7⋅107 spores/m3 in different departments.
Current exposure was not associated with hypersensitivity pneumonitis. However,
as the disease develops after prolonged exposure and workers changed jobs fre-
quently, current exposure was not a good measure of relevant exposure. The role
of P. glabrum was demonstrated by bronchial provocation of 19 cork workers (9)
(Table 11). Although information on exposure levels in the past is lacking, these
may not be very different from current exposure levels as no mention was made of
preventive measures in spite of the large number of workers with hypersensitivity
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pneumonitis. It seems therefore possible that hypersensitivity pneumonitis can
develop after prolonged exposure to the mean levels found in this study,
approximately 107 spores/m3.
Wenzel and Emanuel found 5 cases of hypersensitivity pneumonitis with inter-
stitial pneumonitis and granuloma among 37 papermill workers (prevalence 14%)
exposed to spores of Cryptostroma corticale (243). Cases developed during
periods when exposure was highest (mean level probably 5⋅106 C. corticale
spores/m3). There is uncertainty about this level, however, because stationary
sampling was applied and the presented data did not describe the measurement
unit.
Both studies suggest that prolonged exposure to approximately 107 spores/m3
of P. glabrum and C. corticale can induce hypersensitivity pneumonitis, but these
are crude estimates since exposures were poorly documented and results not
adjusted for confounders.
Highly exposed populations: Asthma
Current physician diagnosed asthma was studied in a cross-sectional study
of 1 614 farmers. Annual exposure levels to fungal spores (one year equalled
geometric mean 2⋅106 spores/m3), bacteria, endotoxins, and ammonia were
estimated (50). Exposure to fungi was positively correlated with asthma in the
highest exposed (4⋅106-4⋅107 spores/m3) non-atopic farmers with OR 1.7 (95%
CI 1.0-2.7). In atopic farmers, exposure to fungi was negatively correlated with
asthma with OR 0.28 (95% CI 0.10-0.78). The associations with fungal spores
were stronger than with endotoxins and of similar strength as with ammonia.
Associations were adjusted for age, smoking, gender, and asthma in the family.
Year-average exposure levels were estimated because it was not clear when
asthma was initiated and occupational asthma may take years of exposure to
develop. Atopic status was important as the association was reversed in atopic
farmers. Endotoxins and amonia may also explain these associations as exposure
levels were correlated, but ammonia as a cause of asthma seems not biologically
plausible, as the annual exposure level was 4 ppm.
In three studies, indicators of asthma were investigated (6, 31, 141). Variability
of peak expiratory flow was studied in 72 waste collectors and exposure was
estimated by a job exposure matrix including total fungi (level approximately
2⋅105 cfu/m3), bacteria and endotoxins (31). Peak flow variability was significantly
increased in the group with the highest exposure to A. fumigatus (level approxima-
tely 104 cfu/m3), but was not associated with the other agents.
Wheezing was studied in 82 joinery and 108 sawmill and chip mill workers (6).
Exposure to fungal spores (arithmetic mean 3⋅104 cfu/m3), dust, Gram-negative
bacteria, endotoxins, and glucans was measured. Wheezing was associated with
fungal exposure (OR 1.4, 95% CI 1.0-2.0) but more strongly with respirable
glucans. The association between wheezing and fungal exposure may be due to
glucan exposure because these exposures were strongly correlated (r=0.76-0.86).
Monsó et al studied wheeze and asthma attacks in 39 greenhouse workers and
measured exposure to endotoxins, bacteria, and fungi (median 5⋅103 cfu/m3) (141).
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No associations were found but the number of cases was small, especially of
asthma attacks (n=3).
Current exposure is probably a valid exposure estimate for peak flow variability
and wheezing, because these outcomes are likely to be a response to recent
exposure. In the first two studies, the role of other bioaerosol components such
as bacteria and endotoxins was also evaluated. The waste collector study (31)
indicated that peak flow variability was a specific response to A. fumigatus but
associations were not adjusted for confounders. The greenhouse worker study
(141) was small and included only three subjects with asthma attacks. The results
of the wood worker study (6) are therefore the most reliable. In that study, wheez-
ing was more strongly associated with glucans than fungi. This may, however,
indicate a response to a fungal component as glucans and fungi were correlated.
In summary, wheezing was associated with fungal exposure in wood workers
exposed to approximately 3⋅105 spores/m3 (arithmetic mean) (6). This level is
lower than indicated by the increased prevalence of asthma in non-atopic farmers,
approximately 1⋅107 spores/m3 (geometric mean of the range) (50). This might
indicate that non-atopic asthma is induced by higher exposure levels than
wheezing. However, atopy was not evaluated in the wood worker study and
the association with wheezing might be due to the atopic individuals in the
population. In the farmer study, atopic individuals had been excluded in the
analysis of non-atopic asthma and this association was therefore not confounded
by atopy. Furthermore, the exposure in the asthma study among farmers was
estimated with considerable random error, which may have attenuated exposure-
response associations. Wheezing is not specific to asthma as the prevalence of
wheezing is much higher than that of asthma. The negative association with
atopic asthma in farmers is special (50). This may be due to a protective effect,
but may also be explained by selection, either by retirement or by changing
production. There is uncertainty about the role of fungi because levels of other
bioaerosol agents that were associated with these outcomes were also correlated
with fungal levels.
Highly exposed populations: Chronic bronchitis
Chronic bronchitis and productive cough were studied in 72 waste collectors.
Symptoms were monitored during two weeks, and exposure to bacteria, endo-
toxins and culturable fungi was estimated by a quantitative job exposure matrix.
Both outcomes were significantly increased in the group with highest exposure
to A. fumigatus (exposure level approximately 104 cfu/m3) but these outcomes
were not associated with total fungi (exposure level approximately 2⋅105 cfu/m3).
The results were not adjusted for confounders, however (31).
Chronic bronchitis was also studied by a general questionnaire in 951 waste
collectors and 423 park workers (73). Exposure of waste collectors to culturable
and total fungi, inorganic dust, organic dust, irritant gases and fumes was estima-
ted by a quantitative job exposure matrix. The waste collectors were categorised
in two groups; those exposed to low (<2⋅105 cfu/m3) and high (≥2⋅105 cfu/m3)
levels, respectively. The groups were of very different sizes (at the 96%-tile)
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without justification, and no other exposure data were presented. The exposure
of the park workers was not measured and assumed to be low. Chronic bronchitis
was significantly elevated in the low exposure group (prevalence proportion ratio
(PPR) 1.9, 95% CI 1.0-3.6) for both culturable fungi and fungal spore count. The
PPR increased further in the high exposure group to 2.5 (95% CI 0.6-11) for
countable fungi and 2.7 (95% CI 0.7-11) for culturable fungi, but not significantly.
Alwis et al studied bronchitis, phlegm, and breathlessness in 82 joinery workers,
and 108 sawmill and chip mill workers (6). Breathlessness (OR 4.8, 95% CI 1.4-
17) was most strongly associated with fungal exposure in sawmill and chip mill
workers (arithmetic mean 4⋅104 cfu/m3). Phlegm (OR 2.0, 95% CI 1.0-3.9) was
also associated with fungal exposure in joinery workers (arithmetic mean 1⋅104
cfu/m3). Endotoxin exposure was also associated with phlegm, but the association
was slightly weaker. Confounding of the association with fungal exposure is not
likely because endotoxin exposure was only moderately correlated with fungal
exposure. Exposure to fungi was also associated with bronchitis in joinery
workers (OR 3.0, 95% CI 1.3-6.6, arithmetic mean 1⋅104 cfu/m3) and sawmill/
chip mill workers (OR 2.9, 95% CI 1.1-7.2, arithmetic mean 4⋅104 cfu/m3). The
associations with glucans were stronger (OR 20, 95% CI 10-41), however, and
the association between bronchitis and fungal exposure may be due to glucan
exposure because these exposures were strongly correlated (r=0.76-0.86). The
associations with glucan exposure may also reflect fungal exposure because
glucans are a structural component of fungi.
Morning cough was associated with exposure to fungal spores in 107 wood
trimmers (54). Exposure to different spore types (42% were from Rhizopus micro-
sporus), pine dust, and spruce dust was measured. Work-related chest tightness
was associated with Rhizopus microsporus spore and wood dust exposure but
this association may suffer from reporting bias because the symptom had been
recorded conditional on handling of mouldy timber. Exposure levels of 2⋅106
spores/m3 predicted an OR of 1.5 for both associations. The study did not include
an external reference group. Therefore, the lowest exposed wood trimmers (4⋅105
spores/m3) were used as an internal reference group.
To sum up, symptoms suggestive of chronic bronchitis were associated with
fungal exposure in five populations with three different occupations. Two studies
of waste collectors specifically reported chronic bronchitis. In one of those, no
association was found with total fungi (exposure level approximately 104 cfu/m3)
but associations were not adjusted for confounders (31). An association was
reported in the other study but the expsure level is unclear (73). A LOEL of 2⋅106
spores/m3 was indicated for morning cough in the wood trimmer study (54), but
this is a high estimate because the lowest exposed group was exposed to 4⋅105
spores/m3 and lower exposure levels could thus not be explored.
The associations with breathlessness and phlegm reported by Alwis et al (6)
and morning cough by Eduard et al (54) in wood workers seem reliable because
the exposure of wood workers is mainly to wood dust and fungal spores. It is
therefore likely that the association between chronic bronchitis symptoms and
exposure to fungal spores is real. LOELs of 1⋅105 and 4⋅105 spores/m3 were
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indicated for phlegm in joinery workers and for breathlessness in sawmill and
chip mill workers, respectively. In wood trimmers, a LOEL of 2⋅106 spores/m3
was found for morning cough, but this is probably a high estimate because the
internal reference group in this population was relatively highly exposed.
In two studies, stronger associations between bronchitis symptoms and specific
fungi were found than with total fungi; A. fumigatus in waste collectors and
R. microsporus spores in wood trimmers (31, 54). However, both studies suffer
from methodological weaknesses.
Highly exposed populations: Lung function
Reduced restrictive lung function (described as a “restrictive effect” but not
further documented) was observed in 648 cork workers (9). Penicillium glabrum
was the dominating fungus and total spore levels ranged from 1⋅106 to 7⋅107
spores/m3 in different departments. Restrictive lung function was not associated
with spore exposure but increased from 8% in workers employed for up to 5
years to 29% after more than 30 years of employment. Impaired lung function is
expected to be associated with long-term exposure as it may take years before the
decline is sufficiently large to be detectable. Duration of employment is probably
a reasonable estimate of cumulative exposure because workers changed jobs fre-
quently. It is possible that current exposure levels were not very different from the
past (see page 73).  These results may therefore indicate that long-term exposure
to approximately 107 spores/m3 induced the restrictive lung function impairment.
Johard et al compared 19 wood trimmers exposed to fungi (median 1⋅105
spores/m3) with 19 not occupationally exposed subjects, all non-smokers (100).
Lung function, (vital capacity, FEV1, diffusion capacity for CO) was not signifi-
cantly different compared to the controls. These results suggest a NOEL of 1⋅105
spores/m3 for long-term decline in FVC and FEV1 decline. However in another
publication of this study an association was found between fungal spore exposure
and short-term decline in FEV1 and MEF25 (38).
Highly exposed populations: Systemic symptoms
Ivens et al studied diarrhoea in 950 waste collectors with 387 outdoor municipal
workers as reference (97). Inhaled doses of culturable fungi, total fungi and
endotoxins were estimated by a quantitative job exposure matrix for the waste
collectors but not the reference group. The waste handlers were categorised in
three exposure groups of very different sizes. Diarrhoea was significantly ele-
vated in the lowest exposed waste collectors (PPR 3.0, 95% CI 1.9-4.9) for
fungal spores, and increased in a dose-response manner in the more highly
exposed groups. Adjustments for confounders were applied but not for other
agents although similar associations were observed for endotoxins.
No other studies of systemic symptoms have been found.
Highly exposed populations: X-ray changes
Wenzel and Emanuel observed diffuse reticulo-nodular infiltrates by chest X-ray
in 40% of 37 papermill workers exposed to spores of Cryptostroma corticale
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(243). These changes were observed during summer and winter, and the mean
exposure was approximately 5⋅106 C. corticale spores/m3. There is, however,
uncertainty about these levels (see Highly exposed populations: Hypersensitivity
pneumonitis page 73 and Appendix 6).
Reticulo-nodular changes were observed by chest X-ray in 57% of 648 cork
workers (9). Penicillium glabrum was the dominating fungus and total spore
levels ranged from 1⋅106 to 7⋅107 spores/m3 in different departments. The X-ray
changes correlated with current exposure to fungal spores in non-smokers but
not with duration of employment.
Both studies indicate that X-ray changes occur in populations exposed to fungal
spores and wood or cork dust. Although confounding was not adjusted for in
the papermill study, and only smoking was considered in the cork worker study,
it seems likely that fungal spores may induce these X-ray changes since the
prevalence of this outcome was high. Wood or cork dust is not known to induce
X-ray changes, while this is a common finding in hypersensitivity pneumonitis.
The cork worker study (9) suggests that exposure levels of 107 Penicillium glabrum
spores/m3 can induce the X-ray changes, and as cork workers changed jobs regu-
larly, the correlation with current exposure levels indicates that the X-ray changes
do not take very long time to develop. A similar value is indicated in the papermill
study (243), but there is uncertainty about the unit of exposure in this study.
Highly exposed populations: Lower airway inflammation
Johard et al studied 19 wood trimmers exposed to approximately 1⋅105 spores/m3
and to 105 bacteria/m3, and 25 subjects not occupationally exposed to fungi, by
bronchoalveolar lavage (100). Cell counts were not different, but albumin,
fibronectin, and hyaluronan were significantly higher in the sawmill workers than
in the controls indicating low intensity alveolar inflammation. Results were not
adjusted for confounders but all participants were non-smokers. Exposures to total
dust, endotoxins and terpenes were reported to be low in another publication of
this study with medians of 0.3 mg/m3, 20 EU/m3 and 10 ppm, respectively (38).
Populations exposed to common indoor air: Respiratory symptoms
Li et al studied cough and phlegm in 264 day-care workers. Fungi were measured
in indoor and outdoor air (geometric means 1 200 cfu/m3 and 1 000 cfu/m3, re-
spectively), and house dust mite allergens in settled dust. Cladosporium, Penicil-
lium, Aspergillus, and yeasts were prevalent species. Cough and phlegm were
associated with Aspergillus levels (geometric mean 32 cfu/m3) but not with other
species or total fungi (124).
Menzies et al compared 107 office workers with work-related respiratory
symptoms and 107 office workers without symptoms. Airborne fungi (mean
Alternaria levels 1 and 0.3 cfu/m3, respectively) were measured as well as fungi
and house dust mite allergens in floor dust. Symptoms were associated with
Alternaria exposure (OR 4.2, 95% CI 1.1-16) (134).
Purokivi et al compared 37 employees from a school with fungal problems
with 23 employees from a school without such problems. Culturable fungi were
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measured during the winter (geometric mean 29 cfu/m3 and 6 cfu/m3, respective-
ly). Respiratory symptom prevalences were not significantly different at the end
of spring, but no confounder adjustments were carried out (181).
Roponen et al recorded symptoms of the lower airways in randomly selected
teachers, and exposure to fungi and bacteria was measured at home and at school.
The population was divided in a low and a high exposure group (median 12
cfu/m3 and 67 cfu/m3, respectively). Lower airways symptoms were similar in
the two groups (203).
No study found associations between respiratory symptoms and total fungi.
The study by Li et al (124) is interesting because they used random selection and
controlled for confounders, which strengthen the reliability of their results.
However, it is not clear how fungal exposure was measured. Fungal levels in this
study were considerable higher than in the other studies, 1 200 cfu/m3, which is
20-500 times higher than in the studies by Purokivi et al (181) and Roponen et al
(203). Menzies et al (134) only quoted Alternaria levels, which were very low.
The study by Li et al (124) suggests a NOEL of approximately 104 spores/m3, and
the study by Roponen et al (203) a NOEL of approximately 7⋅102 spores/m3 for a
24-hour exposure.
Findings in the studies by Li et al (124) and Menzies et al (134) suggest that
Aspergillus and Alternaria are more potent than other species as they were asso-
ciated with symptoms but were not the dominating species.
Populations exposed to common indoor air: Systemic symptoms
Two studies described in the previous chapter also studied systemic symptoms.
Li et al studied lethargy and fatigue in day-care workers and found associations
with Aspergillus levels (geometric mean 32 cfu/m3) but not with total culturable
fungal levels (geometric mean 1 200 cfu/m3) (124).
Roponen et al found that non-specific symptoms in randomly selected teachers
were not different in individuals with low and high exposure (median 12 cfu/m3
and 67 cfu/m3, respectively including exposure both at work and home (203).
The day-care workers were exposed to the highest levels but associations were
only found for Aspergillus, which constituted only a small fraction of the fungal
exposure. This might indicate that Aspergillus species are more potent than other
fungi. However, non-specific symptoms are commonly associated with dampness
in buildings, but a specific role of fungi has not yet been demonstrated; review by
Bornehag et al (16). It can therefore not be ruled out that Aspergillus sp. is just a
marker of humidity in buildings.
Populations exposed to common indoor air: Airway inflammation
Hirvonen et al studied 32 school staff members of a school contaminated with
fungi and 8 or 25 healthy controls from a research institution without known
fungal contamination (the numbers of controls were inconsistent) (83). Increased
levels of NO, TNFα and IL-6 were observed in nasal lavage after the spring
and/or autumn term compared to after vacation. These levels were also higher
than in external controls. Fungal levels in the school in the autumn were 7-100
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cfu/m3. However, no exposure data after vacation or of the control subjects were
reported.
Purokivi et al compared nasal lavage and induced sputum samples of school
employees from schools with and without fungal problems (181). Culturable fungi
were only measured during the winter (geometric mean 29 and 6 cfu/m3, respecti-
vely). Higher levels of IL-1 and IL-4 were found in nasal lavage and of IL-6 in
induced sputum at the end of the spring term in employees from the school with
fungal problems. Differential cell counts were similar. No confounder adjustments
were carried out, however.
Thus, both studies found increased cytokine levels in nasal lavage and/or
induced sputum after school terms. These findings cannot be related to exposure,
however, due to lack of exposure data.
Populations exposed to common indoor air: Asthma and rhinitis
Seuri et al described a cluster of 4 asthma (6 tested) and 11 rhinitis cases in 14
employees from a hospital with water damage (217). Fungal levels exceeded 500
cfu/m3 at three locations with a maximum of 1 400 cfu/m3 (approximately 50%
Sporobolomyces salmonicolor). The asthma and rhinitis cases had positive
challenges with S. salmonicolor extract but skin prick tests with the extract were
negative indicating that the asthma and rhinitis were non-allergic (see also
Chapter 11.2.1). Serum IgG antibodies to typical water-damage fungi and
S. salmonicolor were found in most employees, which further demonstrated
exposure to fungi. Exposure levels had probably been higher as a water-damaged
floor had been repaired a year earlier, but no microbial measurements were then
carried out.
This study indicates that a high proportion of workers in a water-damaged
building developed non-allergic asthma and rhinitis, and the response was specific
for the fungus S. salmonicolor that was also the dominating species in the building.
Symptoms were maintained at exposure levels of approximately 104 spores/m3 but
induction of the diseases probably occurred at higher levels.
11.5.2 Discussion of effects of long-term exposure
Symptoms in employees with non-allergic asthma and rhinitis in the hospital
study (217) indicated a LOEL of 1⋅104 spores/m3. The exposure levels inducing
the diseases were probably higher. In farmers, a much higher LOEL of approxi-
mately 107 spores/m3 was indicated for non-atopic asthma (50). This association
may, however, have been attenuated by considerable non-differential misclassi-
fication of the exposure and have resulted in a high estimate of the effect level.
Also exposure to other biological agents may explain the association in the farmer
study.
The negative association with asthma in atopic farmers is special (50). It may
be due to a protective effect, ascribed to microbial exposure (the so-called hygiene
hypothesis), but may also be due to selection. The role of other biological agents
cannot be ruled out as they were correlated with exposure to fungal spores. It is
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interesting, however, that none of the asthma and rhinitis cases in the hospital
employee study were atopic (217).
Bronchitis symptoms were associated with fungal exposure in five populations
with three different occupations. Most populations were exposed to median levels
of 1⋅104-4⋅104 fungal cfu/m3, which indicate LOELs of 1⋅105-4⋅105 spores/m3.
Studies performed on sawmill workers, and especially wood trimmers, are of
special interest since exposure to agents other than fungal spores is usually low.
For respiratory symptoms such as phlegm and breathlessness in wood workers
LOELs of 1⋅105 spores/m3 and 4⋅105 spores/m3 were reported (6). In wood trim-
mers a LOEL of 2⋅106 spores/m3 was found for morning cough. This is a high
estimate because the population did not include individuals with low exposure
(54).
No associations were found between respiratory symptoms and exposure to
“total fungi” in four common indoor air studies (124, 134, 181, 203). The expo-
sure level in the study with the highest exposure was approximately 104 spores/m3,
which was measured by stationary sampling. Exposure would probably have been
higher if measured by personal sampling. The documentation of the measurements
was poor (124). This NOEL is therefore consistent with the LOELs found for
respiratory symptoms in more highly exposed populations.
The wood worker study indicates a NOEL of 1⋅105 spores/m3 for lung function
changes (100). A reduced FVC observed cross-sectionally in cork workers expo-
sed to approximately 107 spores/m3 may be consistent with this NOEL (9). Results
were poorly documented in both studies, however.
Exposure levels of 107 spores/m3 of P. glabrum and C. corticale were related to
hypersensitivity pneumonitis and X-ray changes (9, 243). These exposure levels
are crude estimates because of poorly documented exposure, and results not
adjusted for confounders. However, the exposure was mainly to fungal spores,
and wood or cork dust and only fungal spores are known to induce these out-
comes. Furthermore, the prevalence of the X-ray changes was very high and cases
of hypersensitivity pneumonitis were confirmed by bronchial provocation tests. It
seems therefore unlikely that confounder adjustment would have changed these
associations substantially.
Inflammatory markers in bronchoalveolar lavage were increased in wood
trimmers exposed to 105 spores/m3 whereas inflammatory cells were not (100).
In two common indoor air studies, inflammatory markers in nasal lavage and
induced sputum in school personnel working in a moisture-damaged building
where higher than in controls and school employees working in a non-problem
building, respectively, but the effects cannot be related to the measured exposure
(83, 181).
An association was reported between fungi and diarrhoea in a study of waste
handlers (97), but no other studies reported this outcome. Two common indoor
studies did not find associations between fungal exposure and the non-specific
symptoms lethargy and fatigue (124, 203).
Few studies have analysed results for specific fungi. A study of a waste handler
reported associations between A. fumigatus and variable peak flow and bronchitis
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symptoms, but no confounder adjustments were applied (31). The indicated
LOEL, 1⋅105 spores/m3, was somewhat lower than that for lung function changes
and respiratory symptoms. In a wood trimmer study, work-related chest tightness
was associated to Rhizopus microspores with a LOEL of 2⋅106 spores/m3 but this
estimate may be biased and is a high estimate since the population did not include
individuals with low exposure (54). X-ray changes and hypersensitivity pneumo-
nitis were observed in wood workers and cork workers exposed to spores mainly
from Cryptostroma corticale and Penicillium glabrum, respectively (9, 243).
Common indoor air studies showed associations between respiratory symptoms
and Aspergillus sp. and Alternaria sp. (124, 134), and between asthma and rhinitis
and Sporobolomyces salmonicolor (217). A role for S. salmonicolor is probable,
as this association was further confirmed by provocation tests with the organism.
The exposure levels of the specific organisms in the other two studies were very
low, however. Three studies support that specific organisms may be more toxic
(31, 124, 134), but these studies have important shortcomings in the exposure
assessment.
11.6 Genotoxic and carcinogenic effects
No studies including fungal spore exposure have been found.
11.7 Reproductive and developmental effects
No studies including fungal spore exposure have been found.
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12. Dose-effect and dose-response relationships
12.1 Dose considerations and extrapolation from animal studies
Intratracheal and intranasal instillation circumvent the normal deposition pro-
cessses in the airways, and distribute spores deeper into the lung. The dose that
reaches the lung is increased compared with inhalation. Further, intratracheally
instilled dust was less homogeneously distributed in the lung with little dust
reaching the periphery (180). This may lead to local overload conditions and
Pritchard et al recommended not to extrapolate dose-response relationships from
animal studies that applied intratracheal instillation to the human condition (180).
Such studies are therefore not considered further.
In some animal inhalation studies the applied dose was estimated by viable
counts in lung tissue obtained shortly (up to 4 hours) after challenge. This method
probably underestimates the applied dose to a large extent and such studies were
also omitted in the dose-effect and dose-response considerations.
Due to differences between the lungs of humans and laboratory animals expo-
sure levels applied in animal experiments should be extrapolated. These factors
vary substantially from 0.03 to 7 and depend on dose metric and particle size (98).
As the relevant dose metric is not clear no attempts were made to specify an
extrapolation factor.
Results from human challenge studies were extrapolated from the dose that was
inhaled during a few minutes to the average concentration over an 8-hour work
shift. This may be an underestimation as “the concentration is often more impor-
tant than duration of exposure” (98).
See also Chapter 10.1.
12.2 Effects related to single and short-term exposure
12.2.1 Animal studies
Only one out of 32 animal studies is relevant for evaluation of dose-effect and
dose-response associations. In that study, Guinea pigs were exposed to airborne
fungal spores for 4 hours/day, for 1 day or for 5 days/week during 3 and 5 weeks,
a time frame not very different from workplace exposure (58). Four fungal and
one actinomycete species were tested, but only exposure to 3⋅108 spores/m3 of
Saccharopolyspora rectivirgula showed increased neutrophil and eosinophil
counts in bronchoalveolar lavage 24 hours after a single exposure for 4 hours.
None of the fungal species induced a response after a single exposure. These
results indicate that a single exposure to fairly high concentrations of four species,
including Aspergillus fumigatus (approximately 3⋅107 spores/m3 and similar or
higher for the other fungi) for 4 hours do not induce inflammation in Guinea
pigs. Table 16 summarises effects after exposures for 3 and 5 weeks. Only one
dose level was applied except for Aspergillus fumigatus that was tested at two
concentrations. Exposure levels were probably underestimated because spores
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Table 16. LOELs of 5 fungal species in Guinea pigs exposed to spore aerosols for
4 hours/day, 5 days/week for 3 and 5 weeks (58).
Species LOEL, Effects
spores/m3
Aspergillus fumigatus 7⋅105 After 3 as well as 5 w:
BAL: Increased lymphocyte and eosinophil counts.
Lung tissue: Slight cell infiltration of the alveoli.
Aspergillus fumigatus 3⋅107 After 3 as well as 5 w:
BAL: Increased AM, lymphocyte, neutrophil and
eosinophil counts.
Lung tissue: Cell aggression in the alveoli, alveolar
wall thickening with interstitial cells and granuloma
formation.
Rhizopus stolonifera 2⋅107 After 3 as well as 5 w:
BAL: Increased AM, neutrophil, lymphocyte and
eosinophil counts.
Lung tissue: Cell infiltration in alveoli and interstitial
tissue, alveolar wall thickening.
Saccharopolyspora rectivirgula 3⋅108 After 3 as well as 5 w:
BAL: Increased AM, neutrophils, lymphocytes and
eosinophils counts.
Lung tissue: Cell infiltration in alveoli and interstitial
tissue, alveolar wall thickening.
Penicillium aurantiogriseum 1⋅109 After 5 w:
BAL: Increased AM, neutrophils, lymphocyte and
eosinophil counts.
Lung tissue: Defined granulomas.
Phanerochaete chrysosporium 2⋅109 After 5 w:
BAL: Increased AM, neutrophil, lymphocyte and
eosinophil counts.
Lung tissue: Severe cell infiltration in alveoli and
interstitial tissue, alveolar wall thickening and
granuloma formation.
AM: alveolar macrophages, BAL: bronchoalveolar lavage, LOEL: lowest observed effect level.
were counted by microscopy after resuspension from membrane filters with a pore
size of 0.8 µm. A fraction of the smaller spore types, e.g. from Aspergillus and
Penicillium will be trapped in the filter matrix and lost in the analysis but this is
not recognised in the paper (Chapter 10.5).
All species induced inflammatory changes in the lung after repeated exposure.
The lowest LOEL was 7⋅105 spores/m3 for A. fumigatus that induced slight lung
inflammation. Extrapolating from 4 to 8 hours of exposure, this level corresponds
to 4⋅105 spores/m3.
It should be noted, however, that probably a smaller proportion of the inhaled
spores reaches the alveolar region in rodents than in humans.
The following differences in inflammatory potency between the fungal and the
actinomycete species can be deduced from these results: A. fumigatus was more
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toxic than Rhizopus stolonifera and Phanerochaete chrysosporium, and Penicil-
lium aurantiogriseum was more toxic than P. chrysosporium. Exposure to 3⋅108
S. rectivirgula spores/m3 induced inflammation at a similar level as exposure to
2⋅107 R. stolonifera spores/m3. Further differences between fungal species have
been reported in other in vivo studies. Especially mycotoxin containing spores and
spores from pathogenic fungi, e.g. A. fumigatus, showed the highest inflammatory
potential (Chapters 10.4.5 and 10.9).
12.2.2 Challenge studies of symptomatic subjects
Human challenge studies with spores are summarised in Table 17. These studies
indicate a LOEL above 1⋅104-2⋅104 spores/m3 for Penicillium species and Alter-
naria alternata in healthy subjects, as this level was the lowest that induced
significant airway obstruction in asthmatic patients allergic to these fungi (125).
The NOELs of 8⋅103 and 4⋅103 spores/m3 observed for Penicillium chrysogenum
and Trichoderma harzianum, respectively, in school employees with sick building
syndrome (135) are consistent with the former study. Higher LOELs were found
in mushroom workers with hypersensitivity pneumonitis, but these workers were
only challenged with a single dose (35, 36).
12.2.3 Epidemiological studies
Epidemiological studies of effects such as short-term changes in lung function,
changes in inflammatory markers in the airways, and studies where symptoms
were recorded on the same day as exposure measurements were performed are
considered here. Studies in highly contaminated environments are summarised
in Table 18 and those in common indoor environments in Table 19. Only epi-
demiological studies fulfilling the inclusion criteria were included, i.e. exposure
assessment based on personal sampling, objective outcomes, or self-reported
symptoms if adjusted for confounders. The criteria were applied less stringent for
studies of populations exposed to common indoor levels, as few studies were
found. Cfu counts were multiplied by 10 in order to estimate spore counts
(Chapters 5 and 11).
A study of wood trimmers showed a NOEL of 1⋅105 spores/m3 and a LOEL
of 3⋅106 spores for a 4-day change in FVC (76) (Table 18). Exposure to fungi
was measured by culture. In the group with highest exposure, a decline in FVC
was observed during the preceding 3 months but no exposure measurements were
performed during that period. It seems unlikely, however, that exposure levels
were very different from those that had been measured during the 4-day period
(Chapter 11.4.2). In another study of Swedish wood trimmers, a LOEL of 1⋅105
spores/m3 for a cross-week change in FEV1 and MEF25 was found (38).
LOELs for nasal congestion and inflammatory markers in the nose of waste
handlers were found at 2⋅105 spores/m3 (79) (Table 18). NOELs of 2⋅105 and 6⋅105
spores/m3 were found for inflammatory markers in induced sputum of the same
population of waste handlers (80), and in the nose in a study of sawmill workers
(n=11) (202), respectively.
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LOELs for cough in waste handlers (78) and in farmers (49) were 3⋅105 and
3⋅106 spores/m3, respectively (Table 18). In farmers, LOELs of 1⋅105 spores/m3
for eye irritation and 3⋅106 spores/m3 for nasal irritation were found (49). For
fever LOELs of 1⋅108-4⋅108 spores/m3 were observed in cases of hypersensitivity
pneumonitis, and 2⋅109 spores/m3 in cases of ODTS (130) (Table 18).
Thus, at exposure levels of 1⋅105 spores of various fungi/m3 both objective find-
ings as well as symptoms emerge in populations working in highly contaminated
environments. The findings in wood workers seem most reliable, as fungal spores
are often the dominating agent besides wood dust. Studies in wood trimmers are
particularly interesting as little wood dust is generated in the sorting and trimming
department. Dust, endotoxin and terpene levels in trimming departments of
Swedish sawmills have been shown to be low (38). Bacterial levels were similar
to fungal levels. However, the counting of bacteria by fluorescence microscopy
has been shown to have poor accuracy (48).
Only one study of effects related to short-term exposure in a population expo-
sed to common indoor levels was found (203) (Table 19). This well-designed
study examined inflammatory markers in nasal lavage and recorded irritation and
systemic symptoms in schoolteachers, which indicated a NOEL of 7⋅102 spores/m3
including exposure in the work and home environment.
12.3 Effects related to long-term exposure
Cross-sectional studies of effects such as lung function and respiratory symptoms
are considered here where the effect registration is not linked individually to the
day(s) that exposure was measured. The measured exposure is therefore expected
to represent an average level over a certain time period. Studies in common indoor
environments are summarised in Table 19 and those in highly contaminated
environments in Table 20. The inclusion criteria used in Chapter 12.2.3 apply also
here.
Increased albumin, fibronectin, and hyaluronan in bronchoalveolar lavage in 19
wood trimmers indicated low intensity inflammation compared to a control group
of 25 healthy subjects without occupational exposure to fungi (all non-smokers)
(100). The exposure level indicated a LOEL of 1⋅105 spores/m3. The design was
cross-sectional but no information on the exposure period was provided. It is
therefore not clear whether these differences are effects of short or long-term
exposure.
In a cross-sectional study of sawmill, joinery, and chip mill workers LOELs
for respiratory symptoms such as phlegm, throat irritation, and breathlessness all
ranged from 1⋅105 to 4⋅105 spores/m3 (6). In another cross-sectional study of wood
trimmers morning cough indicated a LOEL of 2⋅106 spores/m3 (54). This is proba-
bly a high estimate because the population did not include individuals exposed
below 4⋅105 spores/m3.
Exposure levels that correlated with X-ray abnormalities in cork workers were
approximately 107 spores/m3 (9). As hypersensitivity pneumonitis was relatively
prevalent (4%) a similar LOEL is indicated for this outcome as well. Restrictive
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lung function was correlated with duration of employment of the cork workers
indicating an association with cumulative exposure at the level of 107 spores/m3.
There was, however, limited information and uncertainty about previous exposure
levels in this study (9).
In farmers, a LOEL of 107 spores/m3 was found for asthma in non-atopic
farmers (50) but this level may have been attenuated by substantial random errors
in the estimated exposure.
Thus, both objective findings as well as respiratory symptoms begin to appear
at exposure levels of ≥1⋅105 spores of various fungi/m3 in populations exposed to
highly contaminated environments. In cork workers, hypersensitivity pneumonitis,
X-ray changes and restrictive lung function were observed at an exposure level of
1⋅107 spores/m3, mainly from Penicillium glabrum.
In an epidemiological study of a fairly large population (n=264) of randomly
selected day-care centres exposed to common indoor levels a LOEL of 104
spores/m3 of various fungi for nasal symptoms was found (124).
A small cluster of asthma and rhinitis cases in a small population of hospital
workers had positive bronchial challenge tests to Sporobolomyces salmonicolor.
Exposure levels were approximately 104 spores/m3 (50% S. salmonicolor) in the
employees and could indicate a LOEL in sensitive individuals. However, expo-
sure was poorly described (217). In a case-control study, work-related respiratory
symptoms were associated with approximately 10 Alternaria spores/m3. No
exposure levels to total fungi or other species were reported (134).
These studies in common indoor environments indicate lower effect levels
than the studies of highly exposed populations. However, the exposure assessment
in the former studies was insufficient due to stationary sampling and few or an
unknown number of measurements. Furthermore, these LOELs are similar to
the LOELs found by bronchial provocation in a susceptible group of asthmatic
patients allergic to the fungi used in the challenge, which is not very likely since
LOELs are expected to be higher in healthy subjects. There is therefore insufficient
support for the assumption that health effects are induced at lower fungal levels in
common indoor environments than in highly contaminated environments.
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 h
ou
rs
/e
xp
os
ur
e 
tim
e.
b 
Ca
lc
ul
at
ed
 to
 e
qu
al
 a
n 
8-
ho
ur
 e
xp
os
ur
e 
by
 d
iv
id
in
g 
th
e 
ap
pl
ie
d 
do
se
 w
ith
 5
 m
3  a
ss
um
in
g 
a 
m
in
ut
e 
ve
nt
ila
tio
n 
of
 1
0 
l/m
in
 d
ur
in
g 
8 
ho
ur
s.
FV
C:
 fo
rc
ed
 v
ita
l c
ap
ac
ity
, L
O
EL
: l
ow
es
t o
bs
er
ve
d 
ef
fe
ct
 le
ve
l, 
N
O
EL
: n
o 
ob
se
rv
ed
 e
ffe
ct
 le
ve
l, 
Pa
O
2: 
ar
te
ria
l o
xy
ge
n 
te
ns
io
n,
TL
co
: l
un
g 
tra
ns
fe
r f
ac
to
r f
or
 c
ar
bo
n 
m
on
ox
id
e 
(m
ea
su
re
 o
f g
as
 d
iff
us
io
n)
.
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Ta
bl
e 1
8.
 E
ffe
ct
s o
f s
ho
rt-
te
rm
 e
xp
os
ur
e 
in
 e
pi
de
m
io
lo
gi
ca
l s
tu
di
es
 o
f w
or
ke
rs
 e
xp
os
ed
 to
 h
ig
hl
y 
co
nt
am
in
at
ed
 e
nv
iro
nm
en
ts.
N
O
EL
LO
EL
Sp
ec
ie
s
St
ud
y 
gr
ou
p
Ef
fe
ct
s
Co
m
m
en
ts
Re
fe
re
nc
e
   
  s
po
re
s/m
3
 1
⋅1
05
 a
3⋅
10
6 
a
M
ai
nl
y 
Rh
izo
pu
s
29
 w
oo
d 
tri
m
m
er
s
D
ec
lin
e 
in
 F
EV
1 a
nd
 F
V
C
du
rin
g 
4 
da
ys
 a
nd
 3
 m
on
th
s
Fo
llo
w
-u
p 
stu
dy
, a
dj
us
te
d 
fo
r i
nd
iv
id
ua
l f
ac
to
rs
 b
y 
stu
dy
in
g
lu
ng
 fu
nc
tio
n 
ch
an
ge
, o
nl
y 
Ig
G
 a
nt
ib
od
ie
s t
o 
Rh
izo
pu
s 
w
er
e
de
te
ct
ed
, e
xp
os
ur
e 
m
ea
su
re
d 
by
 c
ul
tu
re
 m
et
ho
ds
 d
ur
in
g 
al
l
da
ys
.
(7
6)
1⋅
10
5 
 a
M
ai
nl
y 
Rh
izo
pu
s
an
d 
Pa
ec
ilo
m
yc
es
28
 w
oo
d 
tri
m
m
er
s
D
ec
lin
e 
in
 F
EV
1 a
nd
 M
EF
25
du
rin
g 
1 
w
ee
k
A
dj
us
te
d 
fo
r i
nd
iv
id
ua
l f
ac
to
rs
 b
y 
stu
dy
in
g 
lu
ng
 fu
nc
tio
n
ch
an
ge
, s
pe
ci
es
 w
er
e 
de
te
ct
ed
 b
y 
cu
ltu
re
, e
xp
os
ur
e 
m
ea
su
re
d
on
 o
ne
 d
ay
, b
ac
te
ria
 w
er
e 
m
ea
su
re
d 
bu
t n
ot
 e
va
lu
at
ed
. D
us
t,
en
do
to
xi
n 
an
d 
te
rp
en
e 
le
ve
ls 
w
er
e 
lo
w
.
(3
8)
1⋅
10
5 
b
V
ar
io
us
 fu
ng
i
89
 fa
rm
er
s
Ey
e 
irr
ita
tio
n
Cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
te
d 
fo
r c
on
fo
un
de
rs
 a
nd
 o
th
er
bi
oa
er
os
ol
 a
ge
nt
s, 
ac
ut
e 
sy
m
pt
om
s a
nd
 e
xp
os
ur
e 
re
co
rd
ed
sim
ul
ta
ne
ou
sly
.
(4
9)
 2
⋅1
05
V
ar
io
us
 fu
ng
i
25
 m
un
ic
ip
al
 w
as
te
ha
nd
le
rs
Ch
an
ge
 in
 in
fla
m
m
at
or
y 
ce
lls
an
d 
m
ed
ia
to
rs
 in
 in
du
ce
d
sp
ut
um
 af
te
r 3
 d
ay
s o
f
ex
po
su
re
Cr
os
s-
se
ct
io
na
l s
tu
dy
, q
ua
lit
at
iv
e 
ev
al
ua
tio
n 
of
 sm
ok
in
g 
an
d
ag
e,
 o
th
er
 b
io
ae
ro
so
l a
ge
nt
s w
er
e 
stu
di
ed
 in
 se
pa
ra
te
 m
od
el
s,
ex
po
su
re
 re
co
rd
ed
 d
ur
in
g 
da
ys
 b
et
w
ee
n 
sp
ut
um
 in
du
ct
io
ns
.
(8
0)
 2
⋅1
05
V
ar
io
us
 fu
ng
i
31
 m
un
ic
ip
al
 w
as
te
ha
nd
le
rs
In
cr
ea
se
d 
ne
ut
ro
ph
ils
 in
 n
as
al
la
va
ge
 a
nd
 n
as
al
 c
on
ge
sti
on
af
te
r 3
 d
ay
s o
f e
xp
os
ur
e
Cr
os
s-
se
ct
io
na
l s
tu
dy
, q
ua
lit
at
iv
e 
ev
al
ua
tio
n 
of
 sm
ok
in
g 
an
d
ag
e,
 o
th
er
 b
io
ae
ro
so
l a
ge
nt
s w
er
e 
stu
di
ed
 in
 se
pa
ra
te
 m
od
el
s,
ex
po
su
re
 re
co
rd
ed
 d
ur
in
g 
da
ys
 b
et
w
ee
n 
na
sa
l l
av
ag
es
.
(7
9)
 3
⋅1
05
V
ar
io
us
 fu
ng
i
22
 m
un
ic
ip
al
 w
as
te
ha
nd
le
rs
Co
ug
h
Cr
os
s-
se
ct
io
na
l s
tu
dy
, q
ua
lit
at
iv
e 
ev
al
ua
tio
n 
of
 sm
ok
in
g
an
d 
ag
e,
 o
th
er
 b
io
ae
ro
so
l a
ge
nt
s w
er
e 
stu
di
ed
 in
 se
pa
ra
te
m
od
el
s a
nd
 w
er
e 
m
or
e 
w
ea
kl
y 
as
so
ci
at
ed
 w
ith
 c
ou
gh
, a
cu
te
sy
m
pt
om
s a
nd
 e
xp
os
ur
e 
w
er
e 
re
co
rd
ed
 si
m
ul
ta
ne
ou
sly
.
(7
8)
 6
⋅1
05
M
ai
nl
y 
Rh
izo
pu
s
an
d 
Pe
ni
ci
lli
um
11
 sa
w
m
ill
 w
or
ke
rs
In
fla
m
m
at
or
y 
m
ar
ke
rs
 in
 n
as
al
la
va
ge
Co
m
pa
re
d 
w
or
ke
rs
 a
t w
or
k 
an
d 
on
 h
ol
id
ay
, n
o 
ad
ju
stm
en
ts
fo
r c
on
fo
un
di
ng
, o
th
er
 b
io
ae
ro
so
l a
ge
nt
s w
er
e 
m
ea
su
re
d.
(2
02
)
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Ta
bl
e 1
8.
 C
on
t. 
Ef
fe
ct
s o
f s
ho
rt-
te
rm
 e
xp
os
ur
e 
in
 e
pi
de
m
io
lo
gi
ca
l s
tu
di
es
 o
f w
or
ke
rs
 e
xp
os
ed
 to
 h
ig
hl
y 
co
nt
am
in
at
ed
 e
nv
iro
nm
en
ts.
N
O
EL
LO
EL
Sp
ec
ie
s
St
ud
y 
gr
ou
p
Ef
fe
ct
s
Co
m
m
en
ts
Re
fe
re
nc
e
   
  s
po
re
s/m
3
 3
⋅1
06
 b
V
ar
io
us
 fu
ng
i
89
 fa
rm
er
s
Co
ug
h,
 n
as
al
 ir
rit
at
io
n
Cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
te
d f
or
 co
nf
ou
nd
er
s a
nd
 o
th
er
bi
oa
er
os
ol
 a
ge
nt
s, 
ac
ut
e 
sy
m
pt
om
s a
nd
 e
xp
os
ur
e 
w
er
e
re
co
rd
ed
 si
m
ul
ta
ne
ou
sly
.
(4
9)
1⋅
10
8 -4
⋅1
08
2⋅
10
9
V
ar
io
us
 fu
ng
i a
nd
ac
tin
om
yc
et
es
V
ar
io
us
 fu
ng
i a
nd
ac
tin
om
yc
et
es
4 
fa
rm
er
s w
ith
 h
yp
er
-
se
ns
iti
vi
ty
 p
ne
um
on
is
6 
fa
rm
er
s w
ith
 O
D
TS
Fe
ve
r a
tta
ck
s
Fe
ve
r a
tta
ck
s
Cr
os
s-
se
ct
io
na
l s
tu
dy
, n
o 
co
nf
ou
nd
er
 a
dj
us
tm
en
t, 
co
nf
irm
ed
di
ag
no
sis
, e
xp
os
ur
e 
w
as
 m
ea
su
re
d 
w
he
n 
th
e 
w
or
k 
ca
us
in
g 
a
fe
ve
r a
tta
ck
 w
as
 re
pe
at
ed
.
(1
30
)
a E
sti
m
at
ed
 fr
om
 c
ul
tu
re
 c
ou
nt
s b
y 
m
ul
tip
ly
in
g 
w
ith
 a
 fa
ct
or
 o
f 1
0.
b 
Ca
lc
ul
at
ed
 to
 e
qu
al
 a
n 
8-
ho
ur
 e
xp
os
ur
e 
if 
ex
po
su
re
 ti
m
e 
w
as
 le
ss
 th
an
 8
 h
ou
rs
 b
y 
m
ul
tip
ly
in
g 
w
ith
 th
e 
w
ei
gh
t f
ac
to
r 8
 h
ou
rs
/e
xp
os
ur
e 
tim
e.
FE
V
1: 
fo
rc
ed
 e
xp
ira
to
ry
 v
ol
um
e 
in
 o
ne
 se
co
nd
, F
V
C:
 fo
rc
ed
 v
ita
l c
ap
ac
ity
, I
g:
 Im
m
un
og
lo
bu
lin
, L
O
EL
: l
ow
es
t o
bs
er
ve
d 
ef
fe
ct
 le
ve
l,
M
EF
25
 m
ax
im
um
 e
xp
ira
to
ry
 fl
ow
 a
t 2
5%
 o
f F
V
C,
 N
O
EL
: n
o 
ob
se
rv
ed
 e
ffe
ct
 le
ve
l, 
O
D
TS
: o
rg
an
ic
 d
us
t t
ox
ic
 sy
nd
ro
m
e.
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Ta
bl
e 1
9.
 N
O
EL
s a
nd
 L
O
EL
s o
bs
er
ve
d 
in
 e
pi
de
m
io
lo
gi
ca
l s
tu
di
es
 o
f p
op
ul
at
io
ns
 e
xp
os
ed
 to
 c
om
m
on
 in
do
or
 e
nv
iro
nm
en
ts.
N
O
EL
LO
EL
Sp
ec
ie
s
St
ud
y 
gr
ou
p
Ef
fe
ct
s
Co
m
m
en
ts
Re
fe
re
nc
e
sp
or
es
/m
3
1⋅
10
1  a
Al
te
rn
ar
ia
10
7 
sy
m
pt
om
at
ic
 a
nd
10
7 
no
n-
sy
m
pt
om
at
ic
of
fic
e 
w
or
ke
rs
W
or
k-
re
la
te
d 
re
sp
ira
to
ry
sy
m
pt
om
s.
M
at
ch
in
g 
on
 a
ge
, g
en
de
r, 
an
d 
at
op
y.
 A
dj
us
te
d 
fo
r
sm
ok
in
g,
 h
ou
se
 d
us
t m
ite
 a
lle
rg
en
 in
 fl
oo
r d
us
t a
nd
in
do
or
/o
ut
do
or
 h
um
id
ity
. N
ot
 c
le
ar
 if
 p
er
so
na
l s
am
pl
in
g
w
as
 a
pp
lie
d.
 N
o 
da
ta
 o
n 
ot
he
r f
un
gi
, t
ot
al
 fu
ng
i a
nd
 th
e
nu
m
be
r o
f c
ol
le
ct
ed
 sa
m
pl
es
 w
er
e 
gi
ve
n.
(1
34
)
 7
⋅1
02
 a,
b
V
ar
io
us
 fu
ng
i
41
 te
ac
he
rs
N
o 
ch
an
ge
s i
n 
na
sa
l l
av
ag
e:
N
O
, I
L-
4,
 IL
-5
, I
L-
6,
 a
nd
TN
Fα
. N
o 
na
sa
l, 
ey
e,
 th
ro
at
irr
ita
tio
n,
 lo
w
er
 a
irw
ay
s
sy
m
pt
om
s, 
an
d 
no
n-
sp
ec
ifi
c
sy
m
pt
om
s.
Po
pu
la
tio
n 
ra
nd
om
ly
 se
le
ct
ed
. P
er
so
na
l e
xp
os
ur
e
m
ea
su
re
m
en
ts 
at
 w
or
k 
an
d 
at
 h
om
e.
 E
xp
os
ur
e 
to
ba
ct
er
ia
 w
as
 a
lso
 st
ud
ie
d.
 S
ym
pt
om
s o
f t
he
 la
st 
w
ee
k
w
er
e 
re
co
rd
ed
 a
nd
 n
as
al
 la
va
ge
s w
er
e 
do
ne
 a
t t
he
en
d 
of
 th
e 
sa
m
pl
in
g 
pe
rio
d.
 C
on
fo
un
de
r a
ss
es
sm
en
t b
y
se
pa
ra
te
 a
na
ly
se
s i
n 
as
th
m
at
ic
 a
nd
 sm
ok
in
g 
su
b-
gr
ou
ps
.
(2
03
)
1⋅
10
4  a
3⋅
10
2  a
V
ar
io
us
 fu
ng
i
As
pe
rg
ill
us
 fu
m
ig
at
us
26
4 
da
y-
ca
re
 w
or
ke
rs
fro
m
 2
8 
ce
nt
re
s
N
as
al
 d
isc
ha
rg
e 
an
d c
on
ge
sti
on
.
N
as
al
 c
on
ge
sti
on
, c
ou
gh
 a
nd
ph
le
gm
, l
et
ha
rg
y,
 fa
tig
ue
.
D
ay
-c
ar
e 
ce
nt
re
s r
an
do
m
ly
 se
le
ct
ed
. S
ta
tio
na
ry
m
ea
su
re
m
en
ts 
an
d 
nu
m
be
r o
f m
ea
su
re
m
en
ts 
no
t g
iv
en
.
Ex
po
su
re
 v
ar
ia
bl
es
 n
ot
 sp
ec
ifi
ed
 in
 m
od
el
s. 
A
dj
us
te
d
fo
r a
ge
, g
en
de
r, 
an
d 
ed
uc
at
io
n.
 S
ep
ar
at
e 
m
od
el
s w
ith
ot
he
r f
un
ga
l s
pe
ci
es
, t
ot
al
 c
ul
tu
ra
bl
e 
ba
ct
er
ia
, a
nd
 h
ou
se
du
st 
al
le
rg
en
s o
n 
se
ttl
ed
 d
us
t d
id
 n
ot
 sh
ow
 a
ss
oc
ia
tio
ns
.
(1
24
)
1⋅
10
4  a
V
ar
io
us
 fu
ng
i
(5
0%
 S
po
ro
bo
lo
m
yc
es
sa
lm
on
ic
ol
or
)
14
 h
os
pi
ta
l w
or
ke
rs
w
ith
 a
sth
m
a (
n =
 4
) a
nd
rh
in
iti
s (
n =
 1
1)
A
sth
m
a 
an
d 
rh
in
iti
s s
ym
pt
om
s.
Ig
G
 p
os
iti
ve
 b
ut
 sk
in
 p
ric
k 
te
st 
ne
ga
tiv
e 
to
 S
.
sa
lm
on
ic
ol
or
. P
os
iti
ve
 p
ro
vo
ca
tio
n 
te
sts
 w
ith
 e
xt
ra
ct
 o
f
S.
 sa
lm
on
ic
ol
or
. S
ta
tio
na
ry
 m
ea
su
re
m
en
ts 
at
 1
0
lo
ca
tio
ns
. N
um
be
r o
f m
ea
su
re
m
en
ts 
no
t g
iv
en
.
(2
17
)
a E
sti
m
at
ed
 fr
om
 c
ul
tu
re
 c
ou
nt
s b
y 
m
ul
tip
ly
in
g 
w
ith
 a
 fa
ct
or
 o
f 1
0.
b 
In
cl
ud
in
g 
ex
po
su
re
 in
 th
e 
w
or
k 
an
d 
th
e 
ho
m
e 
en
vi
ro
nm
en
t.
IL
: i
nt
er
le
uk
in
, I
g:
 im
m
un
og
lo
bu
lin
, L
O
EL
: l
ow
es
t o
bs
er
ve
d 
ef
fe
ct
 le
ve
l, 
N
O
: n
itr
ic
 o
xi
de
, N
O
EL
: n
o 
ob
se
rv
ed
 e
ffe
ct
 le
ve
l, 
TN
Fα
: t
um
ou
r n
ec
ro
sis
 fa
ct
or
 a
lp
ha
.
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Ta
bl
e 2
0.
 E
ffe
ct
s o
f l
on
g-
te
rm
 e
xp
os
ur
e 
in
 e
pi
de
m
io
lo
gi
ca
l s
tu
di
es
 o
f w
or
ke
rs
 e
xp
os
ed
 to
 h
ig
hl
y 
co
nt
am
in
at
ed
 e
nv
iro
nm
en
ts.
 N
O
EL
LO
EL
Sp
ec
ie
s
St
ud
y 
gr
ou
p
Ef
fe
ct
s
Co
m
m
en
ts
Re
fe
re
nc
e
   
  s
po
re
s/m
3
 1
⋅1
05
V
ar
io
us
 fu
ng
i
19
 w
oo
d 
tri
m
m
er
s
an
d 
25
 c
on
tro
ls
In
fla
m
m
at
or
y 
m
ar
ke
rs
 in
br
on
ch
oa
lv
eo
la
r l
av
ag
e
A
ll 
no
n-
sm
ok
er
s. 
N
o 
ad
ju
stm
en
ts 
fo
r c
on
fo
un
di
ng
 o
r b
ac
te
ria
(th
at
 w
as
 m
ea
su
re
d)
.
(1
00
)
 1
⋅1
05
V
ar
io
us
 fu
ng
i
19
 w
oo
d 
tri
m
m
er
s
an
d 
25
 c
on
tro
ls
FE
V
1 a
nd
 F
V
C
A
s a
bo
ve
.
(1
00
)
1⋅
10
5 
 a
V
ar
io
us
 fu
ng
i
82
 jo
in
er
y 
w
or
ke
rs
Ph
le
gm
Cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
tm
en
ts 
fo
r c
on
fo
un
de
rs
, o
th
er
bi
oa
er
os
ol
 a
ge
nt
s s
tu
di
ed
 in
 se
pa
ra
te
 m
od
el
s w
er
e 
m
or
e 
w
ea
kl
y
as
so
ci
at
ed
 w
ith
 th
e 
ef
fe
ct
 a
nd
 w
er
e 
no
t s
tro
ng
ly
 c
or
re
la
te
d 
w
ith
fu
ng
al
 e
xp
os
ur
e.
 E
xp
os
ur
e 
w
as
 m
ea
su
re
d 
by
 c
ul
tu
re
 m
et
ho
ds
.
(6
)
 3
⋅1
05
  a
V
ar
io
us
 fu
ng
i
82
 jo
in
er
y 
w
or
ke
rs
an
d 
10
8 
sa
w
-/c
hi
p
m
ill
 w
or
ke
rs
Th
ro
at
 ir
rit
at
io
n
A
s a
bo
ve
.
(6
)
 4
⋅1
05
  a
V
ar
io
us
 fu
ng
i
10
8 
sa
w
m
ill
 a
nd
ch
ip
 m
ill
 w
or
ke
rs
Br
ea
th
le
ss
ne
ss
A
s a
bo
ve
.
(6
)
 2
⋅1
06
V
ar
io
us
 fu
ng
i
(4
2%
 R
hi
zo
pu
s
m
ic
ro
sp
or
us
)
10
7 
w
oo
d
tri
m
m
er
s
M
or
ni
ng
 c
ou
gh
Cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
te
d 
fo
r c
on
fo
un
de
rs
 a
nd
 w
oo
d 
du
st.
Lo
w
es
t e
xp
os
ur
e 
3⋅
10
5  s
po
re
s/m
3 .
(5
4)
 1
⋅1
07
Pe
ni
ci
lli
um
gl
ab
ru
m
64
8 
co
rk
 w
or
ke
rs
H
yp
er
se
ns
iti
vi
ty
 p
ne
um
on
iti
s,
X
-ra
y 
ch
an
ge
s; 
re
str
ic
tiv
e 
lu
ng
fu
nc
tio
n 
re
la
te
d 
to
 y
ea
rs
 e
m
pl
oy
ed
La
rg
e 
cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
tm
en
ts 
fo
r s
m
ok
in
g 
(o
nl
y 
X
-
ra
y 
ch
an
ge
s)
. P
re
va
le
nc
es
 o
f t
he
 o
ut
co
m
es
 w
er
e 
4,
 5
7 
an
d 
30
%
,
re
sp
ec
tiv
el
y.
 N
o 
in
fo
rm
at
io
n 
on
 p
re
vi
ou
s e
xp
os
ur
e.
(9
)
 1
⋅1
07
V
ar
io
us
 fu
ng
i
1 
61
4 
fa
rm
er
s
N
on
-a
to
pi
c 
as
th
m
a
La
rg
e 
cr
os
s-
se
ct
io
na
l s
tu
dy
, a
dj
us
tm
en
ts 
fo
r c
on
fo
un
de
rs
 a
nd
en
do
to
xi
ns
 (c
or
re
la
te
d 
w
ith
 fu
ng
i).
 E
xp
os
ur
e 
w
as
 e
sti
m
at
ed
w
ith
 c
on
sid
er
ab
le
 ra
nd
om
 e
rro
r.
(5
0)
a E
sti
m
at
ed
 fr
om
 c
ul
tu
re
 c
ou
nt
s b
y 
m
ul
tip
ly
in
g 
w
ith
 a
 fa
ct
or
 o
f 1
0.
FE
V
1: 
fo
rc
ed
 e
xp
ira
to
ry
 v
ol
um
e 
in
 o
ne
 se
co
nd
, F
V
C:
 fo
rc
ed
 v
ita
l c
ap
ac
ity
, I
L:
 in
te
rle
uk
in
, L
O
EL
: l
ow
es
t o
bs
er
ve
d 
ef
fe
ct
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13. Previous evaluations by national and international bodies
NEG evaluated microorganisms in 1991 but did not find a scientific basis for
criteria or guidelines for fungal spores (128).
The Russian Federation is the only nation that has adopted official occupational
exposure limits (OELs) for microorganisms. The Russian maximum allowable
concentrations are given for specific fungi and actinomycetes (227). These limits
appear to be based on allergenicity in animal models. The list is shown in Appen-
dix 9. The limits range from 103 to 104 cfu/m3, which may correspond to 104 to 105
spores/m3. However, many of the listed species are used for production of food
and antibiotics and probably have high viability when freshly cultivated. A factor
of 10 for conversion of cfu to spores may therefore be too high. The species are
classified according to hazard and allergenicity but no information is provided on
the classifications.
The current opinion of the American Conference of Governmental Industrial
Hygienists (ACGIH) is that the establishment of threshold limit values (TLVs) for
total culturable or countable bioaerosols is not possible (2). Their most important
arguments are: 1) that bioaerosols are generally complex mixtures of many agents,
2) the diversity of responses to microorganisms, and 3) insufficient information on
exposure-response relationships.
Rao et al reviewed quantitative standards and guidelines for airborne fungi and
found that these recommendations were primarily based on the low exposure
levels in “normal” environments given either as absolute or relative levels by
comparing to outdoor levels, and not on health effects data (186). A number of
guidance documents have been published, e.g. by the ACGIH (1), AIHA (4),
Health Canada (75), and Institute of Medicine in the United States (95). Many of
these guidelines contain recommendations on prevention because dampness-
related symptoms can be remediated by reducing humidity without knowledge of
the causative agent.
14. Evaluation of human health risks
14.1 Assessment of health risks
14.1.1 Airway and lung inflammation
Only one animal study provides relevant information on effects of single exposure
(58). This study showed no lung inflammation after exposure for 4 hours to
3⋅107 spores/m3 of Aspergillus fumigatus and three other fungal species. However,
neutrophil and eosinophil counts increased in bronchoalveolar lavage after a
single exposure to 3⋅108 spores/m3 of the actinomycete Saccharopolyspora
rectivirgula. An exposure level of 3⋅108 spores/m3 seems very high, but the high
incidence of ODTS attacks among college students who participated in a party in
a room where the floor was covered with mouldy straw (20) (Chapter 11.3)
suggests that such exposure situations may occur.
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Lung inflammation was induced by all tested fungal and actinomycete species
in the animal study described above when exposures were repeated daily for 5
weeks. The lowest LOEL was 4⋅105 spores/m3 for Aspergillus fumigatus (calcu-
lated to equal an 8-hour exposure) (58).
Four epidemiological studies in waste handlers (79, 80), sawmill workers (202)
and wood trimmers (100) indicate NOELs at 2⋅105-6⋅105 spores/m3 and LOELs at
somewhat lower levels 1⋅105 -2⋅105 spores/m3. The study of waste handlers has the
strongest design, as exposure was measured on three days between nasal lavages
and sputum inductions. However, inflammatory markers and cells in induced
sputum showed no association with fungal spores indicating a NOEL of 2⋅105
spores/m3, while nasal lavage showed a LOEL of 2⋅105 spores/m3 for increased
neutrophil counts. The effects of exposure to endotoxins, glucans, and bacteria,
and the potential confounders smoking, age and atopy were evaluated qualita-
tively and could not explain the associations with fungal exposure. All studies
were relatively small, however, and there is a considerable risk of false-negative
results. Furthermore, as methods for sputum induction and nasal lavage were
recently developed, little is known about the development of the inflammation
over time, which complicates interpretation of the results.
14.1.2 Respiratory function
Two human challenge studies present information on effect levels regarding
respiratory function. In a single dose study of school employees with sick building
syndrome no changes in mucosal and systemic symptoms, lung function, and
blood leukocytes were found after challenge with 8⋅103 Penicillium chrysogenum
spores/m3 or 4⋅103 Trichoderma harzianum spores/m3 (135). In the other study,
asthmatic patients were exposed to successively increasing doses, and a reduced
airway conductance was found after challenge with 1⋅104 Penicillium sp. spores/
m3 and 2⋅104 Alternaria alternata spores/m3 (125). The patients had specific IgE
to the fungi used in the test, while the sensitisation of the school employees was
not clear (positive basophil histamine-release tests but negative skin prick tests
and RASTs).
In a Swedish study, wood trimmers exposed to 1⋅105 spores/m3 showed no
changes in FVC and FEV1 after 4 days and 3 months, respectively (76). In the
same study, wood trimmers from another sawmill exposed to 3⋅106 spores/m3
showed FVC and FEV1 declines both after 4 days with exposure measurements,
and during the 3 preceding months. It seems unlikely that exposure levels were
very different from those that had been measured previously (Chapter 11.4.2).
An exposure-response association for changes in FVC and MEF25 after 3-5 days
exposure to a median of 1⋅105 spores/m3 was found in another study of Swedish
wood trimmers (38). A LOEL of 2⋅105 spores/m3 was found for increased nasal
congestion after 3 days of exposure among waste handlers (79). In cork workers
exposed to a mean level of approximately 107 spores/m3, exposure duration was
associated with restrictive lung function (9). However, limited information on
current and previous exposure levels, and outcomes complicates interpretation of
the latter study.
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The two Swedish studies of wood trimmers reported different effect levels. A
NOEL of 1⋅105 spores/m3 for short-term FVC and FEV1 decline in wood trimmers
may be based on the study by Hedenstierna et al (76), whereas Dahlquist et al
(38) report an exposure-response association at the same level for FEV1 and
MEF25 decline during a week. This may indicate that effects start to appear at
exposure to 1⋅105 spores/m3. The estimate in the latter study is more reliable as
fungal spores were counted by SEM. This LOEL is consistent with NOELs of
4⋅103-8⋅103 spores/m3 observed in a single dose human challenge study (135),
and with the LOELs of 1⋅104-2⋅104 spores/m3 found in the human challenge study
of asthmatic patients (125) since LOELs are expected to be higher in healthy
subjects. The LOEL for short-term increase in nasal congestion in waste handlers
of 2⋅105 spores/m3 (79) is also in the same region.
14.1.3 Respiratory symptoms
No respiratory and general symptoms were observed in the human challenge
study of school employees after challenge with 8⋅103 Penicillium chrysogenum
spores/m3 or 4⋅103 Trichoderma harzianum spores/m3 calculated to equal an
8-hour exposure (nasal and throat irritation, nasal congestion and headache were
examined) (135). LOELs of 1⋅105-4⋅105 spores/m3 for short-term and long-term
respiratory symptoms such as cough, eye irritation, throat irritation, phlegm and
bronchitis were observed in three epidemiological studies of farmers, waste
handlers, and joinery, sawmill and chip mill workers (6, 49, 78). Cough in wood
trimmers and farmers, and nasal irritation in farmers indicated higher LOELs of
2⋅106-3⋅106 spores/m3 (49, 54). However, the wood trimmer population did not
contain workers exposed to less than 4⋅105 spores/m3, which precluded the
exploration of symptoms at lower exposure levels. The LOEL of work-related
cough in the farmers study seems genuine as exposure to other bioaerosol
components was measured but these agents were not associated with cough and
the internal reference group was exposed to 2⋅103-2⋅104 spores/m3 (49). In this
study the risk of nasal irritation was already high at an exposure level of 1⋅105
spores/m3 although not significantly (OR 4.1, 95% CI 0.88-19).
Thus, most associations with respiratory symptoms indicate LOELs of 1⋅105-
4⋅105 spores/m3, which is similar to the LOELs indicated for short-term respiratory
function decline. However, associations with cough and possibly nasal irritation in
farmers indicate higher LOELs of 2⋅106-3⋅106 spores/m3.
14.1.4 Asthma
Only one epidemiological study related the prevalence of current physician-
diagnosed asthma in non-atopic farmers to exposure to fungal spores and other
agents (50). Annual exposure levels were estimated from task-based measure-
ments, which is likely to have introduced substantial random error. The observed
LOEL of 107 spores/m3 is therefore most likely a high estimate. In addition, endo-
toxins and ammonia were also associated with asthma and could not be adjusted
for due to high correlation between exposure measures.
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In atopic farmers, an inverse exposure-response association was found (50).
Studies from different countries have shown that the occurrence of atopic diseases
in farming populations is lower than in the general population, especially in
children. This seemingly protective effect is associated with contact with farm
animals, and it was postulated in the so-called hygiene hypothesis that exposure
to microbial agents, especially endotoxins from Gram-negative bacteria, mediated
this protective effect; review by Schaub et al (211). The results of the farmer
study indicate that such a protective effect may also result from exposure to the
farm environment as an adult and that also exposure to fungal spores can be
involved (50). It is also possible, however, that farmers with allergic asthma
change their production, methods and/or tasks to lower exposure, or even quit
farming, which would select asthmatic farmers away from highly exposed farm
work (healthy worker effect).
14.1.5 Hypersensitivity pneumonitis and organic dust toxic syndrome
Single dose human challenge studies of patients with hypersensitivity pneumo-
nitis found LOELs for typical attacks of the disease at 2⋅106 Pleurotus ostreatus
spores/m3 and 6⋅106 Lentinus edodes spores/m3, calculated to equal an 8-hour
exposure, respectively (35, 36). These LOELs are lower than the levels that
induced fever attacks in farmers with a clinically confirmed diagnosis of the
disease, 1⋅108-4⋅108 spores/m3 (130). The farmer study also indicates that fever
attacks in farmers with ODTS develop at approximately 10 times higher exposure
levels (2⋅109 spores/m3) than in farmers with hypersensitivity pneumonitis (130).
Further information is obtained from a study of cork workers exposed to 1⋅107
spores/m3 (mainly Penicillium glabrum) where 4% of the population had hyper-
sensitivity pneumonitis and 57% X-ray changes, a typical observation in
hypersensitivity pneumonitis patients, which correlated with current exposure
levels (9).
These data indicate that attacks of hypersensitivity pneumonitis may develop
after exposure to 2⋅106-6⋅106 spores/m3 of a single species, and that the disease can
develop after long-term exposure to 1⋅107 spores/m3. Higher LOELs were reported
in the farmer study (1⋅108-4⋅108 spores/m3). However, farmers were exposed to
spores from various species. As hypersensitivity pneumonitis seems to be species
specific (Chapter 11.2.1) the exposure level of the species that the farmers were
sensitised to is likely to be lower. It cannot be ruled out, however, that the potential
to induce hypersensitivity pneumonitis differs between species.
14.1.6 Studies in common indoor environments
The evidence from epidemiological studies of populations exposed to common
indoor air is insufficient for conclusions about effect levels to be drawn, except
for one well-designed study (203) indicating a NOEL for inflammation in the nose
and respiratory symptoms of 7⋅102 spores/m3 including exposure at home and at
work (Chapters 12.2 and 12.3).
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14.1.7 The role of specific organisms
The animal study by Fogelmark et al (58) shows that all tested species are capable
of inducing inflammation in the airways, but differ in inflammatory potential. This
is further documented in many other animal studies (Chapter 10.9). The limited
number of human challenge studies with intact spores provide little information
on species differences. A few epidemiological studies of long-term effects have
analysed the role of specific fungi (Chapter 11.5.2). Stronger associations have
been found for Aspergillus fumigatus in a waste handler study (31) and for
Aspergillus and Alternaria sp. in common indoor air studies (124, 134). However,
these studies suffer from weaknesses in the exposure assessment. The extremely
low LOEL of 10 Alternaria spores/m3 in the study by Menzies et al (134) is
highly unlikely considering the challenge study by Licorish et al (125) where a
LOEL of 2⋅104 spores/m3 was found in asthmatic patients allergic to the fungus.
The implicated species in these epidemiological studies represented only a frac-
tion of the total number of fungi. In other studies, a single species dominated, e.g.
Penicillium glabrum in a study of cork workers (9), Rhizopus microsporus in a
study of wood trimmers (54), and Sporobolomyces salmonicolor in a common
indoor air study (217). These studies do not indicate lower LOELs to the domi-
nating species than observed in studies where species characterisation was not
performed.
Little information is available about actinomycetes. The animal study by
Fogelmark et al (58) indicated that a 10 times higher exposure level of spores
of the actinomycete Saccharopolyspora rectivirgula induced inflammation in
lung tissue of similar intensity as spores of the fungus Rhizopus stolonifer after
prolonged exposure (Table 10). However, after a single exposure only S. rectivir-
gula and none of the fungal species induced inflammation. Human challenge
studies have further documented that Saccharopolyspora rectivirgula extracts
can induce attacks of hypersensitivity pneumonitis and asthma in farmers’ lung
patients (Tables 11-12) (55, 178). In vitro and in vivo studies further document
that spores from different actinomycetes species can induce airway and lung
inflammation similarly to fungal spores. It is therefore reasonable to assume that
the health effects following exposure to actinomycete spores do not differ quali-
tatively from fungal spores, but data on effect levels are lacking.
14.2 Groups at extra risk
Patients with hypersensitivity pneumonitis respond to fungal exposure with febrile
attacks at a lower level than individuals without the disease. However, the expo-
sure levels that induce typical attacks of the disease are relatively high, ≥ 2⋅106
spores/m3.
Patients with allergic asthma to fungi may have an increased risk. LOELs of
1⋅104-2⋅104 spores/m3 found for airway obstruction in allergic asthmatics are one
order of magnitude lower than LOELs found in epidemiological studies of lung
function in healthy subjects. Children should also be regarded as a vulnerable
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group because they have a higher prevalence of allergic asthma to fungi; review
by Bush and Portnoy (25).
The role of atopy is less clear. In a farmer study, asthma decreased with expo-
sure to fungal spores and other agents in atopic subjects (50). This may be due to
selection, but also the hygiene hypothesis offers an alternative explanation.
No information was identified on sex differences and immunodeficient people.
However, fungal infections may be life threatening in immunocompromised
cancer patients undergoing treatment; review by Richardson (196).
14.3 Scientific basis for an occupational exposure limit
In vitro and in vivo studies have shown that a large number of fungal and actino-
mycete species are capable of inducing inflammatory effects in phagocytic cells
and lung tissue. There is also evidence from those studies that the inflammatory
potency depends on species, with the mycotoxin producing Stachybotrys charta-
rum and the facultative pathogenic Aspergillus fumigatus showing the highest
potencies. However, epidemiological studies of various respiratory outcomes
indicate fairly similar potencies when comparing LOELs expressed as spores/m3.
Thus, the inflammatory potency of most species occurring in the work environ-
ment seems to be fairly similar. Furthermore, fungi with high potency have to
constitute a substantial fraction of the fungal biota before a significant change in
inflammatory potential can be expected.
The response of subjects with hypersensitivity pneumonitis as well as asthma is
species specific as shown by human challenge studies using fungal extracts and
whole spores. It cannot be derived from these findings, however, that the
allergenic potential differs between species because the exposure levels leading
to allergy is not known. For example, Cladosporium, Alternaria, and Aspergillus
species are most often involved in fungal allergy but dominate also in outdoor air
(115).
A series of studies including various fungal species suggests that respiratory
symptoms, airway inflammation, and lung function impairment begin to appear
at exposure levels of approximately 105 spores/m3.
The lung function studies in wood trimmers are most interesting because
the effect is objectively measured and wood trimmers are primarily exposed to
fungal spores besides low levels of wood dust, bacteria, endotoxins, and terpenes.
The effect of agents other than fungal spores is therefore limited. The effect of
confounders was evaluated separately (smoking) or was eliminated by the follow-
up design (age, height and body weight). The study by Dahlquist et al (38) is
preferred, as fungal spores were measured by microscopic counting. A relation-
ship was found between exposure to fungal spores and FEV1 decline in a popu-
lation exposed to a median of 1⋅105 spores/m3. This level is also compatible
with NOELs of 4⋅103-8⋅103 spores/m3 (calculated to equal an 8-hour exposure)
observed in the human challenge study in which subjects inhaled a single con-
centration during 6 minutes (135), and with NOELs of 1⋅104-2⋅104 spores/m3
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(calculated to equal an 8-hour exposure) found in the human challenge study
where asthmatic patients inhaled graded doses by single inhalations (125).
An OEL based on the study by Dahlquist et al (38) is likely to represent a
range of fungal species as studies of other populations suggest LOELs of similar
magnitude. However, such a limit is not applicable if spores from mycotoxin
producing and/or opportunistic pathogenic species are prevalent.
As the fungal spore is the unit of interest in this document, exposure assess-
ments should be based on non-culture methods. Microscopical methods seem
most suitable at present. Characterisation of the fungal biota can be achieved by
cultivation and by molecular biological methods. However, the presence of other
airborne fungal particles as hyphae and fungal fragments have been demonstrated
(Chapters 3.3 and 3.6), but their role in respiratory disease is not clear as no
animal or epidemiological studies addressing these particles have been published.
In vitro studies suggest that the response to hyphae is different from the response
to spores, but the studies have only been performed with pathogenic fungi
(Chapter 8.1).
14.4 Evaluations in common indoor environments
Very few studies of acceptable quality have been found of populations exposed
to common indoor environments. However, the airborne fungal biota found in
such environments do not oppose the application of effect levels based on studies
in highly contaminated environments on common indoor populations as well.
Furthermore, in a challenge study of individuals with sick building syndrome
NOELs of 4⋅103-8⋅103 spores/m3 were found (135). This NOEL is consistent with
effect levels in highly contaminated environments since only a single dose level
was applied in the human challenge study and higher NOELs are not precluded.
It is now generally accepted that dampness in buildings is related to respiratory
effects, and the measurement of airborne fungal spores is just one of several ways
to detect dampness (16). Several strategies are available for the evaluation of
“mould problems” and many criteria have been proposed to evaluate common
indoor environments (186) (Chapter 13). These criteria specify much lower levels
of airborne fungi than the LOELs found in this review, but the criteria are only
indirectly related to health effects as they have been proposed to identify “sick
buildings”.
15. Research needs
More information is needed on NOELs of spores from specific fungi at different
dose levels, including mycotoxin producing and opportunistic pathogenic species.
This requires animal studies as human challenge with whole spores is generally
regarded unethical (Chapter 11.2.1). Studies should be carried out with aerosol
exposure over extended periods.
104
Molecular biological methods seem well suited for non-culture based assess-
ment of fungi. Development of quantitative methods for the measurement of
specific organisms and genera is therefore needed to improve the exposure
assessment in future studies. Even chemical markers of fungi can be considered,
especially agents shown to have inflammatory properties such as β(1→3)-glucans
(42).
The few occupational studies that have examined allergic outcomes show
contradictory results. In some highly exposed populations sensitisation to pre-
valent fungal species is almost absent, whereas fungal allergy is not uncommon
in the general population and in working populations exposed to fungal enzymes
(Chapters 3.5 and 11.2.2). There is some information in the experimental studies
that deserves more attention, however. In animal studies, viable spores induced
allergic responses in contrast to non-viable spores, and repeated exposure studies
also demonstrated eosinophilic inflammation in addition to neutrophils and
macrophages (Chapter 10.9). Mechanistic studies have shown that dendritic
cells prime a non-allergic response to spores and an allergic response to hyphae
(Chapter 8.1). The allergic response to viable spores and to hyphae can be due to
the production of allergens by germinating spores and growing hyphae (Chapter
3.5). Furthermore, Sercombe et al recently demonstrated that germinating spores
in the nasal cavity of healthy subjects were common (216). It is therefore impor-
tant to develop methods for quantification of viable spores and hyphae and apply
these in epidemiological studies.
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16. Summary
Eduard W. The Nordic Expert Group for Criteria Documentation of Health Risks
from Chemicals. 139. Fungal spores. Arbete och Hälsa 2006;21:1-145.
Fungal spores are ubiquitous in the environment. Exposure levels in workplaces
where mouldy materials are handled are much higher than in common indoor and
outdoor environments. Febrile attacks of organic dust toxic syndrome (ODTS) and
hypersensitivity pneumonitis may occur after episodes with excessive exposure.
In common indoor environments irritation symptoms have been ascribed to fungi
at much lower exposure levels, especially in damp buildings.
The specificity of the response to fungi in hypersensitivity pneumonitis and
asthma patients has been clearly demonstrated by bronchial provocation with the
suspected organisms. In vitro and animal studies have further shown differences
in the inflammatory potential of fungal species. In animal studies, non-allergic
responses dominated after a single spore dose but allergic responses, especially to
viable spores, were also observed. Repeated exposures induced both non-allergic
and allergic pulmonary inflammation.
Two human challenge studies with whole spores provide information on effect
levels. A single dose study of subjects with sick building syndrome indicated no
observed effect levels (NOELs) of 4⋅103 spores/m3 for Trichoderma harzianum
and 8⋅103 spores/m3 for Penicillium chrysogenum. The investigated effects were
lung function impairment, mucosal and systemic symptoms and inflammatory
cells in the blood. A study of asthmatic patients allergic to Penicillium sp. or
Alternaria alternata showed lowest observed effect levels (LOELs) for reduced
airway conductance of 1⋅104 and 2⋅104 spores/m3, respectively.
In epidemiological studies of highly exposed populations lung function decline,
respiratory symptoms and airway inflammation began to appear at exposure levels
of 105 spores/m3. LOELs of 1⋅105-4⋅105 spores/m3 have been reported in wood
workers predominantly exposed to fungal spores and wood dust. The only well-
designed study on populations exposed to common indoor air indicates a NOEL
of 7⋅102 spores/m3. The investigated effects were inflammatory markers in nasal
lavage, and eye, throat, lower airways and non-specific symptoms. Fungal species
were seldom identified in the epidemiological studies.
In conclusion, the combined evidence from human challenge and epidemio-
logical studies support fairly consistent LOELs of approximately 105 spores/m3 for
diverse fungal species in non-sensitised populations. However, identification of
the fungal biota is required in order to document the occurrence of the more toxic
mycotoxin containing species and pathogenic species before measurements are
evaluated.
Further epidemiological studies of allergic responses to fungal spores and
effects of pathogenic and mycotoxin containing species are recommended.
Keywords: actinomycetes, fungal spores, hypersensitivity pneumonitis, irritation,
occupational exposure limit, organic dust toxic syndrome, review, toxicity
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17. Summary in Norwegian
Eduard W. The Nordic Expert Group for Criteria Documentation of Health Risks
from Chemicals. 139. Fungal spores. Arbete och Hälsa 2006;21:1-145.
Soppsporer finnes overalt i miljøet. I arbeidsmiljø hvor materialer med soppvekst
håndteres kan eksponeringen for soppsporer bli mye høyere enn det som er vanlig
innendørs og utendørs. Typiske feberanfall av allergisk alveolitt og “organic dust
toxic syndrome” kan utløses etter massiv eksponering for soppsporer. Men også i
arbeidsmiljø med mye lavere eksponering er sopp blitt assosiert med plager, for
eksempel i fuktige bygninger.
Bronkial provokasjon av pasienter med allergisk alveolitt eller astma med
mistenkte organismer har vist tydelig at responsen er artsspesifikk. In vitro og
dyreforsøk har videre vist forskjeller i inflammatorisk potensial hos ulike
sopparter. Hos dyr eksponert én gang dominerte ikke-allergiske responser.
Allergiske responser ble også observert, spesielt på viable sporer, sporer som
inneholder mykotoksiner, og etter gjentatte eksponeringer.
Provokasjon av personer med ”sick building syndrome” som ble eksponert
 én gang viste ’no observed effect levels’ (NOELs) på 4·103 sporer/m3 for Tricho-
derma harzianum og 8·103 sporer/m3 for Penicillium chrysogenum. Lunge-
funksjon, slimhinne og systemiske symptomer og inflammatoriske celler i blod
ble undersøkt. Provokasjon av pasienter med astma som var allergiske for
Penicillium sp. eller Alternaria alternata med økende doser viste ’lowest
observed effect levels’ (LOELs) for redusert luftveismotstand ved henholdsvis
1·104 sporer/m3 og 2·104 sporer/m3.
I epidemiologiske undersøkelser av høyt eksponerte yrkesgrupper ble nedsatt
lungefunksjon, luftveissymptomer og luftveisinflammasjon funnet når ekspo-
neringsnivået overskred 105 sporer/m3. Undersøkelser av trearbeidere som er
hovedsakelig eksponert for soppsporer og trestøv viser LOELs på 1·105-4·105
spores/m3. Få epidemiologiske undersøkelser av yrkesgrupper som jobber i vanlig
innemiljø ble funnet og bare en hadde god design. Denne undersøkelsen viste en
NOEL ved 7·102 sporer/m3 for inflammationsmarkører i neseskyllevæske,
symptomer fra øye, hals og nedre luftveier samt ikke-spesifikke symptomer. Sopp
ble sjeldent identifisert i epidemiologiske undersøkelser.
Konklusjon: Resultatene fra humane provokasjonsstudier og epidemiologiske
undersøkelser underbygger ganske konsistente LOELs på ca. 105 sporer/m3 ved
eksponering for diverse sopparter i ikke-sensibiliserte yrkesgrupper. Identifikasjon
av soppfloraen er nødvendig for å dokumentere forekomst av de mer toksiske
mykotoksin-produserende og patogene arter før evaluering av måleresultater.
Videre epidemiologiske undersøkelser av allergiske sykdommer og effekter av
eksponering for patogene og mykotoksin-produserende arter anbefales.
Stikkord: administrative norm, aktinomycetes, allergisk alveolitt, irritasjon,
review, organic dust toxic syndrome, soppsporer, toksistitet.
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19. Data bases used in the search for literature
A literature search was conducted in the Medline, Toxline, Arbline, OSH-ROM
and ISI bases as well as the author’s own database. Further references were
obtained from reviewed papers. The last search was performed in November
2006. The following terms were used in the literature search:
Agent Effects Occupational environments
Fungal spores Toxicity Agriculture
Fungi In vitro Farmers
Moulds/Molds In vivo Mushroom cultivation
Hyphae Animal Sawmills
Actinomycetes Cytotoxicity Wood industry
Mutagenicity Breweries
Fungal components Carcinogenicity Cheese production
Mycotoxins Teratogenicity Indoor air, built environ-
Fungal antigens Reproductive effects ment, schools
Fungal allergens Human challenge studies Municipal waste
Glucans Provocation tests Sugar mills
Exposure-response
Antibodies Exposure-effect
Fungal antibodies Dose-response
Fungal IgG antibodies Dose-effect
Fungal IgG Respiratory effects
Fungal IgE antibodies Inflammation
Fungal IgE Lung function
Airway disease
Allergic alveolitis
Hypersensitivity pneumonitis
Asthma
Allergy
Chronic bronchitis
Fever
Epidemiology
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Appendix 1. Terms as used in the present document
Term Explanation
Actinomycetes Bacteria that grow and replicate like filamentous fungi.
Actinomycetes may produce large numbers of vegetative spores
that are easily dispersed into the air.
Aerodynamic diameter Diameter of a spherical particle with specific density equal to 1
g/cm3 and the same sedimentation velocity as the actual particle.
Allergen Antigen that can induce hypersensitivity reactions often by
inducing the production of IgE antibodies.
Allergic alveolitis See Hypersensitivity pneumonitis.
Allergy A hypersensitivity reaction initiated by immunological
mechanisms.
Antigen Molecule that may induce the production of immunoglobulin
antibodies.
Asthma Obstructive lung disease characterised by reversible attacks of
airway obstruction following exposure to allergens and non-
specific irritants. In allergic asthma the response is mainly limited
to specific allergens, and IgE antibodies to the allergen can be
demonstrated. Non-allergic asthma does not seem to be IgE-
mediated.
Atopy The ability of an individual to produce IgE antibodies after
exposure to an allergen. Atopy can be tested by the presence of
IgE antibodies to common allergens in serum or by skin prick
tests with these allergens.
Colony forming unit A single microorganism or an aggregate of microorganisms that
has grown into a countable colony by culture on a semi-solid
nutrient medium under controlled conditions.
Conidia Asexual spores produced by fungi.
Culturable microorganisms Microorganisms quantified by culture-based methods.
Eukaryotic organism Organism with cell(s) that have well defined nuclei containing the
genetic material.
Fluorochrome Fluorescent dye used to visualise specific particles in the
fluorescence microscope.
Fungi Organisms belonging to the kingdom Mycota. Fungi can be
divided into filamentous fungi that form hyphae and replicate by
spores, and by budding of cells (yeast).
Genus The next lowest taxonomic category; also called family.
Gram-positive Bacteria are divided in two main groups based on a staining
technique developed by Gram. The Gram-positive bacteria differ
from Gram-negative bacteria by the structure and composition of
the cell wall.
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Term Explanation
Heterophilic microorganisms Microorganisms dependent on organic material from dead or
living organisms for growth.
Hyphae Branched multi-cellular filaments formed by filamentous fungi.
Hypersensitivity Causes objectively reproducible symptoms, or signs, initiated by
exposure to a defined stimulus at a dose tolerated by normal
subjects.
Hypersensitivity pneumonitis Alveolar and bronchiolar inflammation caused by inhalation of
spores from fungi and actinomycetes, and other allergens. Acute
attacks are similar to ODTS (see Organic dust toxic syndrome).
Recurrent attacks may eventually progress into pulmonary
fibrosis. IgG but not IgE can usually be detected. Also called
allergic alveolitis.
Immunoglobulin E Antibodies that are a part of the adaptive immune response.
Specific and total immunoglobulin E can be detected in serum as
a measure of allergic sensitisation.
Immunoglobulin G Antibodies that are a part of the adaptive immune response.
Specific immunoglobulin G antibodies to fungal species in serum
can be used as biomarkers of exposure but the precision is poor.
Impactor Sampling device that collects particles according to inertial
properties when the air stream is diverted after aspiration of the
aerosol.
Impinger Impactor that collects particles in a liquid.
Induced sputum Collection of sputum stimulated by inhalation of a saline aerosol.
Inhalation fever See Organic dust toxic syndrome.
Job exposure matrix A tool to estimate qualitative or quantitative exposure levels using
job characteristics.
Magic Lite test A fluorometric enzyme immunoassay for IgE.
Mesophilic microorganisms Microorganisms with optimal growth at temperatures between 15
and 30 °C.
Metabolites Intermediate compounds and products of metabolism.
Mycelium All aggregated hyphae from a single organism.
Mycotoxins Toxic compounds produced by a number of fungal species.
Mycotoxins can be excreted in substrates and may also be found
in spores from such species.
Organic dust toxic syndrome Attacks of fever/chills with respiratory symptoms and malaise
that develop 4-8 hours after massive exposure to some substances,
e.g. metal fumes and organic particles. The symptoms resolve
within a few days. IgG antibodies against fungi are often not
detectable.
Phadiatop Combined detection of IgE against 10 common respiratory aller-
gens by a radio-allergosorbent test. A positive test indicates the
presence of atopy.
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Term Explanation
Precipitins IgG antibodies detected in serum by the double-diffusion
technique of Ouchterlony through formation of an antigen-
antibody precipitate.
Primary metabolites Metabolites essential for normal growth, development, and
reproduction.
Proliferation Rapid reproduction of microorganisms.
Psychrophilic microorganisms Microorganisms that preferentially grow at temperatures below
15 °C.
Secondary metabolites Metabolites that are not essential for normal growth, development
and reproduction, but usually have important ecological functions.
Examples are toxins such as antibiotics used in competition with
other organisms, and pigments.
Sensitisation Sensitisation is often understood as the presence of serum IgE
antibodies to a specific allergen. However, hypersensitivity
pneumonitis patients are also more sensitive to exposure to
allergens, which is mediated by other mechanisms.
Spores Sexual or asexual reproductive cells of fungi and actinomycetes
(only asexual). Spores are metabolically inactive and tolerate
environmental stress much better than vegetative cells. They are
therefore important means for dispersion of organisms to other
habitats.
Thermophilic microorganisms Microorganisms that preferentially grow at temperatures above
30 °C.
Toxic alveolitis See Organic dust toxic syndrome.
Toxigenic microorganisms Microorganisms that have the capability to produce toxins.
Viable organisms Living organisms capable of germination, growing, and repli-
cation. Viable organisms include organisms that can grow on
nutrient plates as well as living organisms not able to grow in
culture, e.g. obligate parasitic organisms.
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Appendix 2. Synonyms
Recent and previous scientific names of fungi and actinomycetes used in this document.
Previous name Current name
Fungi
Merulius lacrymans Serpula lacrymans
Penicillium cyclopium Penicillium aurantiogriseum
Penicillium frequentans Penicillium glabrum
Penicillium notatum Penicillium chrysogenum
Rhizopus rhizopodiformis Rhizopus microsporus
Stachybotrys atra Stachybotrys chartarum
Actinomycetes
Thermopolyspora polyspora Saccharopolyspora rectivirgula
Micropolyspora faeni Saccharopolyspora rectivirgula
Faeni rectivirgula Saccharopolyspora rectivirgula
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Appendix 3. In vivo studies of spore distribution
Green et al exposed rats and rabbits (n not given) intratracheally to 5⋅107 and 7⋅106
Aspergillus terreus spores or 1⋅105 and 4⋅103 spores/g bw, respectively. Spores
were collected by washing culture plates with 0.01% Tween in saline, and were
washed twice in saline. A. terreus spores migrated only to a minor extent to other
organs. A few spore-containing alveolar macrophages were observed in the
alveolar interstitium after 3 and 24 hours and in the tracheobronchial lymph nodes
after 24 and 48 hours (68).
Kurup and Sheth exposed rabbits (n=2/group) intratracheally to 1⋅107 A. fumi-
gatus spores in saline or 4⋅103 spores/g bw. Spores were washed from culture
plates by 0.05% Tween 80 in saline and washed several times in saline. Dissimi-
nation to the kidneys and spleen was observed after 3 days (114).
Kurup exposed rabbits (n=5) intratracheally to 1⋅107 A. fumigatus spores (4⋅103
spores/g bw, two strains, 90-95% viable, mainly single spores). Spores were
washed from culture plates by saline and filtered. Viable spores were detected
in lung tissue, liver, spleen and kidneys after 4 hours (112).
Olenchock et al exposed pathogen free rats (n=2/group) intratracheally to 5⋅107
A. terreus spores (1⋅105 spores/g bw). Spores were collected by washing culture
plates with 0.01% Tween in saline, and were washed twice in saline. The spores
did not penetrate the alveolar and bronchial epithelium. Peripheral alveolar macro-
phages migrated from the alveoli adjacent to the bronchioles and after 3 hours
some spores were also detected in the tracheobronchial lymph nodes (165).
Schaffner et al immunised mice by intravenous injection of viable A. fumigatus
spores and exposed the animals to aerosols of spores blown from a culture of the
same organism (3⋅105 cfu/g lung tissue after 2 hours, n=9, 4⋅103 spores/g bw). No
dissemination of the spores to the brain, spleen, liver, or kidneys was observed at
24-hour intervals up to 4 days after exposure (210).
Thurston et al exposed rabbits to aerosols of viable Aspergillus fumigatus and
Penicillium sp. 5⋅105-4⋅106 and 1⋅105-5⋅105 cfu/g lung tissue (or 1⋅104-8⋅104 and
2⋅103-1⋅104 spores/g bw, respectively, estimated 1 hour after exposure; n=3-4
/group). Spores were collected by 1) rolling glass beads over a mature culture
plate, and 2) aspiration of the spores from the beads into a filter holder. Viable
spores were found in the lung and in digestive system and intestinal lymphoid
tissue 6 hours after exposure. However, spore counts in gastro-intestinal tissues
were much lower than in the lungs, ≤0.1% of the initial levels in lung tissue.
Spore counts had cleared after 1 week. No other organs were studied (235).
Waldorf and Levitz exposed mice (n=10/group) intranasally to 1⋅106 spores
of A. fumigatus and Rhizopus oryzae (4⋅104 spores/g bw). Spores were harvested
from culture plates in saline, vortex mixed, filtered and washed three times in
saline (viability >95%, hyphae free). After 1 day, spores from both species
were abundant in the lungs, blood, liver, spleen and kidney, but after 10 days,
A fumigatus spores were only found in the lungs whereas R. oryzae spores were
also found in the spleen and liver (241).
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Appendix 4. In vivo studies of spore elimination from the lung
Cooley et al exposed mice intranasally to 1⋅104 spores of Penicillium chryso-
genum (4⋅102 spores/g bw). Spores were washed from culture plates by saline,
washed with phosphate-buffered saline, sonicated, and filtered (single spores,
25% viable). The authors showed by transmission electron microscopy that spores
were phagocytised and digested by alveolar macrophages from 3 to 24 hours after
exposure (33).
Green et al exposed rabbits and rats (n not given) intratracheally to 7⋅106 and
5⋅107 Aspergillus terreus spores or 4⋅103 and 1⋅105 spores/g bw, respectively.
Spores were collected by washing culture plates with 0.01% Tween in saline.
The collected spores were washed twice in saline. Lung tissue was studied by
SEM until 48 hours. The authors observed rapid uptake of the spores by alveolar
macrophages that started immediately and was almost complete after 3 hours.
Peripheral alveolar macrophages moved from the alveoli adjacent to the
bronchioles. A few PMN were observed (68).
Kurup and Sheth exposed rabbits (n=2/group) intratracheally to 1⋅107 A. fumi-
gatus spores in saline (4⋅103 spores/g bw). Spores were washed from culture plates
by 0.05% Tween 80 in saline and washed several times in saline. After 4 hours,
0.3% of the inocculum was recovered by culture of the lungs (114).
Kurup exposed rabbits (n=5) intratracheally to 1⋅107 A. fumigatus spores (two
strains, 90-95% viable, mainly single spores, 4⋅103 spores/g bw). Spores were
washed from culture plates by saline and filtered. Spores and macrophages in
bronchoalveolar lavage fluid were quantified by light microscopy until 4 hours.
Spores were rapidly ingested by pulmonary alveolar macrophages, 53% of the
spores were ingested after 1 hour. After 4 hours, the proportion of internalised
spores in alveolar macrophages had declined to 22% (112).
Olenchock et al exposed pathogen free rats and rabbits (n=2/group) intra-
tracheally to 7⋅106 and 5⋅107 A. terreus spores (4⋅103 and 1⋅105 spores/g bw),
respectively. Spores were collected by washing culture plates with 0.01% Tween
in saline, and were washed twice in saline. Spores and macrophages in lung tissue
were quantified by SEM until 24 hours. Spores were rapidly phagocytised by
alveolar macrophages in rats (42% after 0 hours and 98% after 24 hours) and
in rabbits (only qualitative observations). After 24 hours only 20% of the spores
found at 0-3 hours were observed (165).
Schaffner et al immunised mice by intravenous injection of viable A. fumigatus
spores and exposed the animals to aerosols of spores blown from a culture of the
same organism (3⋅105 spores/g lung tissue after 2 hours, n=9, 4⋅103 spores/g bw).
Lung tissue was cultured until 6 days. Cfu counts in lung tissue decreased by
>99% from 2 to 48 hours after exposure, but were still found in one animal after
6 days (210).
Thurston et al exposed rabbits by inhalation to A. fumigatus spores, 5⋅105-4⋅106
cfu/g lung tissue after 1 hour (n=6, 1⋅104-8⋅104 spores/g bw) and Penicillium sp.
spores, 1⋅105-5⋅105 cfu/g lung tissue after 1 hour (n=3, 2⋅103-1⋅104 spores/g bw).
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Spores were collected by 1) rolling glass beads over a mature culture plate, and
2) aspiration of the spores from the beads into a filter holder. Culture counts in
lung tissue were performed during 3 weeks. Cfu counts of A. fumigatus in lung
tissue reduced to 1-10% after 24 hours, 0.1-2% after 48 hours and were not found
after 1.5-3 weeks. Cfu counts of Penicillium sp. reduced more slowly, 7-30% after
24 hours, 4-7% after 48 hours and 0.02-0.03% after 3 weeks (235).
Voisin et al exposed Guinea pigs by intratracheal instillation of 1⋅107-12⋅107
cells of Candida albicans (n=20/group, 3⋅104-4⋅105 cells/g bw), and by inhalation
to A. fumigatus for 5 minutes (7⋅106 cfu after 2 hours, n=100, 2⋅104 spores/g bw)
and S. rectivirgula spores for 10 minutes (1⋅106-8⋅106 cfu after 2 hours, n=90,
3⋅103-3⋅104 spores/g bw). Culture counts in lung tissue were performed until
day 5, 10 and 59, respectively. The preparation of spores was not described.
Inhaled A. fumigatus spores and intratracheally instilled Candida albicans cells
were rapidly destroyed by alveolar macrophages and spore counts in lung tissue
decreased to 1% within 1-2 days. Cfu counts of S. rectivirgula reduced to 10%
after 2-3 weeks and could still be cultured 2 months after exposure. Mycelial
growth was observed in animals that had been treated with anti-alveolar macro-
phage serum (n=30) before exposure to S. rectivirgula spores (240).
Waldorf and Levitz exposed mice (n=10/group) intranasally to 1⋅106 spores of
A. fumigatus and Rhizopus oryzae (4⋅104 spores/g bw). Spores were harvested
from culture plates in saline, vortex mixed, filtered and washed three times in
saline (viability >95%, hyphae free). Bronchoalveolar lavage was performed
18 hours after exposure and 70% of the A. fumigatus spores in bronchoalveolar
lavage fluid had been killed by alveolar macrophages but only 20% of the
R. oryzae spores. However, germination of spores was not observed by histologi-
cal examinations over a 10-day period for both species (241).
Zaidi et al exposed Guinea pigs (n=30/group) to 800 µg S. rectivirgula spores
(approximately 4⋅106 spores/g bw) with and without hay dust (75 mg) by intra-
tracheal instillation. Culture counts in lung tissue were performed until 7 days.
Spores were scraped of culture plates and suspended in saline. When exposed to
S. rectivirgula only, cfu counts in lung tissue rapidly decreased to 10% after 1 day
and 0.1% after 3 days. However, when combined with hay dust spore counts
remained high for 7 days (256).
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Appendix 5. In vitro studies of spore elimination
Hirvonen et al exposed the mouse macrophage cell line RAW264.7 to spores from
14 actinomycete species (Actinomyces and Streptomyces species isolated from
mouldy environments, 0.01-10 spores/macrophage). Spores were harvested by
adding phosphate-buffered saline containing 0.0001% Triton X-100 to culture
plates, and eventually killed by gamma irradiation. Cytotoxicity to the cell line
and production of nitrite, iNOS and ROS by the macrophages differed across
species. Killed spores induced similar amounts of nitrite, less iNOS (judged
visually) and ROS. Nine species were cytotoxic and cytotoxicity of killed spores
was even higher than that of viable spores for 7 of these species (84).
Hirvonen et al exposed the mouse macrophage cell line RAW264.7 to spores of
Aspergillus sp., Penicillium sp., Cladosporium sp., Candida albicans, Stachy-
botrys sp. and two Streptomyces spp. (0.01-10 spores/macrophage). Spore
suspensions in phosphate-buffered saline were prepared but no details were given.
Streptomyces species induced high levels of nitrite, iNOS, IL-6, and TNFα.
Cladosporium sp., Candida albicans, and Stachybotrys sp. produced moderate
amounts of nitrite and Cladosporium sp. also TNFα. Only Stachybotrys sp. was
cytotoxic to the cell line (81).
Hirvonen et al exposed the mouse macrophage cell line RAW264.7 to viable
spores of the Streptomyces species (used in the study above), now identified
as S. californicus and S. anulatus (0.01-10 spores/macrophage). Spores were
harvested by adding phosphate-buffered saline containing 0.0001% Triton X-100
to culture plates. Nitrite, IL-6 and TNFα were produced in a dose-response
manner and iNOS induction was detected. No cytotoxicity was observed (82).
Hirvonen et al exposed the mouse macrophage cell line RAW264.7 to spores
of Streptomyces anulatus from cultures grown on 15 different substrates (0.01-10
spores/cell). Spores were harvested by adding distilled water to culture plates.
Nitrite, TNFα and IL-6 were produced and cytotoxicity increased in a dose
dependent manner. Only spores grown on one of the substrates induced ROS
production. The substrate used for culture influenced the level of all responses
except TNFα (85).
Huttunen et al compared the inflammatory and cytoxic responses of mouse
RAW264.7 macrophage, human 28SC macrophage and human A549 lung epithe-
lial cell lines to spores from Streptomyces californicus, Penicillium spinolosum,
Aspergillus versicolor and Stachybotrys chartarum (0.2-20 spore/cell). Spores
were collected with a sterile loop and suspended in Hank’s balanced salt solution
containing 0.0001% Triton X-100. TNFα increased in the mouse macrophage cell
line for all species, but not in the human cell lines. Nitrite production increased in
human lung epithelial cells exposed to S. chartarum and S. californicus and in
mouse macrophages exposed to S. californicus. Both mouse and human macro-
phages exposed to S. californicus showed an IL-6 response, and in mouse
macrophages also IL-1β was induced. Such responses were not observed in the
other cell lines. All species were cytotoxic to the macrophage cell lines with
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toxicity of S. chartarum > A. versicolor > P. spinolosum/S. californicus. S. char-
tarum and A. versicolor were also cytotoxic to the human lung epithelial cell line
(91).
Huttunen et al exposed the mouse RAW264.7 macrophage cell line to spores of
Aspergillus versicolor, Penicillium spinulosum and non-trichothecene producing
Stachybotrys chartarum, either alone (0.02-2 spores/cell) or together with Strepto-
myces californicus spores (0.2 spores/cell). The preparation of the spores was not
described. NO, TNFα and IL-6 was not induced by any fungal species alone, but
all species were cytotoxic. S. californicus alone induced NO, TNFα and IL-6, and
was cytotoxic. S. chartarum together with S. californicus showed a strong syner-
gistic interaction on IL-6 production (92).
Jussila et al exposed a human alveolar epithelial cell line to spores from Strep-
tomyces anulatus (0.001-24 spores/cell). Spores were suspended in phosphate-
buffered saline but no further details were given. Nitrite and IL-6 was induced at
the highest exposure levels (12-24 spores/cell) that also caused a substantial cell
death (105).
Kurup exposed normal rabbit pulmonary alveolar macrophages to viable spores
of A. fumigatus (1-3 spores/macrophage). Spores were washed from culture plates
by saline and filtered. Only a small fraction of viable spores of A. fumigatus (19%)
was killed by the macrophages after 4 hours. Activation of macrophages in the
rabbits by repeated intracutaneous injections with complete adjuvant, and/or
opsonisation with anti-A. fumigatus serum increased the fungicidal activity of
the alveolar macrophages only moderately. Remaining ingested spores started
germination 4 hours after exposure. Most viable spores of Aspergillus niger and
Aspergillus flavus were killed by normal pulmonary alveolar macrophages within
4 hours (80-90%) (112).
Murtoniemi et al exposed the mouse macrophage cell line RAW264.7 to spores
from Streptomyces californicus, Penicillium spinolosum, Aspergillus versicolor
and Stachybotrys chartarum grown on different plasterboards under identical
conditions (0.01-1 spore/cell). Different responses of the inflammatory mediators
nitrite, IL-1β, TNFα and IL-6 were observed both between species and strains
grown on different plasterboards. S. californicus showed the strongest responses.
All species were cytotoxic at approximately similar levels (151).
In a similar study by Murtoniemi et al, different inflammatory mediator
responses were also found between fungi grown on the liner and core materials
when tested separately (150). Spore isolation is not clearly described in these
studies (150, 151).
The same author (Murtoniemi et al) describes the use of a sterile swab in a
similar study. In the latter study it was found that cytotoxicity did not correlate
with inflammatory mediators or growth conditions for A. versicolor or S. charta-
rum, whereas a positive association was found between cytotoxicity and inflam-
matory mediators for S. californicus and P. spinolosum (148).
In another study (Murtoniemi et al) of the effect of plasterboard composition on
biological activity of S. chartarum and S. californicus spores, a sterile plastic rod
was used. The composition of the plasterboards, especially the presence of starch
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in the lining material and biocides in both the lining and core material influenced
nitrite, IL-6 and TNFα production as well as cytotoxicity in the mouse RAW264.7
macrophage cell line (149).
Nessa et al exposed human alveolar macrophages obtained by bronchoalveolar
lavage of healthy volunteers to heat-killed A. fumigatus spores and silica particles
of similar size (10 spores/macrophage). Spores were washed from culture plates
with 0.02% Tween 80 solution, heat-killed at 80 °C for 20 minutes, filtered,
centrifuged and washed twice with buffer. Heat-killed A. fumigatus spores that
had attached to alveolar macrophages were ingested more rapidly than silica
particles of similar size, 64 and 39%, respectively, within 30 minutes. The spores
induced production of superoxide anions (153).
Nessa et al exposed rat alveolar macrophages to heat-killed spores of A. fum-
igatus and Aspergillus candidus, and silica particles of similar size (10 spores/
macrophage). Spores were washed from culture plates with 0.02% Tween 80
solution, heat-killed at 80 °C for 20 minutes, filtered, centrifuged and washed
twice with buffer. Heat-killed A. fumigatus and A. candidus spores that had
attached to alveolar macrophages were ingested more rapidly than silica particles
of similar size, 75, 74 and 33%, respectively, within 30 minutes. The spores
induced production of superoxide anions after 1 hour, which level declined to
ca 50% after 24 hours (152).
Nielsen et al (157) examined the metabolic profiles of 20 Stachybotrys sp.
strains studied by Ruotsolainen et al (206). All 11 strains producing the tricho-
thecenes satratoxin G and H were cytotoxic to the mouse macrophage RAW264.7
cell line, but only 1 of the 9 strains that did not produce these toxins. Seven of the
strains that did not contain satratoxins induced IL-6 and TNFα production but
none of the satratoxin containing strains (157).
Penttinen et al exposed the mouse RAW264.7 macrophage cell line to spores
of Stachybotrys chartarum (mycotoxin production not specified; 0.002-0.5
spores/cell) and Streptomyces californicus spores (0.008-3 spores/cell) either
alone, together in a ratio of 1:5 (0.01-3 spores/cell) or spores from a co-culture
(same ratio and spore dose/cell). Spores were collected with a sterile loop and
suspended in Hank’s balanced salt solution containing 0.0001% Triton X-100.
S. californicus alone and in combination with S. chartarum were cytotoxic,
induced IL-6, MIP-2, nitrite and cell cycle arrest in the macrophages. S. charta-
rum alone and in combination with S. californicus induced apoptosis in the
macrophages. Only co-cultured spores increased caspase-3 enzyme activity
significantly. The effect of co-cultured spores compared to mixed spores was
stronger on apoptosis, cell-cycle arrest, and caspase-3 enzyme activity but weaker
on nitrite production (176).
Pylkkänen et al exposed the mouse macrophage cell line RAW264.7 to viable
and heat-killed spores of Aspergillus fumigatus (0.001-1 spores/cell). Spores were
harvested with a sterile loop and suspended in Hank’s balanced salt solution
containing 0.0001% Triton X-100. Spores were used directly or were killed by
autoclaving at 120 °C for 20 minutes. Exposure to viable spores showed upregu-
lation of TNFα mRNA and MCP-1 mRNA but TNFα and MCP-1 did not
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increase. MIP-1α mRNA and MIP-1β mRNA increased but no response was
observed for IL-6 mRNA, IL-1β mRNA or IL-6. The heat-killed spores did not
produce any of these responses. After both 2 and 6 hours, 50% of the macrophages
had phagocitised spores, and viable and heat-killed spores had been phagocitised
to the same extent (182).
Robertson et al exposed human circulatory monocytes and PMN to opsonised
spores of A. fumigatus and Penicillium ochrochloron (0.5 spores/cell). Spores
were suspended in Hanks’ balanced salt solution, homogenised, filtered, op-
sonised with autologous serum, centrifuged and washed. Most spores were
associated with phagocytes after 1 hour (88% and 78% respectively). A large
proportion of the P. ochrochloron spores were phagocytised but spores of
A. fumigatus were to a large extend attached to the cell surface of the phagocytic
cells (qualitative SEM data) (199).
Roponen et al exposed the mouse macrophage cell line RAW264.7 to spores of
Streptomyces anulatus from cultures grown on sterilised and unsterilised concrete,
plaster board and mineral wool (1 spore/cell). Spores were collected with sterile
swabs and suspended in phosphate-buffered saline. The nitrite, TNFα and IL-6
responses as well as cytotoxicity depended on the substrates that the fungi were
grown on, and sterilised plasterboard showed the strongest responses (204).
Ruotsalainen et al exposed human blood PMN to graded doses (1-100/cell)
of viable spores of fungi isolated from common indoor air; Aspergillus sp.,
Penicillium sp., Cladosporium sp., Paecilomyces sp., Stachybotrys sp. and two
Streptomyces spp., as well as Candida sp. cells. Spores were suspended in
phosphate-buffered saline containing 0.0001% Triton X-100, opsonised with
human AB serum, centrifuged, and washed twice in the same solution. They
found positive dose response associations between ROS production and spores of
Penicillium sp., Candida sp. and Streptomyces spp., ∩-shaped associations with
Aspergillus sp. and Cladosporium sp., no response in Paecilomyces sp. and a
negative association in Stachybotrys sp. Opsonisation of the spores and cells
was essential for the response (207).
Ruotsalainen et al exposed mouse macrophage cell line RAW264.7 to graded
doses of spores of 21 strains of Stachybotrys sp. (0.01-1 spore/cell) isolated from
mouldy buildings. Spores were harvested by adding phosphate-buffered saline
containing 0.0001% Triton X-100 to culture plates. They found no induction
of iNOS or production of NO. Only 3 strains induced ROS in a dose-response
manner, while 7 other strains induced TNFα and IL-6. The latter strains were less
cytotoxic than the remaining isolates (206).
Shahan et al exposed bronchoalveolar lavage cells from Guinea pigs to spores
from A. candidus A. fumigatus, A. niger, A. terreus, Eurotium amstelodami,
Cladoporium cladoporoides and Penicillium spinulosum (2⋅10-6-200 spores/
macrophage). Spores were suspended in Hank’s balanced salt solution containing
0.01% Tween 80, vortexed, filtered and washed five times in Hank’s balanced salt
solution using centrifugation. Spores were killed by autoclaving in phosphate-
buffered saline at 121 °C for 30 minutes. Minor differences were detected
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between superoxide anion production by viable and killed spores. The responses
were similar to all species except E. amstelodami, which induced a 2-3 times
lower response than the other species (218).
Shahan et al exposed rat alveolar macrophages to spores of A. fumigatus,
A. niger, A. terreus, A. candidus, E. amstelodami, P. spinulosum, and C. clado-
sporoides (100 spores/macrophage). Spores were killed by autoclaving in
phosphate-buffered saline at 121 °C for 30 minutes and washed five times with
phosphate-buffered saline. No further details on spore collection and treatment
were given. A. fumigatus produced a strong TNFα response and MIP-1 mRNA
was upregulated, which was not observed for the other species. Expression
of mRNA to the cytokines MIP-2 and KC was upregulated by A. fumigatus,
A. candidus, A. niger and E. amstelodami of which A. fumigatus, and A. candidus
induced the strongest response, while no response was detected after exposure to
A. terreus and P. spinulosum (219).
Shahan et al exposed rat alveolar macrophages to spores of A. niger, A. candi-
dus, and E. amstelodami (10 spores/macrophage). Spores were collected with
a sterile loop, suspended in phosphate-buffered saline containing 0.1% Tween
80, homogenised, filtered, centrifuged and washed, killed by autoclaving in
phosphate-buffered saline at 121 °C for 30 minutes and washed five times with
phosphate-buffered saline. Production of ROS was highest after exposure to
A. candidus, intermediate after exposure to A. niger, and E. amstelodami induced
ROS at similar levels as latex particles. The ROS response correlated with
tyrosine kinase activation in the rat alveolar macrophage. It was also shown that
the tyrosine kinase response was primarily dependent on endogenous ROS in rat
alveolar macrophages (220).
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Appendix 6. Epidemiological studies of highly exposed
populations
Alwis et al performed a cross-sectional study of joinery (n=82) and sawmill/chip
mill workers (n=108) from 12 work sites. Exposure to mould spores, dust, Gram-
negative bacteria, endotoxins and glucans was measured by personal sampling
and culture of the microorganisms (n=5-15/site, total 114 measurements). Mean
exposure levels to fungi ranged from 3⋅103-7⋅104 cfu/m3 with an arithmetic mean
of 3⋅104 cfu/m3 for the combined populations, 4⋅104 cfu/m3 in the saw/chip mills
and 1⋅104 cfu/m3 in the joineries. Penicillium sp. (mean frequency 54%) and
Aspergillus sp. (mean frequency 17%, mainly A. fumigatus) dominated. Asso-
ciations between respiratory symptoms and exposures were adjusted for age and
smoking but not for other exposures. Only fungal exposure was associated with
breathlessness (OR 4.8, 95% CI 1.4-17) in sawmill/chip mill workers. Throat
irritation in all wood workers (OR 1.6, 95% CI 1.2-2.1) and phlegm in joinery
workers (OR 2.0, 95% CI 1.0-3.9) were associated with fungal exposure. These
symptoms were also associated with endotoxins (OR 1.5, 95% CI 1.1-2.1 and OR
1.8, 95% CI 1.1-2.9, respectively). The associations with fungi were not likely due
to confounding as the endotoxin exposure was only moderately correlated with
fungal exposure (r=0.46-0.50). Exposure to fungi was also significantly associated
with wheezing (OR 1.4, 95% CI 1.0-2.0 in all workers), bronchitis (OR 3.0, 95%
CI 1.3-6.6 in joinery workers and OR 2.9, 95% CI 1.1-7.2 in saw/chip mill
workers), and ear inflammation (OR 13, 95% CI 5.8-190 in saw mill workers
and OR 2.7, 95% CI 1.5-4.9 in all wood workers). The associations with glucan
exposure were stronger, however, and the associations with fungi may be due to
the strong correlation (r=0.76-0.86) between glucan and fungal exposure. How-
ever, the associations with glucan may also reflect fungal exposure because
glucans are a structural component of fungi (6).
Ávila and Lacey performed a cross-sectional study of 648 workers in two cork
factories exposed to mould spores, mainly from Penicillium glabrum (72-97%
of the spores), and cork dust. Mean exposure levels of workers in different
departments ranged from 1⋅106-7⋅107 spores/m3 (number of samples unknown)
measured by light microscopy and personal sampling. It was not uncommon
that workers changed jobs during their employment in the plant. X-ray showed
reticulo-nodular changes in 57% of the workers, which were correlated with the
current exposure level in non-smokers but not with the number of exposed years.
Spirometry concluded with an “obstructive effect” in 12% and a “restrictive
effect” in 29% (no measurement data). Pulmonary restriction was correlated with
duration of exposure (0 - >30 years) but not with the current exposure level. A
total of 26 patients with hypersensitivity pneumonitis were diagnosed (9).
Coenen et al studied 72 waste collectors in a cross-sectional study exposed to
bacteria, endotoxins, and culturable fungi (n not given, <4⋅102-3⋅105 cfu/m3 of
which 102-5⋅104 cfu/m3 of Aspergillus fumigatus). Exposure was estimated by a
job exposure matrix based on measurements carried out during health monitoring
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and was dichotomised at 1⋅105 cfu/m3 of total fungi and 2⋅103 cfu/m3 of A. fumi-
gatus. Peak expiratory flow variability was measured during two weeks and was
significantly increased in workers with the highest exposure to A. fumigatus. The
prevalences of chronic bronchitis and productive cough (no further information on
questions) were also associated with exposure to A. fumigatus. No confounder
adjustments were applied, however (31).
Dahlquist et al studied 28 wood trimmers in one sawmill during a work week.
Exposure was measured by personal sampling (n=28) and analysis of dust
(median 0.3 mg/m3), terpenes (median 10 ppm), bacteria (median 4⋅102 cfu/m3
and 1⋅105 cells/m3), endotoxins (median 20 EU/m3) and fungi by culture (median
3⋅103 cfu/m3) and by SEM (median 1⋅105 spores/m3). No significant changes in
lung function were observed, but decreases in FEV1 and MEF25 over the work
week correlated with exposure levels. No adjustments were made for confounders
(38).
Eduard et al studied 107 wood trimmers in 10 sawmills in a cross-sectional
study. Exposure to mould spores (arithmetic mean 4⋅106 spores/m3 of which 42%
Rhizopus microsporus), and wood dust were measured during 2-4 weeks in each
sawmill (ntotal=148). Respiratory symptoms were recorded by a general question-
naire. Associations between symptoms and exposure to all agents were studied by
logistic regression using mean exposure levels within each sawmill and adjust-
ments for age, smoking, hay fever and part-time farm work. Morning cough as
well as work-related cough, sore throat and nasal obstruction were most strongly
associated with mould spore exposure, and work-related chest tightness with
R. microsporus spore and wood dust exposure. Exposure levels predicting an OR
of 1.5 were approximately 2⋅106 spores/m3 for all associations. The associations
between work-related symptoms and mould spore exposure may be positively
biased due to wordings in the questionnaire, however (54).
Eduard et al studied 89 farmers and spouses in a cross-sectional study. Expo-
sure was measured by personal sampling when the farmers carried out exposed
farm work, and current work-related respiratory and eye symptoms were recorded
by a questionnaire after the measurement was completed. Exposure to dust,
bacteria, fungi (mean 1⋅106 spores/m3, calculated to equal an 8-hour exposure)
endotoxins, glucans, Aspergillus/Penicllium antigens, organic dust, inorganic
dust, silica, ammonia, hydrogen sulphide, and nitrogen dioxide were measured.
Associations were adjusted for age, smoking, and gender, but not for atopy.
Cough (OR 3.9, 95% CI 1.0-15) and eye irritation (OR 8.3, 95% CI 1.0-70) were
significantly elevated after exposure to 5⋅105-2⋅107 fungal spores/m3 and 2⋅104-
5⋅105 fungal spores/m3, respectively. These symptoms were not associated with
exposure to other agents. Nasal symptoms were significantly associated with
endotoxin, dust, silica, and fungal spores (exposure level 5⋅105-2⋅107 fungal
spores/m3, OR 6.0, 95% CI 1.3-28), of which the latter two agents were equally
strong predictors. The correlation between fungal spores and silica exposure
was not very strong, rPearson<0.6, indicating that both agents may induce nasal
symptoms (49).
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Eduard et al studied 1 614 farmers and spouses in a cross-sectional study.
Annual time weighted average exposure levels were computed from task
participation, mean exposure levels, and mean duration of exposed tasks. Expo-
sure of these tasks was measured by personal sampling and analysis of dust,
bacteria, mould spores, endotoxins, and ammonia. Current physician diagnosed
asthma was recorded by questionnaire and a positive Phadiatope test in serum
(RAST to 10 respiratory allergens) was used as criterion for atopy. Associations
between all exposures and asthma were studied in atopic and non-atopic indivi-
duals separately by logistic regression using exposure levels categorised in tertiles
and adjustments for age, smoking, gender, and asthma in the family. Exposure to
endotoxins, fungi (4⋅106-4⋅107 spores/m3), and ammonia were positively correlated
with asthma in non-atopic farmers (OR 1.7, 95% CI 1.0-2.7) and negatively with
asthma in atopic farmers (OR 0.28, 95% CI 0.10-0.78). The associations with
fungal spores were stronger than with the other agents except ammonia, which
was of approximately equal strength in the association in non-atopic farmers.
Ammonia exposure at the observed level (geometric mean 4 ppm) as a cause of
asthma is not biologically plausible, however (50).
Hansen et al studied 951 waste collectors and 423 park workers (reference
group) in a cross-sectional study. Respiratory symptoms were recorded by a
general questionnaire. The waste collectors’ exposure to culturable and countable
fungal spores was measured by culture-based and microscopical methods and
further estimated by a quantitative job exposure matrix. The waste collectors were
categorised in low and high exposed groups divided by a cutpoint at 1.5⋅105
cfu/m3 (3⋅105 spores/m3). The groups were of very different size, n= 915 and 36,
and n=917 and 34, respectively. The exposure of the reference group was assumed
to be low, but no exposure information was available. Only chronic bronchitis was
significantly elevated among waste collectors compared to the reference group.
Associations with fungal exposure were studied with a generalised linear model
adjusting for age, smoking, residential area, and exposure to inorganic dust,
organic dust, irritant gases, and fumes. The prevalence of chronic bronchitis was
significantly elevated in the low exposed waste collector group, PPR 1.9 (95% CI
1.0-3.6) for both culturable and countable fungal spores. The PPR increased
further in the highest exposed waste collectors to 2.7 (95% CI 3.6-11) and 2.5
(95% CI 0.6-11) for culturable and countable fungal spores, respectively. The first
confidence interval must be wrong because the lower confidence limit is higher
than the central measure. Assuming the same ratio between the central measure
and the lower confidence limit as between the higher confidence limit and the
central measure, the 95% CI becomes 0.7-11. The PPR is thus not significantly
different for the highest exposed group, which was probably due to the relative
small size of this group (73).
Hedenstierna et al studied 29 wood trimmers in 2 sawmills during a working
week. Lung function was measured before work on Monday and after work
on Thursday. Exposure to fungi was measured by personal sampling during all
shifts (median levels 1⋅104 cfu/m3 and 3⋅105 cfu/m3, respectively, n=105). In
non-smoking workers the FVC decline during the 4 days was correlated with
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the exposure levels. Similar associations were found for FVC and FEV1 in
% predicted measured on Thursday. No other confounder adjustments than
stratification on smoking habits and comparison to a reference population
(probably age and height) were done. The lung function had been measured 3
months earlier after the summer holiday and reductions in FVC and FEV1
were observed only in workers from the sawmill with the highest exposure. No
further changes were observed in neither of the group of sawmill workers 27
months after the first lung function measurements (76).
Heldal et al studied 31 municipal waste handlers in a cross-sectional study
of changes of inflammatory markers in nasal lavage and nasal dimensions by
acoustic rhinometry from Monday morning to Thursday morning before work.
Exposure was measured on the 3 days in between by personal sampling and
analysis of fungal spores (n=93; median 2⋅105 spores/m3), bacteria, actinomycetes
spores, endotoxins, and glucans. Thursday levels of neutrophils % and change in
neutrophils % were correlated with exposure to fungal spores but not with other
inflammatory cells, MPO, IL-8 and ECP. Nasal congestion was correlated both
with fungal spores and glucans, which are probably independent effects as these
exposures were weakly correlated. Possible confounding by smoking and age was
evaluated qualitatively (79).
Heldal et al studied 25 organic waste collectors in a cross-sectional study
of changes of inflammatory markers in induced sputum and spirometry from
Monday morning to Thursday morning before work. Work-related symptoms
were recorded daily. Exposure was measured on the 3 days in between by
personal sampling and analysis of fungal spores (n=75; median 2⋅105 spores/m3),
bacteria, actinomycetes spores, endotoxins, and glucans. No associations were
observed between fungal spore exposure and neutrophils %, other inflammatory
cells, IL-8 and ECP, and the work-related symptoms chest tightness, cough and
phlegm (80).
Heldal et al studied 22 household waste collectors from three different climatic
regions in a cross-sectional study of acute work-related symptoms. Exposure
was assessed by personal sampling and analysis of fungal spores (n=22; median
1⋅105 spores/m3), bacteria, endotoxins and dust. Workers reporting cough had
significantly higher exposure to fungal spores (median 3⋅105 spores/m3) than non-
symptomatic workers (median 6⋅104 spores/m3). Cough was not significantly
associated with other agents. Associations were also found between fungal spore
exposure and headache and unusual tiredness, but this could be due to confound-
ing by smoking and age, which was evaluated qualitatively (78).
Ivens et al studied 950 waste collectors and 387 outdoor municipal workers
(reference) in a cross-sectional study. Symptoms were recorded by a general
questionnaire. The doses of culturable fungi, countable fungal spores, and endo-
toxins inhaled by the waste collectors were estimated using a quantitative job
exposure matrix, information on task duration, and lung ventilation estimates. The
population was categorised in low, medium, and high exposed waste handlers by
cut points 1⋅106 and 1⋅107 cfu for culturable fungi, and 2⋅106 and 2⋅107 spores for
countable fungal spores, respectively. The groups were very different in size,
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n= 229, 711 and 10, and 69, 813 and 68, respectively. No exposure information
was available for the reference group. Diarrhoea was significantly elevated among
waste collectors compared to the reference group. The association with fungal
exposure was studied with a generalised linear model adjusting for smoking,
alcohol consumption and psychological demand and support. The symptom
prevalence was significantly elevated in the low exposed waste collectors, PPR
3.0, 95% CI 1.9-4.9 for culturable and PPR 3.5, 95% CI 1.9-6.4 for total fungi,
and increased further in a dose-response manner for culturable fungi in the
medium and high exposed waste collectors. Similar associations were observed
for endotoxins, but no adjustments for exposure to other agents were studied (97).
Johard et al studied 19 non-smoking wood trimmers in one sawmill and a non-
smoking control group (n=25) not occupationally exposed to fungi by broncho-
alveolar lavage and lung function measurements. Exposure to fungi (median 105
spores/m3) and bacteria was assessed by personal sampling (n=16). No significant
changes in lung function were observed compared to 19 non-smoking controls.
Cell counts in bronchoalveolar lavage were not different, but albumin, fibronectin,
and hyaluronan were significantly higher in the sawmill workers indicating low
intensity alveolar inflammation (100).
Malmberg et al studied 32 dairy farmers with febrile episodes, which had been
selected from a population of approximately 6 800 Swedish farmers. Medical
examinations confirmed a diagnosis of hypersensitivity pneumonitis (n=11) or
ODTS (n=17). After episodes that induced fever attacks exposure was measured
by repeating the task using the same materials. Personal samples were collected
and spores of actinomycetes and moulds were counted by fluorescence micro-
scopy and identified by culture. Farmers with diagnosed hypersensitivity
pneumonitis had been exposed to 3⋅109 spores/m3 (n=4, mean, range (4⋅108-4⋅109
spores/m3) and had performed work that lasted 15-30 minutes, 1-2 times/day and
the work had been done for several weeks. Farmers with diagnosed ODTS had
been exposed to 14⋅109 spores/m3 (n=6, mean, range 3⋅109-20⋅1010 spores/m3) and
had performed work that lasted on average 60 minutes, during 1-2 days and the
work was unusual, typically removal of spontaneously heated grain. The species
composition was variable and included species of Aspergillus, Penicillium,
Rhizomucor, Wallemia and Streptomyces but none of the species dominated. The
proportion of actinomycetes varied from <1 to 96%. Exposure of tasks with
highest expected exposure was also measured in a reference group of non-
symptomatic farmers. These levels were 1⋅108 spores/m3 (n=17, mean, range
5⋅106-6⋅108 spores/m3). Endotoxin exposure of symptomatic and non-symptomatic
farmers was similar (129, 130).
Monsó et al studied 39 greenhouse workers in a cross-sectional study of wheeze
(31%) and asthma attacks (8%) during the last year. Sensitisation to moulds by
skin prick testing was found in 7 workers (18%). Exposure to endotoxins, bac-
teria, and moulds (n=39; median 5⋅103 cfu/m3) was measured. No associations
were found with these outcomes (141).
Roponen et al studied 11 sawmill workers with nasal lavage after a work shift
and during vacation (time after the last workday not given). Exposure to endo-
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toxins, terpenes, and moulds (n=10; median 6⋅105 spores/m3, mainly Rhizopus and
Penicillium) was measured. Nasal lavage samples were analysed for NO, TNFα,
IL-4, IL-5, and IL-6. No differences were observed between nasal lavage after
work and during vacation, and no associations were found with fungal spore
exposure (202).
Wenzel and Emanuel examined 37 workers involved in debarking and chipping
of timber in a papermill. Exposure to fungal spores was measured by stationary
sampling and analysis by microscopy. Most particles were spores of Cryptostroma
corticale, which were recognised by ovoid shape, size 4-5 µm and red-brown
colour. Five workers developed severe clinical disease that was confirmed by lung
biopsies showing interstitial pneumonitis and granuloma formation. All workers
were examined 5 times during a 2.5-year period and 15 workers had X-ray
changes on at least one occasion. Disease was initiated in the winter. During this
period exposures were also the highest with a mean level of 1.3⋅105 spores. The
mean exposure during the whole 1.5-year period was 4⋅104 spores (n=35).
Concentration units were not given in the paper (and personal communication
with the corresponding author did not provide the information), but levels are
more likely to be spore counts per ft3 as the study was performed in 1962 and
published in 1967. If so, the mean exposure level is calculated to be 1⋅106
spores/m3 during the whole study, and 5⋅106 spores/m3 during the winter (243).
Zhang et al studied 130 Chinese tobacco workers and 112 controls in a cross-
sectional study. Dust exposure was high (mean 14 to 30 mg/m3 in different
departments). Fungi were measured by sedimentation on culture plates. Specific
IgE and positive skin prick tests to Aspergillus fumigatus were increased, 27% and
19%, respectively, and to Rhizopus nigricans, 52% and 24%. These fungi were
also frequently detected on the sedimentation plates (260).
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Appendix 7. Epidemiological studies of populations exposed to
common indoor air levels
Hirvonen et al studied 32 staff members working in a mould contaminated school
and 8 or 25 healthy controls (specified numbers inconsistent) from a research
institute. Nasal lavage was performed after spring term, vacation, and autumn
term in school staff. Culturable fungi (n not given, range 7 to 100 cfu/m3) were
measured in the school at the end of the autumn term. NO, IL-6, respiratory and
systemic symptoms were higher in school staff after spring term and autimn term
compared to after vacation and control subjects. TNFα was elevated only after the
spring term. The findings cannot be associated to exposure levels because no
measurements were performed after vacation or in the environment of the control
subjects (83).
Li et al studied 264 day-care workers from 28 randomly selected day-care
centres in Taiwan. Culturable fungi were measured indoors and outdoors, and
house dust mite allergens in settled dust. Indoor and outdoor levels of culturable
fungi were similar (n not given, geometric means 1 200 cfu/m3 and 1 000 cfu/m3,
respectively). Cladosporium and Penicillium dominated with Penicillium levels
higher indoors and Cladosporium higher outdoors. Other prevalent fungi were
Aspergillus and yeasts. Associations were found between Aspergillus levels
(geometric mean 32 cfu/m3) and nasal congestion, cough, phlegm, lethargy, and
fatigue. Significant associations were also found between total culturable fungi
and nasal congestion and nasal discharge, and these associations were stronger
than for Aspergillus. Associations were adjusted for age, gender, and education
(124).
Menzies et al studied 107 office workers with work-related respiratory symp-
toms and 107 office workers without symptoms from 6 mechanically ventilated
office buildings in Quebec. The non-symptomatic workers were matched on age,
gender, and presence of atopic disease. Airborne culturable fungi were measured
with a Burkhard personal impactor in the offices in heating, ventilating, and
air conditioning systems (HVAC) and office air. However, this sampler is not
suitable for the culture-based measurements that were reported. Fungi and house
dust mite allergens were measured in floor dust. The mean Alternaria levels were
0.3 and 1 cfu/m3 in offices of non-symptomatic and symptomatic workers, respec-
tively, but no data on other species or total fungi were given or on the number
of collected samples. Work-related respiratory symptoms were associated with
Alternaria exposure with OR 4.2 (95% CI 1.1-16) 1-7 cfu/m3 compared to the
reference group where Alternaria was not detected, after adjustments for smoking,
house dust mite allergen and difference between absolute indoor and outdoor
water content (134).
Purokivi et al studied 37 employees working in a school building with moisture
problems and mould growth and 23 employees from a school without such prob-
lems in Finland. Culturable moulds were measured during the winter, n=17 and
18, geometric mean 29 and 6 cfu/m3 in the moisture-damaged and control schools,
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respectively. Respiratory and eye symptoms were recorded and nasal lavage and
induced sputum samples were analysed for inflammatory cytokines and cells.
Higher levels of IL-1 and IL-4 were found in nasal lavage and of IL-6
in induced sputum at the end of the spring term in employees from the school
with moisture problems compared to employees from the control school. This
was incorrectly claimed for IL-6 and TNFα in nasal lavage in the summary.
Differential cell counts were similar except for elevated eosinophil counts in
atopic employees at the water-damaged school after the summer holiday. Symp-
tom prevalences were not significantly different. Influence of confounders was
assessed by separate analyses in employees with and without atopy. There were
several inconsistencies in the presentation and summaries of the results, however.
Differences were observed compared to biological samples collected after
vacations, but these results are difficult to interpret in terms of exposure levels
(181).
Roponen et al studied 41 randomly selected teachers in Finland. Culturable
fungi and bacteria were measured by personal sampling during 24 hours at home
and 8 hours at work. Nasal, eye, throat, lower airways and non-specific symptoms
during the last week were recorded, nasal lavage samples were analysed for
inflammatory cytokines and the combined particle mass was extracted and tested
with the mouse RAW264.7 macrophage cell line for cytokine production and cell
viability. The subjects were divided in groups with low (median 12 cfu/m3, range
0-31 cfu/m3) and high exposure to fungi (median 67 cfu/m3, range 31-270 cfu/m3).
The study was repeated two weeks later to study intra-subject variability. Symp-
tom prevalences and the levels of NO, IL-4, IL-6 and TNFα in nasal lavage were
similar in both exposure groups. IL-1β was elevated in the high exposure group
but not significantly. Influence of confounders was assessed by separate analyses
in smoking and asthma status subgroups. IL-1β and IL-6 were significantly
elevated in the mouse macrophage assay, but not TNFα and cell viability. Intra-
individual variability of the cytokines in the nasal lavages and mouse macrophage
tests was relatively low. However, the correlations between determinations of IL-
1β, IL-6 and TNFα by these tests were also low (203).
Seuri et al described a cluster of asthma and rhinitis in a small population of 14
employees from a hospital with a history of water damage. The population was
tested with bronchial provocation with histamine and a Sporobolomyces salmoni-
color antigen extract, nasal provocation and skin prick tests with the S. salmoni-
color antigen, skin prick tests with common respiratory allergens, and serum-IgG
to fungi typically found in water-damaged buildings. Exposure to fungi was
measured once by stationary sampling on 10 locations, and exceeded 500 cfu/m3
at three locations with a maximum of 1 400 cfu/m3. About half of the colonies
were S. salmonicolor. Exposure levels had probably been higher as a floor had
been repaired because of water damage a year earlier. Asthma was diagnosed by a
doubling of the airway resistance after inhalation of aerosolised S. salmonicolor
extract as an immediate response, or a 15% fall in peak flow during follow-up
as a late response. A positive nasal provocation was diagnosed by distinct watery
discharge from the nostril where the extract had been applied. Four cases of
142
asthma (6 employees were tested) and eleven cases of rhinitis (14 employees
tested) were diagnosed. The response was probably not IgE-mediated as skin
prick tests with the same antigen were negative. Serum IgG antibodies to this
(8 of 13 employees) and several other fungi typical in water-damaged buildings
(11 of 13) were found (217).
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Appendix 8. Human challenge studies using spores
Cox et al challenged 4 mushroom workers with hypersensitivity pneumonitis
to Pleurotus ostreatus to an aerosol of a spore suspension for 10 minutes. The
workers inhaled a dose of 0.65 mg spores, which is approximately 107 spores, and
developed fever, chills, muscle pain, dyspnoea, leukocytosis and FVC decreases
6-8 hours after the challenge. X-ray changes were negative (35).
Cox et al challenged 5 mushroom workers with hypersensitivity pneumonitis to
Lentinus edodes to an aerosol of a spore suspension for 10 minutes. The workers
inhaled a dose of 0.5 mg spores, which is approximately 3⋅107 spores and deve-
loped fever, chills, muscle pain, dyspnoea, leukocytosis and FVC decreases 6
hours after the challenge. One patient developed decreased TLco and decreased
PaO2. X-ray changes were negative (36).
Licorish et al challenged 7 mild asthmatic patients with whole spores of Alter-
naria alternata and a Penicillium isolate that were inhaled mixed with lactose
(≤1:200 weight ratio spores:lactose) by means of a Spinhaler. Doses of 1 ⋅105-4⋅105
A. alternata spores were sufficient to induce a 35% drop in specific airway
conductance in 4 sensitised patients. The doses that induced the same effect in 2
patients sensitised to Penicillium were more variable, 4⋅104 and 5⋅107 Penicillium
spores, and one patient did not respond at all. The latter patient had a weak
positive skin prick test to the used antigen, however. After bronchial challenge
with spore extracts only immediate reactions were observed whereas both
immediate and late asthma attacks were provoked after bronchial challenge with
whole spores (125).
Meyer et al exposed 8 employees with building-related symptoms from mould-
damaged schools for 6 minutes to aerosols of Penicillium chrysogenum and
Trichoderma harzianum liberated from cultures grown on gypsum boards, and
placebo on different days. The selected participants had positive P. chrysogenum
and negative T. harzianum histamine-release tests, but skin prick tests to the same
moulds were negative. Spore concentrations were approximately 6⋅105 spores/m3
and 3⋅105 spores/m3 of P. chrysogenum and T. harzianum, respectively. Symptoms
(nasal and throat irritation, nasal congestion and headache), lung function, and
leukocytes in blood were recorded. The challenges were performed double blind.
Small but significant changes were observed after challenge compared to before
challenge, but the responses were similar to placebo exposure (135).
Riddle et al challenged a malt worker with hypersensitivity pneumonitis to
a spore extract and dry spores of Aspergillus clavatus and to dry spores of
Penicillium brefeldianum. The workers inhaled a dose of 20 mg of dry spores
of both species which equals approximately 109 spores of A. clavatus (spore size
of P. brefeldianum not found) and developed fever, shortness of breath, nausea,
sweating, headache and aching trunk and limbs and FVC decreases 3-6 hours after
the challenge to A. clavatus. Arterial oxygen tension (PaO2) and lung transfer
factor for carbon monoxide (TLco, measure of gas diffusion) were also decreased,
neutrophils increased and eosinophils were unchanged. The symptoms were
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similar to those experienced at work and the decreased FVC lasted one week.
Challenge with A. clavatus extract or P. brefeldianum spores resulted only in
minor changes (198).
Sigsgaard et al exposed 5 garbage-recycling workers without symptoms and
5 retired garbage workers with occupational asthma intranasally to Aspergillus
fumigatus spores, 10 mg suspended in 10 ml of water for 15 minutes. No changes
in the inflammatory cytokines (TNFα, IL-1β, IL-6 and IL-8) and cells or nasal
volume were observed until 11 hours after the challenge (223).
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Appendix 9. Maximum allowable concentrations of fungi and
actinomycetes issued in the Russian Federation
Translated from Russian by Dr Natalia Romanova (Northwest Public Health Research
Centre, St. Petersburg, Russia).
Microorganism Maximum allowable
concentration, cfu/m3
Hazard classa Allergenicity
Fungi
Acremonium chrysogenum 5⋅103 III +
Ampelomyces quisqualis    104 III
Blakeslea trispora    104 III +
Candida scotti    103 II
Candida tropicalis    103 II
Candida utilis    103 II
Candida valida    103 II
Cryptococcus laurentii var. magnus 0.5 mg/m3 II +
Fusidium coccineum 5⋅103 III
Penicillium canescens 2⋅103 III
Saccharomyces cerevisae 0.5 mg/m3 II +
Actinomycetes
Actinomyces roseolus    103 II
Streptomyces aureofaciens 5⋅103 III +
Streptomyces erythreus 3⋅103 III +
Streptomyces lactis    104 III
Streptomyces kanemyceticus 5⋅103 III +
Streptomyces rimosus 3⋅103 III +
a No information provided on the hazard classification.
